DOI	Title	Authors	Abstract	Journal	Date
10.1111/ppe.12615	acetaminophen use pregnancy risk attention deficit hyperactivity disorder causal association bias	Masarwa R; Platt RW; Filion KB	background association acetaminophen use pregnancy development attention deficit hyperactivity disorder adhd offspring may be due to bias objective primary objective wa to assess role potential unmeasured confounding estimation association acetaminophen use pregnancy risk adhd bias analysis secondary objective wa to assess role selection bias exposure misclassification data source searched medline embase scopus cochrane library up to december study selection data extraction included observational study examining association acetaminophen use pregnancy risk adhd synthesis data study using model conducted bias analysis to study that did not adjust important confounders to explore systematic error related to unmeasured confounding selection bias exposure misclassification result search resulted seven study included when adjusted estimate were pooled study risk ratio rr adhd wa confidence interval ci sensitivity analysis unmeasured confounding showed confounder rr scale would reduce to proportion study true effect size rr gt unmeasured confounding bias analysis decreased point estimate five seven study increased two study suggesting observed association could be confounded parental adhd unadjusted risk ratio bcrrs were rr bcrr rr bcrr rr bcrr rr bcrr rr bcrr rr bcrr rr bcrr conclusion bias analysis suggests previously reported association acetaminophen use pregnancy increased risk adhd offspring may be due to unmeasured confounding ability to conclude causal association is limited	Paediatr Perinat Epidemiol	01/05/2020
10.1038/s41586-025-09574-y	is required maintaining mesenchymal cell fate pancreatic cancer	Li H; Lan L; Chen H; Zaw Thin M; Ps H; Nelson JK; Evans IM; Ruiz EJ; Cheng R; Tran L; Allen M; Ma J; Yi T; Wang C; He Y; Guppy N; Sadanandam A; Lin SZ; Zhang C; Behrens A	elucidating complex network communication tumour cell is central to understanding cell fate decision progression pancreatic ductal adenocarcinoma pdac previously showed constant suppression bmp activity bmp antagonist secreted mesenchymal pdac cell is essential maintaining fate epithelial pdac cell here identify also known osteopontin key regulator mesenchymal cell fate pancreatic cancer proteomic analysis plasma patient pdac showed is substantially upregulated disease inactivation led to delay tumorigenesis mouse pdac model abolished metastasis formation wa expressed epithelial pdac cell inactivation resulted conversion mesenchymal to epithelial pdac cell mechanistically receptor mesenchymal pdac cell to induce expression inhibition bmp signalling wa required expression epithelial cell thereby forming intercellular regulatory loop concomitant inactivation reverted epithelial phenotype knockout to fully mesenchymal pdac conversely heterozygosity combined knockout resulted pdac histology result that confirmed direct antagonistic function factor hence mesenchymal epithelial pdac cell fate are determined reciprocal paracrine regulation soluble factor	Nature	24/09/2025
10.1038/s42255-025-01379-7	cholesterol metabolic reprogramming mediates chronic neuroinflammation hinders neurorestoration following stroke	Zhao Q; Li J; Feng J; Wang X; Liu Y; Wang F; Liu L; Jin B; Lin M; Wang YC; Guo X; Chen J; Hao J	chronic neuroinflammation is major obstacle to recovery underlying mechanism particularly link prolonged microglial activation cholesterol metabolism are not fully known here show ischaemic injury induces persistent microglial activation that perpetuates chronic inflammation leading to microglial cholesterol accumulation metabolic reprogramming using rna sequencing identified distinct foamy microglia cluster characterized extensive reprogramming cholesterol metabolism furthermore direct intracerebral free cholesterol cholesterol crystal infusion recapitulated sustained microglial activation directly linking aberrant cholesterol metabolism to prolonged neuroinflammatory response therapeutically demonstrate reducing microglial cholesterol overload genetic pharmacological activation male mouse promotes white matter repair functional recovery finding highlight microglial cholesterol metabolism key driver inflammation offering therapeutic strategy targeting cholesterol metabolism to mitigate brain damage promote neurorestoration potentially improving disability outcome	Nat Metab	23/09/2025
10.1186/s12933-025-02921-3	association index combined body shape index cardiovascular mortality individual syndrome stage finding two prospective cohort	Chen M; Guo J; Shangguan Y; Sun Z; He X; Tu Q; Yan Q	background tyg index measure insulin resistance ha been confirmed to be associated adverse clinical outcome new composite indicator body type index integrating tyg index body type index ha demonstrated superior efficacy predicting risk cardiovascular death general population compared to traditional indicator study aim to deeply explore association mortality cvd mortality population cardiovascular syndrome ckm stage analysis will be conducted multiple dimension such intensity indicator correlation potential influencing mechanism order to comprehensively reveal relationship two result analyzed data participant nhanes cohort using cox proportional hazard model restricted cubic spline function result indicated elevated value were independently associated higher risk mortality hr ci cardiovascular mortality hr ci receiver operating characteristic roc curve concordance index evaluation demonstrated yielded more accurate prognostic performance other metric area curve auc indicator reached prediction mortality risk year prediction cardiovascular mortality risk external validation using charls data confirmed robustness finding predicting mortality conclusion individual ckm stage demonstrates stronger association mortality risk superior predictive ability compared other metric performance suggests potential role capturing variation diverse clinical subgroup informing optimal timing preventive intervention	Cardiovasc Diabetol	23/09/2025
10.1016/S1474-4422(25)00270-4	diagnosis multiple sclerosis revision mcdonald criterion	Montalban X; Lebrun-Frénay C; Oh J; Arrambide G; Moccia M; Pia Amato M; Amezcua L; Banwell B; Bar-Or A; Barkhof F; Butzkueven H; Ciccarelli O; Chataway J; Cohen JA; Comi G; Correale J; Deisenhammer F; Filippi M; Fiol J; Freedman MS; Fujihara K; Granziera C; Green AJ; Hartung HP; Hellwig K; Kappos L; Kimbrough D; Killestein J; Lublin F; Marignier R; Ann Marrie R; Miller A; Otero-Romero S; Ontaneda D; Ramanathan S; Reich D; Rocca MA; Rovira À; Saidha S; Salter A; Sastre-Garriga J; Saylor D; Solomon AJ; Sormani MP; Stankoff B; Tintore M; Tremlett H; Van der Walt A; Viswanathan S; Wiendl H; Wildemann B; Yamout B; Zaratin P; Calabresi PA; Coetzee T; Thompson AJ	advance understanding multiple sclerosis development biomarkers pathophysiology prompted substantial revision mcdonald diagnostic criterion new mcdonald criterion provide unified approach diagnosing multiple sclerosis individual relapsing progressive course lifespan ie paediatric to presentation optic nerve can now serve fifth anatomical location cns diagnosis central vein sign paramagnetic rim lesion kappa chain concentration csf can be used when available to provide supportive evidence confer specificity diagnosis multiple sclerosis specific situation certain case radiologically isolated syndrome neurological symptom that do not constitute clear attack progression disability can fulfil criterion multiple sclerosis diagnosis also provide guidance diagnosis multiple sclerosis older individual year comorbidities revised criterion should expedite diagnosis multiple sclerosis maintaining specificity	Lancet Neurol	01/10/2025
10.3390/ijms21030969	precision psychiatry application pharmacogenomics artificial intelligence machine learning approach	Lin E; Lin CH; Lane HY	growing body evidence now suggests precision psychiatry interdisciplinary field psychiatry precision medicine pharmacogenomics serf indispensable foundation medical practice offering accurate medication accurate dose accurate time to patient psychiatric disorder light latest advancement artificial intelligence machine learning technique numerous biomarkers genetic locus associated psychiatric disease relevant treatment are being discovered precision psychiatry research employing neuroimaging review focus latest development precision psychiatry research using artificial intelligence machine learning approach such deep learning neural network algorithm together neuroimaging data firstly review precision psychiatry pharmacogenomics study that leverage various artificial intelligence machine learning technique to assess treatment prediction prognosis prediction diagnosis prediction detection potential biomarkers addition describe potential biomarkers genetic locus that have been discovered to be associated psychiatric disease relevant treatment moreover outline limitation regard to previous precision psychiatry pharmacogenomics study finally present discussion direction challenge future research	Int J Mol Sci	01/02/2020
10.1177/1060028015606469	association prenatal acetaminophen exposure future risk attention disorder child	Hoover RM; Hayes VA; Erramouspe J	objective to evaluate effect prenatal acetaminophen exposure future development attention disorder adhd child data source literature search medline to june international pharmaceutical abstract to june cochrane database publication june prospective clinical trial assessing relationship prenatal acetaminophen exposure development attention deficit disorder hyperactivity study selection data extraction study comparing maternal acetaminophen use pregnancy to development adhd behavior offspring age year data synthesis four study examining effect prenatal acetaminophen exposure subsequent adhd behavior were identified one early study found link to adhd behavior other study found statistically significant correlation most prominent being study finding higher risk using adhd medication hazard ratio ci having behavior age year determined strength difficulty questionnaire risk ratio ci child whose mother used acetaminophen pregnancy conclusion there doe appear to be mild correlation prenatal acetaminophen use development adhd symptom child current data do not provide sufficient evidence prenatal acetaminophen exposure lead to development adhd symptom late life acetaminophen is preferred option pain management pregnancy when compared other medication such nonsteroidal drug opioids pyretic pain relief	Ann Pharmacother	01/12/2015
10.1007/s10549-022-06562-y	feasibility using autologous breast cancer vaccine to induce immunity patient stage metastatic breast cancer	Anderson KS; Erick TK; Chen M; Daley H; Campbell M; Colson Y; Mihm M; Zakka LR; Hopper M; Barry W; Winer EP; Dranoff G; Overmoyer B	purpose antigenic target immunity role vaccination breast cancer are unknown performed phase study autologous breast cancer vaccine patient metastatic stage breast cancer method tumor cell patient metastatic stage disease were transduced adenoviral vector encoding then irradiated twelve seven patient metastatic stage disease respectively received weekly vaccination three week followed other week disease progression vaccine supply wa exhausted metastatic six total vaccine dos were administered stage result patient metastatic disease who received vaccination eight had progressive disease two month three had stable disease month one ha had evidence disease year patient stage disease five died metastatic disease year start vaccination median year two are alive september toxicity included injection site reaction fatigue fever upper respiratory symptom joint pain nausea edema four five evaluable patient metastatic disease developed skin reaction immune cell infiltration fifth injection unmodified irradiated tumor cell conclusion conclude tumor cell can be harvested patient metastatic stage breast cancer to prepare autologous vaccine that induce coordinated immune response limited toxicity trial registration date registration april april	Breast Cancer Res Treat	01/07/2022
10.1016/j.cmet.2025.08.009	glutamine competition tumor macrophage dictate immunotherapy efficacy breast cancer	Xiao Y （肖毅）; Xu Y （徐颖）; Wang H （王晗）; Yang F （杨帆）; Ding XH （丁晓洪）; Fu T （傅彤）; Chen L （陈力）; Jin X （金希）; Zhao YX （赵雅鑫）; Wang Y （王莹）; Chen F （陈芬芳）; Shao ZM （邵志敏）; Jiang YZ （江一舟）	immunotherapy demonstrates limited efficacy breast cancer tnbc influenced intricate metabolic interaction tumor microenvironment here developed rna sequencing immunotherapy cohort spatial transcriptomics cohort to elucidate metabolic crosstalk associated therapeutic efficacy tnbc illustrated heme binding protein high tumor cell featured active glutathione metabolism macrophage characterized oxidative metabolism indicated immunotherapy efficacy were quantitatively spatially negatively correlated glutamine cell type induced phenomenon mechanistically disrupted cytoplasmic phase separation promoting nuclear translocation to upregulate glutathione expression glutamine consumption tumor cell metabolic shift induced ferroptosis macrophage impairing antitumor immunity utilization inhibitor sensitized tnbc to immunotherapy collectively delineate metabolic checkpoint governed axis pioneer immunometabolism paradigm evaluating immunotherapeutic vulnerability	Cell Metab	23/09/2025
10.1007/s00421-010-1658-5	association basal serum bdnf cardiorespiratory fitness cardiovascular disease risk factor untrained healthy korean men	Jung SH; Kim J; Davis JM; Blair SN; Cho HC	evidence suggests serum neurotrophic factor serum bdnf can be affected cardiorespiratory fitness crf relationship is far clear recent report show inverse relationship serum bdnf crf healthy individual other study suggest possible association serum bdnf cardiovascular disease however possible interaction serum bdnf crf cardiovascular disease risk ha not been studied purpose study wa to examine association serum bdnf crf cardiovascular disease risk factor healthy men investigation involved large sample men age range year who live central area south korea were recruited preventive health study study showed significant inverse relationship serum bdnf relative vo max lt heart rate reserve lt serum bdnf wa positively correlated body mass index lt total cholesterol lt triglyceride lt data suggest serum bdnf may be associated effect increased crf cardiovascular disease however more research is clearly needed determination to what extent serum bdnf may be responsible health benefit associated crf	Eur J Appl Physiol	01/02/2011
10.4088/JCP.18m12612	prenatal exposure to acetaminophen risk disorder nationwide study taiwan	Chen MH; Pan TL; Wang PW; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Chen TJ; Bai YM	background study have suggested significant association exists prenatal exposure to acetaminophen offspring disorder adhd risk however association ha largely been unexplored asian population generally taiwanese population specifically method study study pair child adhd code mother control pair child adhd mother matched demographic characteristic were identified taiwan longitudinal health insurance database maternal use acetaminophen wa assessed first trimester second trimester third trimester pregnancy period month pregnancy to date last menstrual cycle result logistic regression analysis adjustment demographic data gestational infection comorbid perinatal condition maternal mental health disorder indicated exposure to acetaminophen second trimester odds ratio ci both first second trimester ci trimester ci wa associated increased risk adhd offspring sensitivity analysis excluding gestational infection maternal mental health disorder confirmed association ci conclusion prenatal exposure to acetaminophen wa associated increased risk adhd offspring regardless gestational infection maternal mental health disorder additional study are necessary to clarify underlying mechanism which prenatal exposure to acetaminophen lead to neurodevelopmental risk	J Clin Psychiatry	10/09/2019
10.1038/s41591-025-03937-8	cell systemic lupus erythematosus phase trial	Feng J; Huo D; Hong R; Jin X; Cao H; Shao M; Wen R; Zhang Q; Zhang M; Fu S; Wang D; Xu H; Wei G; Cui J; Huang S; Cui D; Chang AH; Liu Z; Lu L; Lin J; Hu Y; Huang H	systemic lupus erythematosus sle remains refractory to conventional immunosuppression subset patient sle show peripheral cell bone marrow plasma cell are dominant autoantibody source motivating dual bcma targeting here report result cohort patient female one male ongoing phase trial autologous chimeric antigen receptor car cell lymphodepletion primary endpoint were toxicity dlts day adverse event week key secondary endpoint comprised attainment lupus low disease activity state lldas doris remission week vivo persistence week exploratory endpoint were duration cell depletion time to recovery kinetics immune reconstitution longitudinal change autoantibody titer serum immunoglobulin concentration therapy median range dlts occurred grade cytokine release syndrome developed patient neurotoxicity death most common grade higher adverse event were neutropenia thrombocytopenia anemia which were reversible supportive care week patient fulfilled lldas doris remission criterion multiomic analysis confirmed elimination autoreactive clone reconstitution naive cell durable downregulation signature indicating improved immune homeostasis longitudinal monitoring three patient year demonstrated sustained eradication pathogenic clone suggesting potential cure dual cell therapy demonstrates good safety promising clinical efficacy sle study support further development treatment approach patient rsle identifier	Nat Med	24/09/2025
10.1136/gutjnl-2025-335642	alleviated cell exhaustion dictate chemoimmunotherapy efficacy oesophageal squamous cell carcinoma	Xiang S; Chen Y; Wang C; Wang M; He Y; Liu Z; Zhang JL; Yang LP; Wei YF; Wu QN; Wang ZX; Xi SY; Li Z; Zhao Q; Xu RH; Wang F	background combining chemotherapy cell death improves clinical outcome oesophageal squamous cell carcinoma escc yet underlying synergistic mechanism remains obscured moreover patient still derive therapeutic benefit combination strategy highlighting need to decipher overcome resistance objective sought to investigate mechanism which chemotherapy augments response to immune checkpoint blockade elucidate factor contributing to persistent resistance patient design designed systematic investigation involving longitudinal sampling escc tissue patient treated chemotherapy monotherapy tumour microenvironment tme wa then comprehensively characterised using transcriptomics cell receptor repertoire analysis multiplex immunohistochemistry murine model result demonstrated combination therapy exerted superior antitumour efficacy mitigating immune checkpoint engagement tumour cell cell thereby preventing cell exhaustion boosting vitality identified subset tumour cell high expression which localised tumour boundary interacted myofibroblastic fibroblast inducing extracellular tme that hindered infiltration cell inhibiting significantly enhanced efficacy chemotherapy underscoring potential therapeutic target conclusion study elucidates synergistic mechanism identifies key resistance pathway underlying combination patient escc providing scientific basis refining future combination therapeutic regimen	Gut	22/09/2025
10.1038/s41418-025-01587-4	lactylation promotes ferroptosis diabetic nephropathy	Hong J; Xu H; Yu L; Yu Z; Chen X; Meng Z; Zhu J; Li J; Zhu M	diabetic nephropathy dn is primary cause renal disease worldwide recent study have revealed histone lactylation which function novel epigenetic modification is involved occurrence development complication however little is known role lactyltransferase dn synthetase wa identified novel lactyltransferase that modulates histone lactylation present study determined participates pathogenesis dn more importantly explored potential mechanism involved mouse dn model consisting synthetase heterozygote mouse wa utilized study transcriptomic lipidomic analysis combined variety molecular biological methodology were employed to elucidate potential mechanism which regulates ferroptosis dn result indicated increase expression were involved kidney dysfunction renal cell death modulation ferroptosis dn model moreover induced lipid peroxidation increasing fatty acid transcription ultimately contributing to ferroptosis induction furthermore interacted signal transducer activator transcription to jointly regulate transcription additionally treatment inhibitor fludarabine delayed dn progression addition observed modulated lactylation to regulate transcription thus triggering ferroptosis inhibition lactylation attenuated ferroptosis dn model mouse hyperglycaemic cell present study showed induced lactylation to regulate transcription thus triggering ferroptosis diabetic nephropathy model	Cell Death Differ	23/09/2025
10.1038/s41564-025-02120-6	nasal staphylococcus aureus carriage promotes depressive behaviour mouse sex hormone degradation	Xiang G; Wang Y; Ni K; Luo H; Liu Q; Song Y; Miao P; He L; Jian Y; Yang Z; Chen T; Xu K; Sun X; Shen Z; Ji C; Zhao N; He M; Pan Y; Luo Y; Hu J; Otto M; Li M	human microbiome ha pronounced impact human physiology behaviour unique anatomical connection to brain role nasal microbiome neurological disease is understudied here using human data experiment mouse show nasal staphylococcus aureus is linked to depression microbiome analysis revealed positive correlation depression score aureus abundance patient depression healthy control metabolomics nasal cavity showed decreased sex hormone estradiol testosterone patient depression versus control nasal microbiota transplant patient reproduced behaviour mouse differential abundance aureus further homology mutational analysis uncovered aureus sex enzyme dehydrogenase which degraded testosterone estradiol mouse leading to lower level dopamine serotonin murine brain finding reveal nasal commensal that influence depressive behaviour provides insight axis	Nat Microbiol	22/09/2025
10.1038/s41392-025-02391-9	mediates cell lysis detrimental inflammation panoptosis influenza virus infection	Xu Y; Zheng Y; Liu Y; Wei C; Ren J; Zuo W; Gu R; Liu H; Deng X; Liu Y; Shang X; Ge W; Li Z; Huang Y; He D; Shen X; Wang Z; Lyu C; Wang Z; Mu Y; Zhang Z; Wu H; Li H; Cao B	influenza virus iav induces panoptosis form lytic inflammatory cell death characterized concurrent activation pyroptosis necroptosis apoptosis pathway is recently identified mediator plasma membrane rupture function diversely different type cell death however little is known role panoptosis viral pneumonia here report iav infection triggered increase expression which then oligomerized mediated cell lysis infected macrophage deficiency prevented plasma membrane rupture release damp affecting progression cell death activation single panoptosis pathway wa sufficient to trigger oligomerization robust cell lysis accordingly only when panoptosis pathway were concurrently blocked could oligomerization cell death cell rupture be prevented ablation vivo also alleviated lung injury mortality furthermore revealed association upregulation poor outcome patient collectively finding indicate pivotal role immunopathology iav infection potential bioindicator disease severity prognosis viral pneumonia viral sepsis	Signal Transduct Target Ther	23/09/2025
10.1089/rej.2012.1389	protective effect ginger root extract alzheimer behavioral dysfunction rat	Zeng GF; Zhang ZY; Lu L; Xiao DQ; Zong SH; He JM	aim study wa to assess ability traditional chinese medicinal ginger root extract gre to prevent behavioral dysfunction alzheimer disease ad rat model rat ad model were established operation op which rat were treated injection amyloid aβ continuous gavage aluminum chloride day week gre wa administered to rat day learning memory were assessed rat brain section were processed immunohistochemistry hematoxylin amp amp nissl staining latency to show significant memory deficit wa shorter group that received high dose gre hg group that received low moderate dose gre lg mg lt expression superoxide dismutase sod catalase cat group wa compared to group lt rat group had lower level nuclear malondialdehyde mda expression rat group lt experiment demonstrates administration gre revers behavioral dysfunction prevents symptom rat model	Rejuvenation Res	01/04/2013
10.1038/s41586-025-09541-7	ribonucleotide incorporation mitochondrial dna drive inflammation	Bahat A; Milenkovic D; Cors E; Barnett M; Niftullayev S; Katsalifis A; Schwill M; Kirschner P; MacVicar T; Giavalisco P; Jenninger L; Clausen AR; Paupe V; Prudent J; Larsson NG; Rogg M; Schell C; Muylaert I; Lekholm E; Nolte H; Falkenberg M; Langer T	metabolic dysregulation can lead to inflammatory response imbalanced synthesis trigger release mitochondrial dna mtdna to cytosol innate immune response signalling however how nucleotide deficiency drive inflammation ha not been elucidated here show nucleotide imbalance lead to increased misincorporation ribonucleotides mtdna renal inflammation mouse model lacking mitochondrial exonuclease various tissue aged mouse cell lacking mitochondrial protease similarly reduced deoxyribonucleotide synthesis increase ribonucleotide content mtdna senescent cell lead to mtdna release cytosol activation secretory phenotype sasp which can be suppressed exogenously added deoxyribonucleosides result highlight sensitivity mtdna to aberrant ribonucleotide incorporation show imbalanced nucleotide metabolism lead to inflammatory response sasp senescence	Nature	24/09/2025
10.1038/s41392-025-02390-w	spatiotemporal analysis uncovers immunosuppressive niche triggering early gastric cancer	Gao P; Zuo C; Yuan W; Cai J; Chai X; Gong R; Yu J; Yao L; Su W; Liu Z; Lin S; Wang Y; Cai M; Ma L; Li Q; Zhou P	understanding cellular origin early evolutionary dynamic that drive initiation carcinogenesis is critical to advancing early detection prevention strategy characterizing key molecular cellular niche event precancerous tipping point early gastric cancer egc aimed to develop more precise screening tool design targeted intervention to prevent malignant transformation stage utilized ai model to integrate spatial multimodal data nine egc endoscopic submucosal dissection esd sample covering sequential stage normal to cancer construct profile disease progression identify critical tipping point characterized microenvironment early cancer development stage inflammatory pit mucous cell stemness interact fibroblast nampt macrophage areg signaling fostering cancer initiation established gastric precancerous cell line organoids to demonstrate nampt areg promote cellular proliferation vitro furthermore transgenic mouse model targeting areg nampt disrupted key cell interaction inhibited mapk nfκb pathway reduced expression which wa also confirmed western blot vitro intervention delayed disease progression reversed immunosuppressive microenvironment prevented malignant transformation clinical validation wa conducted using endoscopically resected egc specimen study provides precise spatiotemporal depiction egc development identifies novel diagnostic marker therapeutic target early intervention	Signal Transduct Target Ther	22/09/2025
10.1136/jitc-2025-012230	mvp upregulation boost immunotherapy resistance inhibiting degradation hepatocellular carcinoma	Liu S; Pan Y; Liu W; Bu X; Shao R; Wang Q; Wu J; Wu C; Hu W; Xu J; Wu C; Jiang J	background hepatocellular carcinoma hcc is prevalent malignancy third leading cause mortality worldwide immune checkpoint inhibitor icis have emerged therapy advanced hcc substantially improving clinical outcome however resistance to icis remains major therapeutic challenge lactylation recently identified modification ha been implicated tumor progression role icis resistance hcc remains unclear method cytotoxicity assay flow cytometry orthotopic hcc mouse model were used to evaluate effect lactylation remodeling immune microenvironment chromatin immunoprecipitation sequencing rna sequencing were employed to identify gene profile programmed cell protein degradation wa assayed analysis ubiquitination assay interaction major vault protein mvp protein were analyzed experiment mutagenesis truncation mutant were designed to determine binding site complex result elevated lactylation correlate poor prognosis icis resistance patient hcc inhibition lactylation enhances infiltration cytokine production multiomics analysis identify mvp factor that suppresses antitumor immunity elevated mvp expression is associated resistance to checkpoint blockade therapy mechanistic study reveal histone mvp upregulation stabilizes preventing proteasomal degradation pharmacological inhibition lactylation restores icis sensitivity orthotopic hcc mouse model conclusion finding demonstrate histone lactylation promotes icis resistance stabilization therefore targeting lactylation combination programmed cell death blockade offer promising strategy to overcome immunotherapy resistance hcc	J Immunother Cancer	21/09/2025
10.1097/JS9.0000000000003476	polyethylene terephthalate microplastics exposure enhances risk ulcerative colitis insight integration machine learning molecular docking reveal intestinal toxicity mechanism	Yang X; Yan B; Zhao Y; Zhou L; Liu M; Chen G; Shen L; Deng T	background recent decade widespread use polyethylene terephthalate pet ha led to proliferation pet microplastics environment posing potential threat to human health including ulcerative colitis uc however underlying molecular mechanism remain unclear method data sourced public database were harnessed to predict target identify differentially expressed gene functional enrichment analysis were conducted to uncover relevant biological pathway three machine learning algorithm were utilized to screen hub gene associated uc followed evaluation hub gene using eight machine learning algorithm shap analysis subsequently nomogram wa constructed validated based risk prediction model sequencing analysis molecular docking were performed animal model wa established dextran sulfate sodium ds western blot analysis wa employed to verify protein expression level intestinal tissue result eleven potential target related to uc toxicity were identified four hub gene ctsk naaa were successfully screened out exhibiting significant expression disparity uc sample constructed risk prediction model demonstrated high prediction accuracy analysis revealed distinct expression pattern hub gene different cell type molecular docking confirmed strong binding affinity gene animal experiment revealed expression level ctsk ds group were significantly upregulated expression level naaa wa significantly downregulated compared ds group conclusion study offer valuable insight molecular mechanism which may induce uc providing theoretical foundation understanding potential health risk associated exposure	Int J Surg	22/09/2025
10.1038/s41586-025-09500-2	is receptor encephalitis virus	Mittler E; Tse AL; Tran PT; Florez C; Janer J; Varnaite R; Kasikci E; Mv VK; Loomis M; Christ W; Cazares E; Bakken RR; Martin CK; Zeng X; Raymond JL; Shahsavani M; Khanal S; Wilkinson ER; Oktavia RM; Slough MM; Haslwanter D; Han J; Berrigan J; Rosendal E; Kielian M; Manicassamy B; Överby AK; Falk A; Barba-Spaeth G; Rey FA; Klingström J; Gavathiotis E; Herbert AS; Chandran K; Gredmark-Russ S	encephalitis virus tbev cause encephalitis tbe severe sometimes disease characterized viral invasion central nervous system symptom neuroinflammation other rna factor required tbev entry remain poorly defined here used screen to identify apolipoprotein reelin receptor high expression brain tbev receptor downregulation reduced tbev infection human cell overexpression enhanced infection bound directly to tbev glycoprotein mediated viral attachment internalization cell soluble decoy blocked infection human cell line neuronal cell protected mouse lethal tbev challenge role tbev receptor ha implication tbev neuropathogenesis development antiviral countermeasure	Nature	24/09/2025
10.1038/s41586-025-09507-9	systematic discovery car cell immunotherapy	Datlinger P; Pankevich EV; Arnold CD; Pranckevicius N; Lin J; Romanovskaia D; Schaefer M; Piras F; Orts AC; Nemc A; Biesaga PN; Chan M; Neuwirth T; Artemov AV; Li W; Ladstätter S; Krausgruber T; Bock C	chimeric antigen receptor car cell therapy ha shown remarkable success treating blood cancer car cell dysfunction remains common cause treatment failure here present cellfie crispr screening platform enhancing car cell multiple clinical objective performed screen human primary car cell readout capturing key aspect cell biology including proliferation target cell recognition activation apoptosis fratricide exhaustion screening hit were prioritized using new vivo method xenograft model human leukaemia establishing several gene knockout that boost car cell efficacy most notably discovered rhog knockout is potent unexpected car cell enhancer individually together fa knockout which wa validated multiple vivo model car design sample donor cell demonstrating versatility cellfie platform also conducted combinatorial crispr screen to identify synergistic gene pair saturation screen to characterize rhog variant summary discovered validated biologically characterized car cell that outperform standard car cell widely used benchmark establishing foundational resource optimizing immunotherapy	Nature	24/09/2025
10.1038/s41586-025-09489-8	vivo crispr screen identify modifier car cell function myeloma	Knudsen NH; Escobar G; Korell F; Kienka T; Nobrega C; Anderson S; Cheng AY; Zschummel M; Armstrong A; Bouffard A; Kann MC; Goncalves S; Pope HW; Pezeshki M; Rojas A; Suermondt JSMT; Phillips M; Berger TR; Park S; Salas-Benito D; Darnell EP; Birocchi F; Leick MB; Larson RC; Doench JG; Sen D; Yates KB; Manguso RT; Maus MV	chimeric antigen receptor car cell are highly effective haematological malignancy however progressive loss car cell contributes to relapse many patient here performed vivo crispr screen car cell targeting cell maturation antigen to investigate gene that influence car cell persistence function human multiple myeloma model tracked expansion persistence crispr cell vitro early late time point vivo to track performance car cell manufacturing to survival tumour screen revealed regulator car cell expansion persistence ablation enhanced cell expansion vitro whereas loss conferred early growth advantage to car cell vivo notably identified kinase inhibitor encoded cell cycle regulator most important factor limiting car cell fitness late time point vivo ablation increased car cell proliferation effector function significantly enhancing tumour clearance overall survival finding reveal differing effect gene perturbation car cell time different environment highlight promising target to generate highly effective car cell multiple myeloma potential vivo screening identifying gene to enhance car cell efficacy	Nature	24/09/2025
10.1038/s41418-025-01580-x	induction ferroptosis prostate cancer ubiquitination	Cheng B; Wang Q; Li Z; Luo T; Xie J; Singh S; Luo Y; Gao X; Li H; Wang Z; Wu P; Huang H	prostate cancer is one most prevalent malignancy men increasing incidence mortality largely attributed to treatment resistance metastasis effectiveness current therapy advanced case is hindered intricate genetic microenvironmental factor emphasizing urgent need novel therapeutic target chimeric rna have emerged promising biomarkers cancer research which circular chimeric rna is frequently identified prostate cancer study reveals that expression is markedly reduced advanced recurrent prostate cancer where low level serve independent predictor poor prognosis functional experiment demonstrate overexpression inhibits cell proliferation induces apoptosis suppresses tumor growth vivo knockdown revers effect mechanistically encodes novel protein which trigger ferroptosis interacting facilitating ubiquitination degradation notably treatment recombinant effectively suppresses tumor growth xenograft model toxicity enhances efficacy docetaxel enzalutamide vitro finding establish significant prognostic marker potential therapeutic target prostate cancer recombinant protein offering promise combination therapy advanced case	Cell Death Differ	22/09/2025
10.1016/j.cmet.2025.08.010	hepatic metabolism modulates neuroinflammation depression susceptibility acetate	Cao Y; Zhao Y; Deng T; Zhou Q; Hu G; Hu ZL; Jiang YY; Yang XH; Wang F; Wu PF; Chen JG	extensive research highlight impaired brain energy metabolism neuropsychiatric disorder whereas much less is known role peripheral metabolic state liver is metabolic hub herein demonstrate hepatic hydrolysis central metabolic intermediate signal brain help buffer stress using chronic social defeat stress paradigm male mouse observed hepatic metabolic switch followed transcription hydrolase thioesterase to confer stress vulnerability hepatic overexpression thioesterase alleviated phenotype increasing acetate output to promote histone acetylation ventral hippocampus which bolstered expression programmed cell death ligand astrocyte limiting neuroinflammation rescuing inhibitory synaptic transmission dysfunction finding demonstrate hepatic hydrolysis serf key axis component that regulates depression susceptibility	Cell Metab	23/09/2025
10.1126/science.adn8754	lysosome signal epigenome to regulate longevity generation	Zhang Q; Dang W; Wang MC	epigenome is sensitive to metabolic input is crucial aging lysosome act signaling hub to sense metabolic cue regulate longevity found lysosomal metabolic pathway signal epigenome to regulate transgenerational longevity caenorhabditis elegans activation lysosomal lipid signaling lysosomal adenosine protein kinase ampk reduction lysosomal mechanistic target rapamycin mtor signaling increased expression histone variant increased methylation leading to extension multiple generation transgenerational prolongevity effect required transportation histone methyltransferase wa recapitulated overexpressing methyltransferase thus signal lysosome affect epigenome link soma germ line to mediate transgenerational inheritance longevity	Science	25/09/2025
10.1093/eurheartj/ehaf742	shear endothelial signalling regulates vascular tone blood pressure	Wu W; Liu J; Chen X; Zhu P; Xu J; Yue J; Liu X; Fang J; Chen X; Pi J; Zheng L; Zhang Q; Zhang L; Schneider CV; Schneider KM; Trautwein C; Gao P; Reilly MP; Zhang Y; Zheng X; Liu J	background aim endothelial cell ec sense flow shear stress vasodilation crucial mechanism maintaining systemic blood pressure bp impaired shear stress signalling contributes to endothelial dysfunction hypertension heart development protein domain protein is inversely associated cardiovascular risk study aimed to elucidate role endothelial bp regulation underlying mechanism method association study computational fluid dynamic analysis rna sequencing artery plasma sample independent cohort vitro shear stress analysis were used to assess association hypertension shear stress level deletion mouse bp monitoring vascular function analysis were employed to characterize role endothelial function hypertension proteomics transcriptomics ubiquitination assay were used to identify regulatory pathway involved result plasma level were hypertensive subject due to reduced wall shear stress endothelium which diminished expression release circulation deletion mouse resulted elevated bp impaired vasodilation hypertensive level especially apoeko dyslipidaemia background mechanistically facilitated degradation deletion led to increased level nuclear translocation suppression enos transcription production inhibition nuclear localization prevented impaired vasodilation hypertension conclusion study identifies novel endothelial signalling pathway bp regulation providing potential therapeutic target hypertension	Eur Heart J	23/09/2025
10.1038/s41586-025-09564-0	reprogramming neuroblastoma polyamine depletion	Cherkaoui S; Turn CS; Yuan Y; Lu W; Yang L; McBride MJ; Eigenmann C; Allen GE; Panasenko OO; Zhang L; Vu A; Liu K; Li Y; Gandhi OH; Surrey LF; Kienast SD; Leidel SA; Wierer M; White E; Rabinowitz JD; Hogarty MD; Morscher RJ	neuroblastoma is highly lethal childhood tumour derived neural crest cell cancer growth is fuelled metabolite obtained circulation local biosynthesis neuroblastoma depend local polyamine biosynthesis inhibitor difluoromethylornithine ha shown clinical activity here show such inhibition can be augmented dietary restriction upstream amino acid substrate leading to disruption oncogenic protein translation tumour differentiation profound survival gain mouse model specifically diet decrease amount polyamine precursor ornithine enhances tumour polyamine depletion difluoromethylornithine polyamine depletion cause ribosome stalling unexpectedly specifically codon adenosine third position such codon are selectively enriched cell cycle gene low neuronal differentiation gene thus impaired translation codon induced combined dietary pharmacological intervention favour proteome result suggest gene specific cellular programme have evolved hallmark codon usage preference that enable coherent translational rewiring response to metabolic stress process can be targeted to activate differentiation paediatric cancer	Nature	24/09/2025
10.1001/jamapsychiatry.2025.2579	soft drink consumption depression mediated gut microbiome alteration	Edwin Thanarajah S; Ribeiro AH; Lee J; Winter NR; Stein F; Lippert RN; Hanssen R; Schiweck C; Fehse L; Bloemendaal M; Aichholzer M; Bouzouina A; Uckermark C; Welzel M; Repple J; Matura S; Meinert S; Bang C; Franke A; Leenings R; Konowski M; Ernsting J; Fisch L; Barkhau C; Thomas-Odenthal F; Usemann P; Teutenberg L; Straube B; Alexander N; Jamalabadi H; Nenadic I; Lügering A; Nitsch R; Kittel-Schneider S; Cryan JF; Reif A; Kircher T; Heider D; Dannlowski U; Hahn T	importance soft drink consumption is linked to negative physical mental health outcome association major depressive disorder mdd underlying mechanism remains unclear objective to examine association soft drink consumption mdd diagnosis severity association is mediated change gut microbiota particularly eggerthella hungatella abundance design setting participant multicenter cohort study wa conducted germany using data affective cohort patient mdd healthy control aged year recruited general population primary care september september were analyzed data analysis were conducted may december main outcome measure primary analysis included multivariable regression analysis variance anova model examining association soft drink consumption mdd diagnosis symptom severity controlling site education eggerthella hungatella abundance controlling site education library size mediation analysis tested microbiota abundance mediated soft link result total patient mdd female patient sd age year healthy control female control sd age year were included soft drink consumption predicted mdd diagnosis odds ratio ci symptom severity lt partial ci stronger effect woman diagnosis ci severity lt ci woman consumption wa linked to increased eggerthella ci not hungatella abundance mediation analysis confirmed eggerthella significantly mediated soft association diagnosis severity explaining effect respectively conclusion relevance cohort study wa found soft drink consumption may contribute to mdd gut microbiota alteration notably involving eggerthella public health strategy to reduce soft drink intake may help mitigate depression risk especially vulnerable population addition intervention depression targeting microbiome composition promising	JAMA Psychiatry	24/09/2025
10.1126/science.adj9141	dynamic cycling defines two phase cotranscriptional splicing	Shao C; Hao Y; Jiang L; Wang D; Wang R; Li Y; Wang H; Ge Y; Bai R; Du X; Chen X; Wu T; Gou LT; Wan R; Xu Y; Ji X; Fu XD	distinguishing functional splice site abundant cryptic site precursor messenger rna represents fundamental challenge decoding mammalian genome demonstrate specific rna polymerase ii pol ii subunit directly interacts binding factor to initiate site recognition combined recent structural insight pol site selection finding support cotranscriptional mechanism to recognize paired splice site individual exon initial exon definition event facilitate recruitment to heterodimerize which also trigger release elongating pol ii collectively result reveal dynamic cycling partition pol ii splice site recognition subsequent pol spliceosome assembly step cotranscriptional splicing	Science	25/09/2025
10.1038/cgt.2010.39	compensatory induction function primary fibroblast patient	Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML	multiple endocrine neoplasia type syndrome is characterized occurrence tumor parathyroid neuroendocrine cell tract anterior pituitary gene encodes protein loss heterozygosity is typical tumor have analyzed mrna menin expression fibroblast normal skin biopsy patient two frameshift exon mutation introducing premature stop codon individual exon nonsense mutation expression menin protein did not differ normal fibroblast allele mrna were expressed patient whereas mutant allele were partially degraded mrna decay pathway suggesting mechanism compensation allelic loss menin expression level rna silencing mrna allele abolished menin compensation ribozyme silencing mrna allele resulted strongly enhanced menin expression analysis showed complex to mrna finding contribute to understanding tumorigenesis offering basis development therapy gene mutation carrier	Cancer Gene Ther	01/11/2010
10.1038/s41579-025-01237-z	fusobacterium nucleatum ecology pathogenesis clinical implication	Jiang SS; Chen YX; Fang JY	fusobacterium nucleatum commensal microorganism opportunistic pathogen pathobiont ha emerged key player local systemic disease human nucleatum is found oral microbiota certain condition can spread to other ecological niche body such gut microbiota importantly nucleatum ha pathogenic role periodontal disease inflammatory bowel disease various cancer particularly colorectal cancer nucleatum can promote oncogenesis several mechanism including virulence factor chronic inflammation immune evasion direct interaction tumour cell strong link pathobiont microorganism cancer ha led to emergence several potential diagnostic strategy possible therapeutic intervention given increasing association cancer progression poor clinical outcome understanding role nucleatum disease treatment offer critical insight future research clinical application review underscore importance nucleatum microbiology oncology translational medicine	Nat Rev Microbiol	22/09/2025
10.1038/s41551-025-01517-2	intranasal vaccine combining adenovirus trimeric subunit protein provides superior immunity omicron variant	Hong W; Cheng P; Yang J; Shi H; Wang Z; Li J; Lei H; Peng D; He C; Ren W; Pan X; Huang Y; Alu A; Qin F; Wang B; Zhou Y; Yang Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Ai J; Chen L; Que H; Zeng Z; Liu J; Hao Y; Ao D; Zhang Y; Huang X; Ye C; Fu M; He X; Bi Z; Han X; Luo M; Hu H; Cheng W; Dong H; Lei J; Chen L; Zhou X; Wang W; Shen G; Yang J; Song X; Wei Y; Lu S; Sun Q; Lu G; Wang Y; Yang L; Li W; Wei X	mucosal immunity provides efficient protection infection limiting viral shedding transmission however currently nasal spray vaccine are approved who global use here develop intranasal vaccine that combine adenovirus vector expressing spike protein variant trimeric recombinant protein derived receptor binding domain rbd vaccine elicits superior humoral cellular immunity variant compared individual component also provides protective immunity live virus challenge mouse prevents virus transmission hamster model notably activation sting signalling pathway mucosal dendritic cell is essential adjuvant effect adenovirus vector also incorporate trimeric protein variant rbd creating vaccine rbd rbd that show enhanced neutralization vaccine demonstrates high tolerability safety human inducing enhanced mucosal immunity high level neutralizing antibody participant finding underscore strategy clinical intranasal vaccine development	Nat Biomed Eng	22/09/2025
10.1002/alz.70689	relationship soluble tau specie alzheimer disease amyloid plaque removal tau pathology	McDade EM; Barthélemy NR; Wang G; Li Y; Cao Y; Gordon B; Benzinger TLS; Clifford D; Goate AM; Renton AE; Hassenstab J; Llibre-Guerra JJ; Perrin RJ; Xiong C; Cruchaga C; Mummery CJ; Berman SB; Lah J; Roberson ED; Van Dyck C; Gauthier S; Masters CL; Masellis M; Bittner T; Yaari R; Chhatwal J; Chrem P; Brooks W; Suzuki K; Levin JJ; Jucker M; Ringman J; Wallon D; Ikeuchi T; Lee JH; Roh JH; Schofield P; Fox NC; Ryan NS; Vöglein J; Karch C; Ibáñez L; Day GS; Sánchez-Valle R; Daniels A; Morris JC; Supnet-Bell C; Levey AI; Bateman RJ	background cerebrospinal fluid csf biomarkers correlate aβ plaque tau tangle alzheimer disease ad study assessed effect antibody amyloid plaque tau tangle csf tau specie to determine relationship method analysis trial examined participant risk dominantly inherited ad randomized to solanezumab gantenerumab placebo mass spectrometry quantified csf tau specie four year result phosphorylated tau specie increased early preclinical ad were reduced aβ plaque reduction nearly decade later increased showing association aβ reduction aligning tau tangle pathology progression discussion initially changing soluble specie track aβ plaque reduction reflect tau tangle pathology informing different pathway therapeutic strategy highlight correlate respond to lowering therapy aβ immunotherapy trial support direct link change aβ plaque gantenerumab reduces aβ plaque doe not affect tau biomarkers assay may provide tool to monitor aβ therapy strongly correlate tau pet track nft pathology progression further study are needed to validate tau biomarkers tracking therapy	Alzheimers Dement	01/09/2025
10.1038/s41467-025-63935-9	comparative spatial profiling sjögren disease reveals common distinct immune activation inflammation	Inamo J; Takeshita M; Suzuki K; Tsunoda K; Usuda S; Kuramoto J; Moody J; Hon CC; Ando Y; Sasaki T; Yoshitake K; Mitsuyama S; Asakawa S; Kanai Y; Takeuchi T; Kaneko Y	sjögren disease sjd is autoimmune disease that cause salivary gland dysfunction due to destruction autoantibody such cent are associated distinct clinical manifestation molecular feature remain to be elucidated study apply technology rna sequencing cell cell receptor sequencing spatial transcriptomics to salivary gland lesion aiming to elucidate common unique cellular transcriptional signature linked to different autoantibody profile analysis demonstrates gzmb gnly cell are main expanded subset different autoantibody status highlighting central role sjd pathogenesis enrichment memory cell is more prominent patient cytokine signaling also differs autoantibody profile activated interferon signature patient whereas tgfβ signaling is enhanced patient furthermore spatial profiling reveals fibroblast expressing complement gene chemokines key hub orchestrating inflammation salivary gland finding deepen understanding pathogenesis sjd may inform development targeted personalized therapeutic strategy	Nat Commun	22/09/2025
10.1371/journal.pmed.1004722	association lower fasting plasma glucose level oral glucose tolerance test adverse perinatal outcome chinese cohort study	Wang L; Tang C; Cheng M; Hao Y; Chen S; Zhang S; Zhang C; Mol BW; Wu Y; Huang H	background is unknown fasting plasma glucose fpg level normal range defined international association diabetes pregnancy study group iadpsg criterion is associated perinatal outcome study explored association fpg level lower iadpsg threshold oral glucose tolerance test ogtt adverse perinatal outcome woman gestational diabetes mellitus gdm method finding january to may retrospective cohort study included woman singleton pregnancy obstetrics gynecology hospital fudan university shanghai china woman underwent ogtt gestational week primary endpoint wa composite adverse outcome including gestational hypertension preeclampsia fetal death stillbirth preterm birth primary cesarean delivery small large gestational age overall woman had gdm whom had fpg level iadpsg threshold compared to gdm population woman fpg level were significantly greater risk adverse outcome adjusted odds ratio aor ci aor ci aor ci glucose level nonetheless woman demonstrated significantly lower risk aor ci compared to gdm counterpart exhibiting low fasting glycemia however study wa limited retrospective design may lack generalizability to other ethnic group conclusion even fpg level lower iadpsg threshold fpg wa significantly associated adverse perinatal outcome association presented different pattern woman gdm	PLoS Med	01/09/2025
10.1056/NEJMoa2504650	aspirin localized colorectal cancer	Martling A; Hed Myrberg I; Nilbert M; Grönberg H; Granath F; Eklund M; Öresland T; Iversen LH; Haapamäki C; Janson M; Westberg K; Segelman J; Ersson U; Prytz M; Angenete E; Bergström R; Mayrhofer M; Glimelius B; Lindberg J	background aspirin reduces incidence colorectal adenoma colorectal cancer person observational study suggest aspirin may also improve survival diagnosis particularly patient tumor harboring somatic mutation however data randomized trial are lacking method conducted randomized trial involving patient stage ii iii rectal cancer stage ii iii colon cancer somatic alteration pathway gene patient were assigned ratio to receive mg aspirin matched placebo once daily year patient prespecified hotspot mutation exon group alteration other somatic variant pten group alteration were eligible randomization primary end point wa colorectal cancer recurrence assessed analysis patient group alteration secondary end point included colorectal cancer recurrence patient group alteration survival safety result alteration pathway gene were detected patient complete genomic data patient group alteration patient group alteration respectively were assigned to receive aspirin placebo estimated cumulative incidence recurrence wa aspirin placebo hazard ratio confidence interval ci to patient group alteration respectively hazard ratio ci to group alteration estimated survival wa aspirin placebo hazard ratio ci to patient group alteration respectively hazard ratio ci to group alteration severe adverse event occurred aspirin recipient placebo recipient conclusion aspirin led to significantly lower incidence colorectal cancer recurrence placebo patient hotspot mutation exon appeared to have similar benefit other somatic alteration pathway gene funded swedish research council others alascca number eudract number	N Engl J Med	18/09/2025
10.1158/2159-8290.CD-25-0323	development prospective validation model early detection pancreatic cancer	Wang X; Wang H; Zhang M; Li H; Liu Y; Huang H; Pei J; Huang J; Zang F; Zhang Y; Chen X; Gao S; Zhao T; Wang J; Ma W; Liang Y; Shi S; Li S; Li W; Zhou T; Zhang Y; Cui X; Ye ZX; Sun Y; Peng L; Hu X; Li Z; Zhang H; Zhu D; Chang S; Zhang J; Yang R; Bao H; Wu X; Shao Y; Yu J; Gao C; Cui Y; Hao J	pancreatic cancer pc remains highly lethal malignancy due to diagnosis limited therapeutic option study present development validation circulating dna cfdna model early pc detection study comprising pc patient healthy control model demonstrated high diagnostic accuracy training validation prospective cohort study involving individual diabetes obesity established risk factor pc further assessed clinical applicability model detected pc case including stage patient lead time to day significantly outperforming additionally demonstrates potential distinguishing pancreatic cyst thereby facilitating more precise risk stratification study highlight potential screening scalable tool early pc detection warranting further clinical validation to enhance patient outcome	Cancer Discov	22/09/2025
10.1038/s41593-025-02056-4	septal inhibitory circuit mediates anticipatory control drinking	Xu L; Sun Y; Huang C; Zheng Y; Chen J; Ma X; Shi Q; Liu M; Qiu X; Zhao Q; Gao C; Liao J; Wang Y; Chen Z	drinking behavior is not only homeostatically regulated also rapidly adjusted change blood osmolality occur known anticipatory thirst satiation homeostatic anticipatory signal converge subfornical organ sfo however neural pathway conveying peripheral information to sfo change blood composition are incompletely understood here reveal inhibitory pathway medial septum m to sfo that is involved control anticipatory drinking behavior mouse m acid gaba ergic neuron encode signal integrating cue oral cavity tracking gastrointestinal signal neuron receive input parabrachial nucleus relay to sfo camkii neuron forming pathway activity prevents overhydration disruption circuit lead to excessive water intake hyponatremia finding reveal septal pathway that integrates multiple layer presystemic signal to drinking behavior	Nat Neurosci	22/09/2025
10.1038/s42255-025-01365-z	neurolipid atlas lipidomics resource neurodegenerative disease	Feringa FM; Koppes-den Hertog SJ; Wang LY; Derks RJE; Kruijff I; Erlebach L; Heijneman J; Miramontes R; Pömpner N; Blomberg N; Olivier-Jimenez D; Johansen LE; Cammack AJ; Giblin A; Toomey CE; Rose IVL; Yuan H; Ward ME; Isaacs AM; Kampmann M; Kronenberg-Versteeg D; Lashley T; Thompson LM; Ori A; Mohammed Y; Giera M; van der Kant R	lipid alteration brain have been implicated many neurodegenerative disease to facilitate comparative lipidomic research brain disease establish data common named neurolipid atlas prepopulated isogenic induced pluripotent stem cell ip cell lipidomics data different brain disease additionally resource contains lipidomics data human mouse brain tissue leveraging multiple datasets demonstrate ip neuron microglia astrocyte exhibit distinct lipid profile that recapitulate vivo lipotypes notably alzheimer disease ad risk gene drive cholesterol ester ce accumulation specifically human astrocyte also observe ce accumulation lipidomics person ad multiomics interrogation ip astrocyte revealed altered cholesterol metabolism ha major role astrocyte immune pathway such immunoproteasome major histocompatibility complex class antigen presentation data common available online http allows data deposition community provides tool knowledge base better understanding lipid dyshomeostasis neurodegenerative disease	Nat Metab	22/09/2025
10.1038/s42255-025-01360-4	consensus guide to preclinical indirect calorimetry experiment	Banks AS; Allison DB; Alquier T; Ansarullah; Austad SN; Auwerx J; Ayala JE; Baur JA; Carobbio S; Churchill GA; Dall M; de Cabo R; Donato J Jr; Dragano NRV; Elias CF; Ferrante AW Jr; Finck BN; Galgani JE; Gerhart-Hines Z; Goodyear LJ; Grobe JL; Gupta RK; Habegger KM; Hartig SM; Hevener AL; Heymsfield SB; Holman CD; de Angelis MH; James DE; Kazak L; Kim JB; Klingenspor M; Kong X; Kooijman S; Lantier L; Lloyd KCK; Lo JC; Lodhi IJ; MacLean PS; McGuinness OP; Medina-Gómez G; Mirmira RG; Morrison CD; Morton GJ; Müller TD; Ogawa Y; Pajuelo-Reguera D; Potthoff MJ; Qi N; Reitman ML; Rensen PCN; Rozman J; Rutkowsky JM; Sakamoto K; Scherer PE; Schwartz GJ; Sedlacek R; Selloum M; Shaikh SR; Chen S; Shulman GI; Škop V; Soukas AA; Speakman JR; Spiegelman BM; Steinberg GR; Svensson KJ; Thyfault JP; Tiganis T; Titchenell PM; Turner N; Velloso LA; Vidal-Puig A; Ward CS; Williams AS; Wolfrum C; Xu AW; Xu Y; Zierath JR	understanding complex factor influencing mammalian metabolism body weight homeostasis is challenge requiring knowledge energy intake absorption expenditure using measurement respiratory gas exchange indirect calorimetry can provide estimate energy expenditure however inconsistent measurement unit flawed data normalization method have slowed progress field guide aim to establish consensus standard to unify indirect calorimetry experiment analysis more consistent meaningful reproducible result establishing standard hope to facilitate data comparison research datasets advance will allow creation data repository built shared standard overdue initiative stand to markedly improve accuracy depth effort to interrogate mammalian metabolism data sharing according to established best practice will also accelerate translation basic finding clinical application metabolic disease afflicting global population	Nat Metab	01/09/2025
10.1038/s41392-025-02399-1	conjugate promising cancer therapy comprehensive evaluation rodent to primate	Su M; Liu Y; Lin H; Wang X; Ying D; Zhang L; Yang C; Jiang M; Xu L; Wang X; Sun Y; Xu H; Zhang Z; Wang X; Fu T; Xie S; He J; Liu X; Tan W	aptamers serve unique targeting ligand making conjugate apdcs attractive strategy targeted cancer therapy study performs comprehensive evaluation rodent to primate nhp protein tyrosine kinase apdc made conjugating potent antimitotic agent monomethyl auristatin mmae to classic aptamer efficacy study various cancer type overexpression showed effectively induces sustained tumor regression cell xenograft outperforming unconjugated mmae chemotherapy drug paclitaxel conjugate pharmacokinetic pk study mouse revealed lead to rapid accumulation sustained mmae level tumor fast clearance plasma normal tissue further study rat confirmed rapid clearance most organ revealed mmae wa excreted urine feces toxicokinetic tk assessment indicated comparable systemic drug exposure accumulation repeated dos compared to single administration toxicity evaluation showed therapeutic dose high efficacy wa safe toxicity resulting extremely high dos could be reversibly controlled encouraged finding evaluated profile safety cynomolgus monkey similar to profile observed rat demonstrated good drug exposure wa moreover well tolerated monkey obvious accumulation following multiple administration finding highlight potential effective antitumor agent provide useful insight clinical translation emerging apdcs	Signal Transduct Target Ther	24/09/2025
10.1073/pnas.2514948122	is negative regulator sting signaling cancer cell inhibition reactivates immune surveillance cold tumor	Chowdhury SR; Parikh CN; Kaur AN; DeMarco KD; Giwa HK; Mishra AK; Murphy KC; Zhou L; Ma B; Ye T; Li J; Liu H; Bai S; Johnson C; Simin K; Pitarresi JR; Zhu LJ; Watson EV; Kelliher MA; Green MR; Fitzgerald KA; Ruscetti M	immunotherapy modality have revolutionized cancer treatment number metastatic tumor type still many malignancy that lack cell infiltration are termed immunologically quot cold quot fail to respond to modality one approach to increase tumor immunogenicity ha been to induce stimulator interferon gene sting downstream interferon signaling that is often dysregulated cold tumor early success sting agonist preclinical cancer model approach have not been successful clinic due to poor tumor penetrance systemic toxicity here performed crispr screen to uncover therapeutic target to activate sting expression human tumor identified lysosomal hydrolase palmitoyl protein negative regulator sting highly expressed cold ovarian prostate tumor genetic pharmacological suppression increased sting protein stability downstream activation interferon inflammatory cytokine signaling to enhance cell migration treatment preclinical prostate ovarian cancer model expressing low level sting small molecule inhibitor enhanced sting expression activation leading to infiltration activation cytotoxic cell that turned tumor quot hot quot reduced tumor growth fibrosis dissemination toxicity further analysis demonstrated is associated reduced sting expression cell number overall survival immunotherapy outcome ovarian prostate cancer patient thus inhibition may be promising approach to activate sting potentiate effect immunotherapy cold tumor	Proc Natl Acad Sci U S A	30/09/2025
10.1093/eurheartj/ehaf763	axis pulmonary arterial hypertension therapeutic implication	Xu H; Ye L; Du C; Tang H; Zheng Q; Zhu C; Liang B; Wang Y; Mao X; Liang Q; Zhang J; Shao H; Sun X; Yuan R; Yun W; Luo C; Xiu J; Su W; Fan F; Dai Z; Chen L; Guan Y; Zhang X	background aim pulmonary arterial hypertension pah is progressive condition marked abnormal proliferation pulmonary artery smooth muscle cell pasmcs leading to significant remodelling pulmonary artery pa cyclooxygenase metabolite arachidonic acid prostaglandin receptor are crucial maintaining vascular homeostasis study aimed to determine role pathogenesis pah evaluate potential therapeutic target pah method two pah model rat model mouse model were used study pharmacological intervention including antagonist grapiprant agonist genetic strategy including vascular smooth muscle cell vsmc knockout mouse human transgenic mouse were used to comprehensively investigate role pathogenesis pah multiple cellular molecular biology approach were employed to investigate underlying mechanism result result showed pharmacological blockade receptor genetic deletion gene vsmcs led to significant improvement pah pa remodelling conversely pharmacological activation overexpression exacerbate pah progression further analysis identified annexin critical downstream mediator pah progression mechanistically activation wa found to enhance translation phosphorylation pathway promoting pasmc proliferation migration increased nuclear translocation key signalling molecule canonical wnt pathway importantly pharmacological inhibition genetic deletion effectively protected pah rodent suggesting pathogenic role pah development conclusion study reveals crucial pathway involving pah development progression targeting downstream effector represents promising therapeutic strategy pah management	Eur Heart J	25/09/2025
10.1111/epi.17410	drug resistance idiopathic generalized epilepsy evidence concept	Gesche J; Beier CP	approximately patient idiopathic generalized epilepsy ige generalized epilepsy remain there is consensus established concept regarding underlying mechanism prevalence review summarizes recent data current hypothesis mechanism that may contribute to ige literature search wa conducted pubmed embase study mechanism drug resistance published literature show consensus definition widely accepted model to explain drug resistance ige one subsyndromes genetic study have failed to identify distinct genetic cause affected gene involved pharmacokinetics found clinical experimental evidence support four hypothesis quot network hypothesis quot degree drug resistance ige reflects severity cortical network alteration quot minor focal lesion predisposed brain hypothesis quot cortical lesion are important drug resistance quot hypothesis quot functioning acidergic interneurons contributes to drug resistance quot change drug kinetics quot impaired kinetics antiseizure medication asm reduce effectiveness available asms summary exact definition cause drug resistance ige is unknown however published evidence suggests four different mechanism that may warrant further investigation	Epilepsia	01/12/2022
10.1186/s12933-025-02826-1	association index mortality patient different glucose metabolism status	Liu J; Kang J; Liang P; Song Z; Li G; Jin X; Wu H	objective index tyg is emerging marker metabolic health association mortality different glucose metabolism status remains unclear study aimed to investigate relationship tyg risk cardiovascular mortality individual normoglycemia dysglycemia diabetes mellitus method participant nine cycle national health nutrition examination survey nhanes were included categorized three group normoglycemia dysglycemia diabetes cox regression restricted cubic spline rcs analysis were performed to evaluate linear nonlinear association tyg mortality to assess predictive power tyg atherogenic index plasma aip mortality receiver operating characteristic roc curve were constructed subgroup analysis were conducted based age sex blood pressure status result median year total death cardiovascular death were documented normoglycemic group single standard unit increase tyg wa associated higher risk mortality higher risk cardiovascular mortality hr ci hr ci respectively participant diabetes rcs analysis revealed association tyg mortality inflection point significant association were observed dysglycemia group tyg demonstrated superior predictive performance compared to aip mortality normoglycemic diabetic individual subgroup analysis identified significant interaction effect age sex association tyg mortality conclusion tyg wa associated increased risk cardiovascular death normoglycemic subgroup not dysglycemic subgroup diabetes subgroup association tyg mortality wa nonlinear predictive value tyg different glucose metabolism status provides new evidence medical practice	Cardiovasc Diabetol	24/09/2025
10.1111/jdv.70067	effectiveness safety baricitinib severe alopecia areata result	Piraccini BM; Cedirian S; Pampaloni F; Rapparini L; Quadrelli F; Bruni F; Ala L; Acri MC; Rossi A; Pellacani G; Lacarrubba F; Dall&#x27;Oglio F; Micali G; Foggia L; Cantelli M; Nappa P; Diluvio L; Bianchi L; Luigi N; Bolzon A; Peris K; Caldarola G; Girolomoni G; Marangoni F; Bellinato F; Gisondi P; Silvi G; Prignano F; Pimpinelli N; Tomasini C; Barruscotti S; Simonetti O; de Simoni E; Ambrogio F; Foti C; Boccaletti V; Fraghì A; Marzano AV; Mattioli MA; Ferrucci S; Sechi A; Valtellini L; Barbareschi M; Gallo G; Ribero S; Quaglino P; Di Corteranzo IG; Balestri R; Pagliarello C; Caposiena RD; Zalaudek I; Vagnozzi E; Fargnoli MC; Caponio C; Rubegni P; Cinotti E; Trovato E; Romanelli M; Dini V; Manzo Margiotta F; Feliciani C; De Felici Del Giudice MB; Atzori L; Sanna S; Lembo S; Raimondo A; Magnano M; Argenziano G; Babino G; Fulgione E; Rongioletti F; Pesce N; Guida S; Guglielmo A; Schettini N; Starace M	background alopecia areata aa is autoimmune condition leading to hair loss baricitinib janus kinase jak inhibitor ha demonstrated efficacy controlled clinical trial data effectiveness safety remain limited objective study aimed to assess effectiveness safety baricitinib mg daily italian adult patient severe aa treatment period method conducted retrospective observational multicenter study italian university hospital adult patient year severe aa severity alopecia tool salt score who initiated baricitinib mg daily treatment november october were included effectiveness wa measured percentage patient achieving salt week secondary outcome included change mean salt score trichoscopic finding quality life hospital anxiety depression scale hads outcome clinro eyebrow eyelash adverse event were also documented result total patient female mean age year were included week achieved salt achieved salt mean salt score significantly decreased baseline to week lt trichoscopic assessment showed decline yellow dot black dot dystrophic hair whilst regrowing hair increased score improved significantly to lt did hads anxiety to lt hads depression to lt adverse event were reported patient conclusion study confirms effectiveness baricitinib achieving significant hair regrowth improving psychological severe aa patient	J Eur Acad Dermatol Venereol	23/09/2025
10.1186/s13102-021-00259-3	influence athletic performance highest position final ranking serie season	Longo UG; Sofi F; Candela V; Risi Ambrogioni L; Pagliai G; Massaroni C; Schena E; Cimmino M; D&#x27;Ancona F; Denaro V	background previous study serie season showed greater likelihood reaching top position italian league quot quot seemed to be mainly related to sprint activity goal attempt total throw target shot assist therefore aim to evaluate following season data same league to compare confirm improve result method data all match played quot quot season were obtained italian soccer league team analysis wa performed term total distance covered km jogging running sprint activity average speed match statistic total shot shot target goal attempt assist turnover steal result team that reached first four position revealed lower percentage running lt higher percentage jogging sprint activity lt match statistic seem to be statistically different first four team other team total goal are strongly associated total score end championship lt position final ranking lt conclusion result suggest team have lower running rate higher percentage jogging sprinting other team	BMC Sports Sci Med Rehabil	25/03/2021
10.3390/biom14040437	role epigenetics glial cell autism spectrum disorder	Csoka AB; El Kouhen N; Bennani S; Getachew B; Aschner M; Tizabi Y	autism spectrum disorder asd is neurodevelopmental disorder characterized severe deficit social communication interaction repetitive movement abnormal focusing object activity that can significantly affect quality life afflicted neuronal glial cell have been implicated ha genetic component can also be triggered environmental factor drug example prenatal exposure to valproic acid acetaminophen ingestion propionic acid can increase risk asd recently epigenetic influence asd have come to forefront investigation etiology prevention treatment disorder epigenetics refers to dna modification alter gene expression making change to dna sequence increasing number pharmaceutical environmental chemical are being implicated etiology asd here specifically focus molecular influence abovementioned chemical epigenetic alteration neuronal glial cell potential connection to asd conclude better understanding phenomenon can lead to more effective intervention asd	Biomolecules	03/04/2024
10.1038/s41467-025-64035-4	macrophage ferroptosis potentiates deficiency induced pulmonary venous arterialization	Zhang J; Mao P; Zhou T; Yue B; Li Y; Qiu Y; Ying K; Wang F; Chen J; Yang J	pulmonary disease pvod is fatal disease characterized remodelling pulmonary vein haemosiderin accumulation macrophage general control nonderepressible deficiency ha been reported pvod patient underlying mechanism which deficiency affect pulmonary venous cell surrounding cell remains unclear here perform immunohistochemistry analysis to show macrophage are major population affected deficiency ferroptosis gene are upregulated lung macrophage pvod patient treatment specific ferroptosis inhibitor revers change haemodynamic index observed hypoxia mouse pvod model rat furthermore deficiency increase iron level to facilitate ferroptosis macrophage enhances arterial marker expression venous endothelial cell vecs specifically spatial transcriptome analysis show increased expression kdr vecs pvod patient finding suggest potential targeting macrophage ferroptosis therapeutic strategy treating related vascular disease using expression specific marker set venous arterialization	Nat Commun	22/09/2025
10.4088/JCP.16f10721	use acetaminophen paracetamol pregnancy risk disorder offspring	Andrade C	prenatal exposure to acetaminophen may result compromised neurodevelopment inflammatory immunologic mechanism predisposition to oxidative stress endocrine endogenous cannabinoid other mechanism several small large prospective study have found association gestational acetaminophen exposure disorder adhd behavior use adhd medication adhd diagnosis offspring childhood only negative study wa small investigation that examined only one aspect attention outcome creditably most study adjusted analysis many not confounds associated adhd risk importantly one pivotal study also adjusted pain infection inflammation fever to reduce confounding indication study found risk light finding single study infection fever pregnancy do not raise adhd risk appears possible use acetaminophen pregnancy is responsible increased risk adhd suggests acetaminophen may not be safe pregnancy is widely believed however fever pregnancy may be associated adverse gestational outcome given present level uncertainty adhd risk acetaminophen is suggested more data are available use acetaminophen pregnancy should not be denied situation which need drug is clear	J Clin Psychiatry	01/03/2016
10.1038/s41564-025-02119-z	metagenomics reveals microbiome diversity tick specie	Du LF; Shi W; Cui XM; Fan H; Jiang JF; Bian C; Ye RZ; Wang Q; Zhang MZ; Yuan TT; Xia LY; Ruan XD; Chang QC; Du CH; Que TC; Wang X; Han XH; Yang TC; Jiang BG; Chen JY; Wang XR; Tan LF; Liu YW; Deng LL; Liu Y; Zhu Y; Pan YS; Wang N; Lin ZT; Li LF; Li C; Shen SJ; Liu YT; Tian D; Han XY; Wang J; Wang YF; Gao WY; Li YY; Xiong T; Wang TH; Shi XY; Zhu DY; Zhu JG; Wang CC; Shi WQ; Zhan L; Liu ZH; Feng D; Zhao L; Sun Y; Wang J; Jia N; Zhao F; Cao WC	tick are arthropod vector capable transmitting wide spectrum pathogen affecting human animal however have relatively limited information genomic characteristic diversity associated microbiomes here used sequencing sample tick specie eight genus china to determine genome associated pathogen microbiome novo assembly reconstructed bacterial genome representing bacterial specie which genome represented potentially pathogenic specie computational analysis found nutritional endosymbionts to be prevalent highly specific to tick genus microbiome association study revealed host genetic variant linked to pathogen diversity abundance key biological pathway essential to tick biology including pathogen invasion finding provide resource studying interaction tick paving way strategy to control tick population disease	Nat Microbiol	23/09/2025
10.7314/apjcp.2013.14.4.2191	equol adiponectin insulin level risk breast cancer	Minatoya M; Kutomi G; Asakura S; Otokozawa S; Sugiyama Y; Nagata Y; Mori M; Hirata K	breast cancer is one most frequently diagnosed cancer leading cause cancer death woman soy isoflavones have been widely studied isoflavones equol ha been gaining interest regard to relationship breast cancer risk obesity ha been revealed one breast cancer risk factor known to be associated high level circulating insulin decreased level adiponectin hence there have been many study investigating relationship insulin adiponectin level breast cancer risk additionally recent finding have suggested insulin adiponectin may have influence breast cancer development independent obesity present review discus relationship breast cancer risk equol insulin adiponectin level which are three important factor ongoing study herein factor are reviewed not only clinical viewpoint also possible chemical biological point view which may explain clinical observation	Asian Pac J Cancer Prev	01/01/2013
10.1038/s43587-025-00957-4	herbal terpenoids activate autophagy mitophagy modulation bioenergetics protect metabolic stress sarcopenia epigenetic aging	Civiletto G; Brunetti D; Lizzo G; Muller K; Jacot GE; Daskalaki I; Sizzano F; Huh M; Di Meo I; Colombo MN; Sanchez-Garcia JL; Bétrisey BJ; Zollinger A; Lino P; Neal C; Egesipe AL; Richard J; Chimen M; Hermant A; Brinon B; Texari L; Metairon S; Qureshi MA; Patel DS; Vanapalli SA; Malavolta M; Gao AW; Lalou A; Provinciali M; Orlando F; Tiranti V; Brooke RT; Horvath S; Auwerx J; Feige JN; Gut P	small molecular food component contribute to health benefit diet rich fruit vegetable herb spice cellular mechanism which noncaloric bioactives promote healthspan are not well understood limiting use disease prevention here deploy screen zebrafish to profile compound activation autophagy cellular quality control mechanism that promotes healthy aging identify thymol carvacrol activator autophagy mitophagy transient dampening mitochondrial membrane potential chemical stabilization mitochondrial depolarization block mitophagy activation suggesting mechanism originating mitochondrial membrane supplementation thymol prevents excess liver fat accumulation mouse model obesity improves heat stress resilience caenorhabditis elegans slows decline skeletal muscle performance delaying epigenetic aging mouse thus terpenoids common herb promote autophagy aging metabolic overload making attractive molecule healthspan promotion	Nat Aging	24/09/2025
10.1038/s41590-025-02267-8	spatial genomics atlas human skin fibroblast reveals shared fibroblast subtypes tissue	Steele L; Olabi B; Roberts K; Mazin PV; Koplev S; Tudor C; Rumney B; Admane C; Jiang T; Correa-Gallegos D; Chakala KP; Binkevich A; Gopee NH; Predeus A; Prete M; Winheim E; Annusver K; Forsthuber A; Francis L; Frech S; Ganier C; Layton T; Liu Y; Yuan H; Gudjonsson JE; Lichtenberger BM; Mahil S; Nanchahal J; O&#x27;Toole EA; Plikus MV; Rinkevich Y; Rognoni E; Smith CH; Teichmann SA; Kasper M; Foster AR; Lotfollahi M; Haniffa M	fibroblast sculpt architecture cellular microenvironments various tissue here constructed spatially resolved atlas human skin fibroblast healthy skin skin disease comparison to disease define six major skin fibroblast subtypes health three that are characterize two fibroblast subtypes further are conserved tissue are first fibroblastic reticular fibroblast is fibroblastic reticular subtype that is predicted to maintain superficial perivascular immune niche second inflammatory myofibroblasts characterizes early human skin wound inflammatory disease scarring risk cancer inflammatory myofibroblasts were predicted to recruit neutrophil monocyte cell multiple human tissue study provides harmonized nomenclature skin fibroblast health disease contextualized finding clinical skin disease profile	Nat Immunol	24/09/2025
10.4088/JCP.16f10637	use acetaminophen paracetamol pregnancy risk autism spectrum disorder offspring	Andrade C	acetaminophen paracetamol is available counter most country is widely considered to be safe use pregnancy study report gestational exposure to acetaminophen lie range acetaminophen influence inflammatory immunologic mechanism may predispose to oxidative stress other effect are hypothesized to have potential to compromise neurodevelopment fetal infant brain two ecological study suggested trend use acetaminophen were associated trend autism one study specifically examined acetaminophen use pregnancy one large prospective observational cohort study found gestational exposure to acetaminophen especially when duration exposure wa day more wa associated motor milestone delay gross fine motor impairment communication impairment impairment internalizing externalizing behavior hyperactivity age year however social emotional developmental behavior were mostly unaffected very recent large cohort study found gestational exposure to acetaminophen wa associated increased risk autism spectrum disorder only when hyperkinetic disorder wa also present light existing data associating acetaminophen use pregnancy subsequent risk disorder new finding suggests predisposition is hyperkinetic syndrome rather to autism summary empirical data are very limited whatever empirical data exist do not support suggestion use acetaminophen pregnancy increase risk autism offspring	J Clin Psychiatry	01/02/2016
10.1038/s41568-025-00872-1	immune microenvironment colorectal cancer	Kennel KB; Greten FR	colorectal cancer crc progression depends close interaction tumour cell tumour microenvironment tme tme contributes to poor therapy response immune evasion immune cell tme can be therapeutically leveraged exemplified immune checkpoint blockade icb unfortunately only small subset patient crc benefit icb therapy microsatellite unstable crc respond predominant group patient crc tumour do not challenging modulating tme crc to convert lowly immunogenic immunosuppressed tumour tumour hold tremendous therapeutic potential review provide overview cellular molecular component immunity tme crcs various stage disease a well mechanism immunosuppression immune evasion further describe how systemic local therapy crc impact tumour systemic immune microenvironments how immunity could serve therapeutic prognostic biomarker lastly highlight novel immunotherapeutic strategy approach that modulate tme crcs to make amenable to immunotherapy	Nat Rev Cancer	22/09/2025
10.1001/jama.2025.15185	levodopa added to stroke rehabilitation estrel randomized clinical trial	Engelter ST; Kaufmann JE; Zietz A; Luft AR; Polymeris A; Altersberger VL; Wiesner K; Wiegert M; Held JPO; Rottenberger Y; Schwarz A; Medlin F; Accolla EA; Foucras S; Kägi G; De Marchis GM; Politz S; Greulich M; Tarnutzer AA; Sturzenegger R; Katan M; Fischer U; Nedeltchev K; Schär J; Van Den Keybus Deglon K; Rapin PA; Salerno A; Seiffge DJ; Auer E; Lippert J; Bonati LH; Schuster-Amft C; Gäumann S; Chabwine JN; Humm A; Möller JC; Schweinfurther R; Bujan B; Jedrysiak P; Sandor PS; Gonzenbach R; Mylius V; Lutz D; Lienert C; Peters N; Michel P; Müri RM; Schädelin S; Hemkens LG; Ford GA; Lyrer PA; Gensicke H; Traenka C	importance levodopa enhances dopaminergic signaling may stimulate neuroplasticity which could potentially enhance motor recovery stroke levodopa is used stroke rehabilitation mixed evidence effectiveness objective to determine levodopa compared placebo administered addition to standardized rehabilitation based active training is associated enhanced motor recovery patient acute stroke design setting participant randomized clinical trial stroke unit center collaborating rehabilitation center switzerland june first patient first visit august last patient last visit patient acute ischemic hemorrhagic stroke clinically meaningful hemiparesis ie total score point following national institute health stroke scale item motor arm motor leg limb ataxia were randomized to receive levodopa placebo statistical analysis were conducted november to august intervention patient received mg placebo time daily day alongside standardized rehabilitation therapy based active training main outcome measure primary outcome wa adjusted mean difference assessment fma total score range point fewer point indicate worse motor function difference considered month result participant median iqr age year female median baseline fma total score participant died month leaving participant eligible primary analysis month median iqr fma total score wa point levodopa group point placebo group mean difference fma total score levodopa placebo group wa point ci to there were serious adverse event levodopa group placebo group most common wa infection levodopa placebo conclusion relevance randomized clinical trial patient receiving inpatient rehabilitation acute stroke levodopa added to standardized rehabilitation did not significantly improve motor function month compared placebo standardized rehabilitation result do not support use levodopa adjunct to rehabilitation therapy enhancing motor recovery acute stroke trial registration identifier	JAMA	22/09/2025
10.1136/vr.128.9.199	bovine spongiform encephalopathy epidemiological study origin	Wilesmith JW; Ryan JB; Atkinson MJ	result further epidemiological study bovine spongiform encephalopathy bse support previous finding onset exposure cattle population to agent sufficient to result clinical disease occurred onset exposure wa related to cessation two rendering plant hydrocarbon solvent extraction fat meat bone meal further possible explanation related to geographical variation reprocessing greave to produce meat bone meal wa identified geographical variation incidence bse	Vet Rec	02/03/1991
10.1136/bmj-2025-085029	first mammography screening participation breast cancer incidence mortality subsequent year population based cohort study	Ma Z; He W; Zhang Y; Mao X; Tapia J; Hall P; Humphreys K; Czene K	objective to determine woman who did not attend first mammography screening invitation have long term risk poor screening adherence breast cancer outcome design population based cohort study setting stockholm sweden participant woman who received invitation to swedish mammography screening programme were initially invited year age year age main outcome measure screening adherence breast cancer incidence tumour characteristic breast cancer mortality tracked linkage to multiple swedish national register to year period cumulative breast cancer incidence were calculated first screening participation cox proportional hazard model estimated hazard ratio breast cancer mortality logistic regression model assessed association tumour characteristic odds ratio result total person year new case breast cancer were documented woman invited to first mammography screening did not participate were persistently less likely to attend subsequent screening were more likely have symptom detected advanced stage breast cancer diagnosed specifically compared first screening participant had odds ratio confidence interval to stage iii cancer case to stage iv cancer case total person year death breast cancer were documented first screening wa also associated significantly higher breast cancer mortality year cumulative mortality versus participant adjusted hazard ratio confidence interval to contrast year breast cancer incidence wa similar group participant versus suggesting elevated mortality first screening likely reflects delayed detection rather increased incidence conclusion study show first screening represent large population long term risk dying breast cancer providing opportunity targeted intervention to improve adherence to screening thereby decrease mortality risk	BMJ	24/09/2025
10.1016/j.cell.2025.08.035	fluorescent protein expand fluorescent microscopy temporal spectral domain	Tan Z; Hsiung CH; Feng J; Zhang Y; Wan Y; Chen J; Sun K; Lu P; Zang J; Yang W; Gao Y; Yin J; Zhu T; Lu Y; Pan Z; Zou Y; Liao C; Li X; Ye Y; Liu Y; Zhang X	fluorescence microscopy ha been widely applied life science while intensity signal is widely used tr signal using fluorescence lifetime remains underexplored herein present family fluorescent protein rationally controlled lifetime using strategy that regulates lifetime affecting spectrum fps have developed series cover visible spectrum wide range lifetime are employed resolved microscopy allowing simultaneous imaging different protein live cell correlation multiple activity to cell cycle furthermore enable multiplexing microscopy that concurrently visualizes protein using lifetime signal are demonstrated to quantify stoichiometry cellular protein work introduces concept development transformative toolset presenting opportunity to integrate system complexity quantitative accuracy biological research	Cell	22/09/2025
10.1152/japplphysiol.01354.2007	resistance training induces qualitative change muscle morphology muscle architecture muscle function elderly postoperative patient	Suetta C; Andersen JL; Dalgas U; Berget J; Koskinen S; Aagaard P; Magnusson SP; Kjaer M	negative effect bed rest muscle strength muscle mass are well established still remains challenge to identify effective method to restore physical capacity elderly patient recovering hospitalization present study compared different training regime respect to muscle strength muscle fiber size muscle architecture stair walking power elderly postoperative patient patient yr scheduled unilateral hip replacement surgery due to hip osteoarthritis were randomized to resistance training rt wk electrical stimulation e wk standard rehabilitation sr wk measurement were performed baseline wk wk postsurgery wk resistance training maximal dynamic muscle strength increased degree lt degree lt muscle fiber area increased type lt type iia lt type iix muscle fiber lt muscle fiber pennation angle increased muscle thickness increased lt furthermore stair walking power increased lt wa related to increase type ii fiber area lt contrast there wa increase measurement outcome electrical stimulation standard rehabilitation present study is first to demonstrate effectiveness resistance training to induce beneficial qualitative change muscle fiber morphology muscle architecture elderly postoperative patient contrast rehabilitation regime based functional exercise neuromuscular electrical stimulation had effect present data emphasize importance resistance training future rehabilitation program elderly individual	J Appl Physiol (1985)	01/07/2008
10.1182/blood.2025029360	talquetamab daratumumab treatment relapsed refractory multiple myeloma study	Chari A; van de Donk NWCJ; Dholaria B; Weisel KC; Mateos MV; Goldschmidt H; Martin TG; Morillo D; Reece D; Rodriguez-Otero P; Bhutani M; D&#x27;Souza A; Oriol A; Rosiñol L; Bahlis NJ; Vishwamitra D; Skerget S; Verona RI; Bakshi KK; Kang L; Prior TJ; Vandenberk L; Tolbert J; Lee S; Smit D; Wäsch R	talquetamab bispecific antibody multiple myeloma rrmm daratumumab may lead to deeper more durable response therapy alone phase study patient rrmm least prior line therapy double refractory to proteasome inhibitor immunomodulatory drug received subcutaneous talquetamab weekly qw quot cohort quot other week quot cohort quot daratumumab mg approved schedule primary end point wa safety secondary end point included overall response duration response survival wa exploratory end point patient median prior line therapy refractory bispecific received talquetamab daratumumab qw median month most common adverse event were oral event skin event cytokine release syndrome infection grade event occurred two patient had toxicity cohort grade mucositis grade maculopapular rash response occurred qw cohort cohort patient median survival wa month respectively cohort pharmacodynamic result suggest immunomodulatory action daratumumab contributes to conducive environment talquetamab reducing immunosuppressive cell talquetamab daratumumab demonstrated promising efficacy outcome heavily pretreated patient safety profile consistent agent monotherapy id	Blood	22/09/2025
10.1016/S2213-2600(25)00209-7	retifanlimab versus placebo combination chemotherapy patient squamous metastatic lung cancer phase multiregional randomised study	Lu S; Vynnychenko O; Kulyaba Y; Kuchava V; Ibrahim A; Moiseenko F; Arslan C; Nguyen DT; Petrovic M; Cicin I; Bibichadze K; Cil T; Shi J; Olmez OF; Gogishvili M; Artac M; Nguyen HG; Cornfeld M; Tian C; Munteanu MC; Sette CVM; Bondarenko I	background checkpoint inhibitor including combination chemotherapy have shown survival benefit patient metastatic lung cancer nsclc however access to drug varies aimed to evaluate efficacy inhibitor retifanlimab chemotherapy treatment squamous metastatic nsclc method wa phase multiregional randomised study conducted approximately hospital private clinical centre country male female adult aged year older squamous stage iv nsclc staging american joint committee cancer version eastern cooperative oncology group performance status previous systemic therapy metastatic nsclc were eligible patient were randomly assigned using interactive response technology to receive intravenous retifanlimab mg matching placebo day cycle standard chemotherapy according to tumour histology to year patient nsclc received pemetrexed cisplatin day four cycle carboplatin area curve auc day four cycle followed pemetrexed day subsequent cycle administered intravenously disease progression unacceptable toxicity patient squamous nsclc received intravenous carboplatin auc intravenous paclitaxel day four cycle intravenous day four cycle treatment retifanlimab placebo wa given up to cycle there wa disease progression unacceptable toxicity withdrawal consent randomisation wa stratified expression tumour proportion score geographical region predominant tumour histology primary endpoint wa overall survival defined time randomisation death due to cause analysed full analysis set safety wa evaluated randomly assigned patient who received least one dose study drug trial is registered is active longer enrolling finding sept march patient were assessed eligibility whom were randomly assigned to retifanlimab plus chemotherapy placebo chemotherapy patient had nsclc had squamous nsclc patient were male were female median age wa year iqr median overall survival wa longer retifanlimab chemotherapy group placebo chemotherapy group month ci v month ratio ci overall higher incidence adverse event that were serious v grade worse v led to retifanlimab placebo dose delay v discontinuation v nine were observed retifanlimab chemotherapy group placebo chemotherapy group proportion fatal adverse event were similar retifanlimab chemotherapy group placebo chemotherapy group four v five interpretation retifanlimab improved overall survival compared placebo when added to chemotherapy safety profile that is representative previous combination adding retifanlimab to chemotherapy could be potential treatment option patient squamous metastatic nsclc funding incyte	Lancet Respir Med	19/09/2025
10.4239/wjd.v16.i9.109123	saving muscle losing weight vital strategy sustainable result related drug	Cigrovski Berkovic M; Ruzic L; Cigrovski V; Strollo F	obesity affect billion people worldwide is linked to more health complication cardiovascular disease being leading cause mortality losing body weight is considered clinically significant improving health weight loss can be achieved pharmacotherapy including peptide receptor agonist insulinotropic dual receptor agonist insulinotropic triple receptor agonist such semaglutide tirzepatide retatrutide respectively much weight loss come fat mass treatment also result loss lean mass including muscle loss muscle may contribute to difficulty maintaining weight long term can lead to sarcopenia therefore focus new treatment should be primarily reducing fat mass minimizing loss muscle mass ideally promoting muscle gain research focusing human myocytes ha identified more myokines associated muscle contraction which may play crucial role preserving muscle mass function explored potential new agent combination therapy to achieve outcome further study are needed to better understand functional implication lean mass expansion weight loss weight maintenance program	World J Diabetes	15/09/2025
10.1038/s41467-025-62419-0	shared genetic architecture contributes to risk major cardiovascular disease	Qiao J; Jiang L; Cai L; Chang M; Wang C; Zhao R; Song S; Zhao Y; Chen M; Ding S; Tan N; He P; Sadayappan S; Xu J; Pauklin S; Liu Z; Feng Y	extensive cardiovascular disease cvds evidenced epidemiological study is supported positive genetic correlation identified comprehensive genetic investigation suggesting shared genetic basis however precise genetic mechanism underlying association remain elusive assessing genetic correlation genetic overlap causal connection aim to shed light common genetic underpinnings major cvds employing analysis pursue diverse strategy to unveil shared genetic element encompassing snp gene gene set functional category pleiotropic implication study systematically quantifies genetic overlap genetic correlation cvds identifying putative causal relationship coronary artery disease cad heart failure hf then pinpointed genomic locus pleiotropic influence cvds which most influential pleiotropic locus is located lpa gene notably locus present high evidence colocalization display congruent directional effect examination gene gene set linked to locus unveiled robust association circulatory system development process intriguingly distinct pattern predominantly driven atrial fibrillation coronary artery disease venous thromboembolism significant disparity clinically defined cvd classification underlying shared biological mechanism according to functional annotation finding	Nat Commun	24/09/2025
10.1038/s42255-025-01371-1	mapping plasma metabolome to human health disease adult	You J; Cui XH; Chen YL; Wang YX; Li HY; Qiang YX; Cheng JY; Deng YT; Guo Y; Ren P; Zhang Y; He Y; He XY; Chen SD; Zhang YR; Huang YY; Mao Y; Feng JF; Cheng W; Yu JT	systematic characterization metabolic profile human health disease enhances precision medicine here present comprehensive human atlas using data uk biobank participant nuclear magnetic resonance metabolic measure atlas link plasma metabolite to disease trait participant being prospectively followed median year atlas uncovered association where ratio cholesterol to total lipid large lipoprotein percentage wa found metabolite associated highest number disease addition found more half metabolite showed statistical variation healthy individual decade disease onset combined demographic metabolic risk score signified top metabolite biomarkers yielding favourable classification performance area curve gt prevalent incident disease finally mendelian randomization analysis provided support causal relationship pair which exhibited shared genetic determinant additional insight can be gleaned accessible interactive resource http	Nat Metab	19/09/2025
10.1093/jnci/djaf201	adiposity distribution risk cancer mendelian randomization analysis	Hazelwood E; Goudswaard LJ; Lee MA; Vabistsevits M; Pournaras DJ; Brenner H; Buchanan DD; Gruber SB; Gsur A; Li L; Vodickova L; Grant RC; Samadder NJ; Timpson NJ; Gunter MJ; Schuster-Böckler B; Yarmolinsky J; Richardson TG; Freisling H; Murphy N; Vincent EE	introduction there is convincing evidence overall adiposity increase risk several cancer distribution adiposity play similar role is unclear method used mendelian randomization mr to examine causal relationship adiposity distribution trait abdominal subcutaneous adipose tissue asat visceral adipose tissue vat gluteofemoral adipose tissue gfat fat pancreas fat risk cancer endometrial ovarian breast colorectal pancreas multiple myeloma liver kidney renal cell thyroid gallbladder esophageal adenocarcinoma meningioma result sample size association study gwas ranged to median found evidence higher genetically predicted asat increased risk endometrial cancer liver cancer esophageal adenocarcinoma odds ratio confidence interval ci standard deviation sd higher asat to to to respectively conversely found evidence higher genetically predicted gfat decreased risk breast cancer meningioma or ci sd higher genetically predicted gfat to to respectively also found evidence effect higher genetically predicted vat liver fat increased liver cancer risk or ci sd higher genetically predicted adiposity trait to to respectively discussion analysis provide novel insight relationship adiposity distribution cancer risk insight highlight potential importance adipose tissue distribution maintaining healthy weight cancer prevention	J Natl Cancer Inst	24/09/2025
10.1093/nar/gkaf875	dna polymerase kappa is primary translesion synthesis polymerase aldehyde icls	van der Sluijs RV; Verkennis AEE; Hodskinson MR; Barnett J; Cruz VM; Hernandez-Quiles M; Liolios T; Morton SB; Hendrikx A; Bos C; Post H; Millington CL; Rouillon C; Ricci G; Mattiroli F; Williams DM; Altelaar M; Vermeulen M; Patel KJ; Knipscheer P	dna interstrand crosslinks icls are highly cytotoxic lesion that block essential cellular process replication transcription endogenous icls can be induced reactive aldehyde produced normal cellular metabolism defective repair icls is associated fanconi anaemia fa cancer predisposition syndrome previously showed icls are repaired fa pathway novel pathway here demonstrate icls induced acrolein cellular aldehyde are also repaired pathway establishing generality aldehyde icl repair focusing fa pathway identify dna polymerase kappa polκ primary translesion synthesis tl polymerase responsible insertion step lesion bypass unhooked aldehyde icls function requires polκ catalytic activity pcna interaction domain is independent interaction contrast polκ ha role extension step cisplatin icl repair that is dependent interaction work reveals key role polκ aldehyde icl repair provides mechanistic insight how different icl structure determine choice tl polymerase repair	Nucleic Acids Res	23/09/2025
10.1111/apa.14614	study early randomised paracetamol trial to preterm infant found adverse reaction corrected age	Juujärvi S; Kallankari H; Pätsi P; Leskinen M; Saarela T; Hallman M; Aikio O	aim examined outcome safety early intravenous paracetamol ductus arteriosus closure corrected age two year method wa randomised preterm infant paracetamol study oulu university hospital finland which recruited very preterm infant hour birth received intravenous paracetamol placebo four day followed up infant two year corrected age included clinical neurodevelopmental assessment parental medical history questionnaire result infant boy were born week gestation difference cardiac parameter including blood pressure ultrasound scan result were found neurodevelopmental stage quantified griffith test were similar sign autism were reported asthma medication wa more common control group difference wa not significant atopy score number infection use public health service were similar two group conclusion adverse reaction early intravenous paracetamol were detected two year later larger trial are needed safety efficacy paracetamol prophylaxis early ductal closure very preterm infant	Acta Paediatr	01/03/2019
10.1016/j.ijnurstu.2025.105216	nursing judgment age generative artificial intelligence study clinical performance emergency nurse	Levin C; Zaboli A; Turcato G; Saban M	background clinical is core competency emergency nursing requiring rapid accurate assessment growing integration generative artificial intelligence healthcare there is pressing need to understand potential clinical decision support tool generative artificial intelligence model show high accuracy consistency ability to navigate complex scenario remains question objective study aimed to compare clinical performance emergency nurse israel italy generative artificial intelligence model evaluated difference severity assessment hospitalization decision test selection exploring influence demographic professional characteristic decision accuracy method prospective observational study wa conducted emergency nurse italy israel independently evaluating five standardized clinical case decision were compared generated generative artificial intelligence model using structured evaluation rubric statistical analysis included anova test logistic regression receiver operating characteristic curve analysis to assess predictive accuracy result generative artificial intelligence model exhibited higher overall decision accuracy stronger alignment expert recommendation however notable discrepancy emerged hospitalization decision severity assessment example case generative artificial intelligence rated severity level italian israeli nurse rated respectively lt case only italian nurse recommended hospitalization compared to israeli nurse generative artificial intelligence model advised hospitalization nurse showed greater variability test selection severity judgment reflecting use clinical intuition contextual reasoning demographic such age gender year experience did not significantly predict accuracy conclusion generative artificial intelligence model demonstrated consistency expert alignment lacked contextual sensitivity vital emergency care result highlight potential generative artificial intelligence clinical tool emphasizing continued importance human clinical judgment	Int J Nurs Stud	12/09/2025
10.1146/annurev-virology-092818-015907	cancer human lifelong search contribution infectious agent autobiographic note	Zur Hausen H	review briefly cover period early life experience world war ii school education period medical student bonn hamburg düsseldorf mainly emphasized is scientific career finishing medical internship period postdoc institute microbiology düsseldorf virus laboratory child hospital philadelphia senior research fellow institute virology würzburg germany subsequent appointment chairman newly established institute virology university similar position university freiburg then year scientific director deutsches krebsforschungszentrum heidelberg are discussed covering scientific development period emeritus period wa particularly exciting leading to discovery autonomously replicating plasmid derived specific bacteria link to common human cancer colon breast prostate	Annu Rev Virol	29/09/2019
10.1038/s41564-025-02107-3	oxaloacetate sensing promotes innate immune antiviral defence influenza virus infection	Jin S; He X; Wang Z; Zhou T; Wang J; Pan G; Zhang Y; Ma L; Yang S; Wang L; Wu Y; Zou Y; Qi N; Cui J	metabolic pathway determine cellular fate function however exact role metabolite host defence influenza virus remain undefined here employed pharmacological inhibition metabolomics analysis to show metabolic pathway oxaloacetate oaa are integrated antiviral response to influenza virus cytosolic malate dehydrogenase sens intracellular oaa to undergo dimerization function scaffold to recruit transcription factor phosphorylation kinase serine phosphorylated translocates nucleus support optimal expression indispensable activator type interferon response oaa supplementation provides antiviral ability oaa deficiency caused acly genetic ablation decrease antiviral immunity render mouse more susceptible to lethal virus infection result signalling pathway cellular oaa sensing link metabolism innate immunity to coordinate defence viral challenge	Nat Microbiol	22/09/2025
10.4274/dir.2025.253249	imaging chronic thromboembolic pulmonary hypertension review current literature	Hekimoglu K; Gopalan D; Onur MR; Kahraman G; Akay T	chronic thromboembolic pulmonary hypertension cteph is severe complication pulmonary embolism pulmonary hypertension ph combination insufficient resolution thrombus following pulmonary embolus accompanying microvascular disease result ph advance imaging can offer better insight cteph diagnosis management lack disease awareness radiologist ha been shown to be cause cteph misdiagnosis delayed diagnosis review highlight feature pertinent to cteph diagnosis primary focus is different modality distinctive sign newly developed technology employing artificial intelligence system	Diagn Interv Radiol	23/09/2025
10.1016/j.xcrm.2025.102348	global regional national burden headache disorder forecast to global burden disease study	Wijeratne T; Oh J; Kim S; Yim Y; Kim MS; Shin JI; Oh YS; Jung R; Kim YS; Smith L; Aalruz H; Abd-Rabu R; Abdulah DM; Aboagye RG; Abolmaali M; Abtahi D; Abualhasan A; Adedoyin RA; Adnani QES; Afrashteh F; Aggarwal N; Ahmad D; Ahmadi A; Ahmadi NS; Ahmadzade AM; Ahmed SA; Al Awaidy S; Alabbad S; Alajlani MM; Al-Ajlouni Y; Ali MU; Ali SS; Ali W; Almazan JU; Alshahrani NZ; Altaf A; Al-Wardat M; Alzoubi KH; Amiri S; Amu H; Amusa GA; Anderson DB; Anwar S; Areda D; Asghari-Jafarabadi M; Ashina S; Ashraf J; Ashraf T; Azargoonjahromi A; Bahurupi Y; Baig AA; Bandyopadhyay S; Bardhan M; Barqawi HJ; Bashiri A; Bastan MM; Bemanalizadeh M; Bensenor IM; Berhie AYY; Bhagavathula AS; Bhaskar S; Bhat V; Bhatti GK; Bhatti JS; Bilgin C; Biswas A; Bizzozero-Peroni B; Bustanji Y; Cámera LA; Caronna E; Carvalho AF; Chakraborty S; Ching PR; Christodoulou N; Chu DT; Chu H; Cruz-Martins N; Dadras O; Dai X; D&#x27;Amico E; Darwish AH; Deekonda S; Devanbu VGC; Dharmaratne SD; Dima A; Dinkayehu TE; Do H; Doku PN; Doshi OP; E&#x27;mar AR; Eissazade N; Eltaha C; Fahim A; Fares J; Farjoud Kouhanjani M; Faro A; Fazeli P; Fereshtehnejad SM; Ferrara P; Ferreira N; Fischer F; Fornari A; Gajdács M; Gebregergis MW; Ghadimi DJ; Ghaffari Jolfayi A; Gnedovskaya EV; Golechha M; Gomez Figueroa E; Hashempur MH; Hasnain MS; Hassan A; Hassan N; Hassan Zadeh Tabatabaei MS; Hegazy MI; Heidari G; Helfer B; Hossain MM; Househ M; Hu C; Iavicoli I; Ilesanmi OS; Ilic IM; Ilyas MF; Ilyasu S; Ismail NE; Jafari-Khounigh A; Jahrami H; Janodia MD; Jayasinghe RD; Jeswani BM; Jonas JB; Joseph N; Kalani R; Khan MAB; Khateri S; Khatib MN; Khayat Kashani HR; Khidri FF; Khormali M; Khosravi S; Kim YJ; Kompani F; Kostev K; Krishan K; Krishnan B; Defo BK; Kuddus M; Kulimbet M; Kumar R; Kumar V; Kytö V; Lasrado S; Lee SW; Lenzi J; Leonardi M; Lucchetti G; Lugo A; Makhdoom IF; Mallahzadeh A; Mansouri V; Marzo RR; Mathangasinghe Y; Mayeli M; Mehmood A; Meretoja A; Mestrovic T; Mettananda S; Minervini G; Mishra A; Mithra P; Mohamed Ahmed KAH; Mohammadzadeh I; Mohammed S; Monasta L; Morrison SD; Nabavi A; Natto ZS; Nauman J; Nieddu L; Nugen F; Olagunju AT; Oliveira AB; Oliveira WS; Omar HA; Omer GL; Otstavnov N; P A M; Panos LD; Parikh RR; Patil S; Patra A; Pedersini P; Pensato U; Peprah P; Peres MFP; Piradov MA; Pozo-Rosich P; Pradhan J; Prakash S; Prashant A; Puvvula J; Rafiei A; Raggi A; Rahmani AM; Ramadan MM; Rathish D; Rautalin I; Rawaf S; Rezaeian M; Rezazadeh Eidgahi D; Rhee TG; Roy P; Saad Eddin A; Sabet CJ; Saddik BA; Sadeghi E; Saeed U; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Sahoo PM; Salimi S; Samy AM; Saulam J; Sawhney M; Senol YC; Senthilkumaran S; Sethi Y; Seyedmirzaei H; Shafie M; Shamsi A; Sharifan A; Shehata HS; Shenoy RR; Shokraneh F; Sidhu JK; Singh B; Singh H; Singh JA; Singh S; Skryabina AA; Sobia F; Srichawla BS; Suresh V; Swain CK; T Y SS; Tabaee Damavandi P; Tabche C; Tabish M; Tanwar M; Temsah MH; Teramoto M; Tran NM; Tran TH; Tsatsakis A; Udoakang AJ; Usman JS; Uzunçıbuk H; Van den Eynde J; Vasankari TJ; Venketasubramanian N; Villafañe JH; Wang L; Wang X; Wang YP; Wiangkham T; Winkler AS; Wollie AM; Xiao Z; Yismaw YEE; Yousuf A; Zhao Z; Zielińska M; Chu MK; Song TJ; Yon DK; Feigin VL	headache disorder especially migraine headache tths are major global public health concern shown global burden disease injury risk factor study gbd provide updated global estimate prevalence year lived disability ylds to country territory forecast there are billion people tth billion migraine tth is more prevalent migraine cause higher disability crude prevalence ylds increased rate remained stable are projected to continue trend due to population growth there is disproportionately higher burden woman aged country higher index healthcare access quality index migraine remain underrecognized health policy funding study emphasizes urgent need to prioritize headache disorder global health agenda	Cell Rep Med	18/09/2025
10.1002/advs.202504088	transcriptomics reveals metabolic reprogramming immune crosstalk pediatric thyroid carcinogenesis	Zhan ZJ; Li N; Sun Y; Chen L; Yin JD; Shan YH; Zeng JX; Li ZC; Tan HL; Tang N; Chang S; Huang P	pediatric papillary thyroid carcinoma pptc ha exhibited progressive increase incidence recent year characterized heightened biological aggressiveness relative to adult papillary thyroid carcinoma aptc nevertheless molecular mechanism governing pathobiology remain elusive rna sequencing analysis cellular transcriptomes pptc aptc clinical specimen phenotypically distinct cellular subpopulation hi cell mechanistically responsible pptc distinct clinical behavior is identified integrating organoid model vivo functional validation multiplex immunohistochemistry is demonstrated orchestrates dual oncogenic pathway augmentation glycolytic flux induction macrophage polarization synergistic mechanism fundamentally drive pptc oncogenesis metastatic progression independent clinical cohort consistently confirms translational significance finding characterization cellular ecosystem signaling cascade establishes mechanistic framework advancing diagnostic precision targeted therapeutic development	Adv Sci (Weinh)	23/09/2025
10.1097/JS9.0000000000003525	simultaneous assessment stress hyperglycemia ratio glucose variability to predict mortality sepsis patient different glucose metabolic state observational cohort study interpretable machine learning approach	Wang F; Guo Y; Jiao C; Zhao S; Sui L; Mao Z; Lu R; Hou R; Zhu X	background stress hyperglycemia ratio shr glycemic variability gv reflect acute glucose elevation fluctuation which are associated adverse outcome patient disease however relationship combined assessment shr gv mortality risk sepsis remains unclear study aim to investigate association shr gv combination sepsis mortality individual different glucose metabolic state to develop mortality prediction model using machine learning ml model method patient sepsis were screened database stratified normal glucose regulation ngr mellitus diabetes mellitus dm group based glucose metabolic status association mortality were analyzed using km curve cox proportional hazard model restricted cubic spline rcs landmark analysis five ml algorithm were employed prediction shapley additive explanation shap interpreting key predictor result total patient were enrolled median age year overall patient died icu patient died day admission to icu ngr patient combined high shr gt highest tertile high gv gt highest tertile based tertile highest mortality risk hr ci patient low gv shr lt gv gt showed greatest mortality risk hr ci dm patient high gv shr gt gv lt had highest mortality risk hr ci machine learning xgboost auc random forest auc logistic regression auc strongest predictive performance endpoint conclusion combined assessment shr gv may provide useful information predicting mortality sepsis individual ngr integrated approach highlight potential need personalized glycemic management strategy which warrant further investigation prospective study	Int J Surg	24/09/2025
10.1097/HEP.0000000000001523	fxr splicing promotes hepatocarcinogenesis	Wang X; Luo J; Han L; Xu T; Wang H; Zhang M; Li G; Li X; Zhang W; Zhang Y	background aim dysregulation myc oncogene is major genetic event hepatocellular carcinoma hcc farnesoid receptor fxr bile acid ba receptor ha emerged promising therapeutic target various liver disease ba composition fxr isoforms have been shown to be significantly altered human hccs study aimed to investigate potential role hepatocarcinogenesis approach result hcc wa induced mouse hydrodynamic injection myc oncogene analysis revealed elevated ba level particularly primary conjugated ba serum liver hcc mouse qpcr western blot analysis demonstrated suppression bsep dysregulation fxr splicing liver mouse using rna antisense purification coupled mass spectrometry splicing factor wa identified regulator fxr splicing silico vitro study confirmed is direct downstream target myc mouse human functionally overexpression deletion significantly impeded hepatocarcinogenesis mouse moreover combination treatment inhibitor fxr agonist synergistically suppressed proliferation hcc cell analysis clinical hcc sample revealed positive correlation relative expression conclusion is key downstream effector hepatocarcinogenesis critical regulator fxr splicing fxr represent druggable vulnerability hcc	Hepatology	23/09/2025
10.1073/pnas.2504697122	demethylates modification alleviates neuroinflammation brain injury	Cai L; Liang Y; Li X; Fu R; Niu X; Jin Y; Li Y; Zhang Y; Ouyang P; Wang C; Gong Q; Yang Y; Wei L; Jing Y; Yang D; Xu Z; Yuan F; Ding J; Chen H; Peng B; Rao Y; Tian H	neuroinflammation play crucial role progression traumatic brain injury tbi however involvement rna modification process remains elusive rna sequencing rna immunoprecipitation sequencing multiple time point postinjury revealed strong correlation modification gene enriched furthermore demethylase wa identified key regulator dynamic pattern injury site suppression exacerbated neuroinflammation vitro worsened neurological deficit controlled cortical impact cci model rna assay revealed wa downstream target demethylation demethylation stabilized mrna enhanced protein expression which turn suppressed neuroinflammation inhibiting pathway conversely depletion impaired functional recovery injury finding unveiled critical regulatory axis that mitigated neuroinflammation tbi underscoring potential therapeutic intervention target tbi progression	Proc Natl Acad Sci U S A	30/09/2025
10.1136/bmj-2025-084062	risk prediction model cancer therapy related cardiac dysfunction patient cancer cancer survivor systematic review	Gomes C; Geels J; Debray TPA; Malekzadeh A; Asselbergs FW; Linschoten M	objective to systematically review prediction model developed validated cancer therapy related cardiac dysfunction ctrcd to quantitatively analyse performance design systematic review data source embase medline cochrane central register controlled trial inception to august eligibility criterion selecting study study that developed externally validated multivariable model to predict ctrcd risk young people child adolescent young adult year older adult year cancer cancer survivor treated systemic antineoplastic agent study radiation induced cardiotoxicity were excluded method two reviewer independently screened study extracted data assessed risk bias using prediction model risk bias assessment tool performance measure were pooled using random effect result study were included reporting developed model externally validated model most model were developed adult primarily breast cancer haematological malignancy to determine pretreatment risk young people most developed model focused long term risk assessment mostly survivor haematological malignancy discrimination calibration metric were reported developed model external validation nearly model were high risk bias developed model underwent external validation four young people eight adult population heart failure society tool wa most frequently validated time mainly patient breast cancer receiving human epidermal growth factor receptor targeted therapy external validation tool consistently underestimated risk observed event rate exceeding predicted risk especially study where mild ctrcd wa most frequently reported outcome patient breast cancer treated agent pooled statistic wa confidence interval to population observed pooled event rate were low risk group lt predicted medium risk group high risk group very high risk group conclusion existing prediction model ctrcd need additional evidence widespread clinical adoption poor reporting key performance metric limited external validation study currently restrict thorough evaluation tool show suboptimal performance especially when mild form ctrcd are included event future research should prioritise validating updating existing model using large clustered datasets various malignancy to enhance assessment performance generalisability clinical utility routine practice systematic review registration prospero	BMJ	23/09/2025
10.1172/jci.insight.193038	cell regulatory phenotype are main producer palmoplantar pustulosis	Do TH; Bogle R; Zhang H; Xing X; Gharaee-Kermani M; Raducu M; Fox J; Jiang R; Plazyo O; Harms PW; Nakamura M; Xing E; Gilliet M; Billi AC; Kahlenberg JM; Modlin RL; Uluckan O; Tsoi LC; Gudjonsson JE	palmoplantar pustulosis ppp is chronic inflammatory skin disorder marked erythematous pustule desquamation palm sol pathway are implicated ppp blocker have shown modest efficacy underscoring need deeper understanding involvement to dissect cellular spatial architecture ppp performed lesional nonlesional healthy acral skin to examine cellular composition transcriptomic profile interaction unbiased clustering revealed major cell type including inflammatory keratinocyte subset enriched signature marked high expression lymphocyte compartment identified hybrid quot quot population coexpressing regulatory marker tigit subset wa distinguished elevated suggesting differentiation spatial analysis demonstrated significant neighborhood enrichment cell supraspinous keratinocytes cell were predominant source signal whereas keratinocytes were predicted main receiver further observed coexpressing gitr specifically site keratinocyte interaction implicating pathway amplification inflammatory loop together integrated spatial profiling uncovers plasticity ppp identifies interaction highlight candidate target precision therapy challenging disease	JCI Insight	23/09/2025
10.1186/s12902-025-02025-9	soluble receptor advanced glycation end product srage level adolescent obesity insulin resistance metabolic syndrome study review literature	Ustkoyuncu PS; Kocer D	objective aim study is to evaluate srage level adolescent obesity to determine relationship srage insulin resistance metabolic syndrome study method thirty adolescent insulin resistance adolescent insulin resistance year old healthy gender age matched control group were included study patient body mass index comprised obesity group value wa accepted insulin resistance metabolic syndrome wa defined based international diabetes federation definition result srage level group obesity were lower control were negative correlated weight body mass index protein uric acid diastolic blood pressure waist circumference waist ratio white blood cell count there were significant difference srage level adolescent metabolic syndrome boy girl also there were significant difference srage level insulin resistance conclusion srage level adolescent obesity decreased there wa difference srage level insulin resistance metabolic syndrome compared to metabolic complication associated obesity are important term causing mortality morbidity understanding mechanism could help to identify therapeutic strategy trial registration http clinicaltrials clinical trial registration date	BMC Endocr Disord	23/09/2025
10.1093/eurjpc/zwaf598	variation remnant cholesterol risk cardiovascular disease national longitudinal cohort study	Zhu X; Xu W; Hao B; Chen Q; Xiong Z; Wang Q; Hou X; Chen Y; Guo J; Chen T	aim remnant cholesterol rc ha been recognized modifiable risk factor cardiovascular disease cvd however association change rc incident cvd remains underexplored most research focusing baseline rc level method data prospective cohort study were derived china health retirement longitudinal study charls rc level were calculated using friedewald equation change rc cumulative rc change rc δrc were assessed comparing rc level wave cox proportional hazard model adjusted potential confounders were used to evaluate impact baseline dynamic rc level incident cvd risk result participant male mean age year followed year participant initially high rc who decreased to low level showed reduced cvd risk hr ci low baseline rc escalating to high level showed similar risk hr ci compared to consistently high rc level highest tertile cumulative rc significantly increased cvd risk hr ci high baseline rc participant lowest δrc tertile had reduced cvd risk hr ci conclusion longitudinal rc increase were associated higher cvd risk rc reduction were associated decreased risk rc monitoring management may contribute to cvd risk assessment prevention further research direct rc measurement clinically validated outcome is needed	Eur J Prev Cardiol	22/09/2025
10.1002/advs.202503897	histone upregulation expression promotes stemness proliferation glioma stem cell	Li J; Tang C; Zhang X; Xing R; Guo Q	glioblastoma gbm is most malignant primary brain tumor adult glioma stem cell gscs subpopulation contributing to treatment resistance recurrence study investigates role lactate regulatory gene kinase regulation gsc stemness utilizing multiple database gscs is discovered lactate enhances stemness proliferation gscs mechanistically lactate promotes histone lactylation promoter gscs thereby upregulating expression enhances binding protein protein stability inhibiting ubiquitination degradation phosphorylates to promote nuclear translocation thereby regulating gsc stemness proliferation pathway additionally nanoliposome effectively suppresses stemness proliferation gscs demonstrating therapeutic potential conclusion lactate regulates stemness proliferation gscs pathway study elucidates role histone lactylation stem cell regulation suggests is potential therapeutic target gbm	Adv Sci (Weinh)	24/09/2025
10.1038/s41413-025-00455-8	research progress sarcopenia musculoskeletal system	Mao X; Lv K; Qi W; Cheng W; Li T; Sun Y; Jin H; Pan H; Wang D	sarcopenia progressive systemic skeletal muscle disorder marked accelerated deterioration muscle function mass is highly prevalent elderly population significantly contributing to elevated risk adverse outcome including fall fracture muscle weakness clinical investigation have identified strong correlation sarcopenia several prevalent degenerative skeletal muscle disorder correlation is attributed to imbalance joint mechanic resulting localized muscle atrophy influence musculoskeletal secretory factor review discus broader implication sarcopenia critically evaluate currently established assessment method furthermore clinical significance prevalent musculoskeletal disorder including osteoporosis osteoarthritis spinal pathology relation to sarcopenia underlying mechanism influencing relationship is summarized additionally effect sarcopenia therapeutic efficacy medication surgical intervention musculoskeletal condition are reviewed sarcopenia is intricately linked to onset progression prognosis musculoskeletal disorder future research should prioritize elucidating potential mechanism that connect muscle loss skeletal muscle disease investigating mitigating sarcopenia symptom could decelerate progression disorder thereby paving new pathway therapeutic intervention	Bone Res	23/09/2025
10.1038/s41582-025-01136-0	progress challenge sporadic cerebellar ataxia	Wirth T; Faber J; Depienne C; Roze E; Honnorat J; Meissner WG; Giunti P; Tranchant C; Klockgether T; Anheim M	sporadic cerebellar ataxia sloca is syndrome defined subacute chronic progressive ataxia occurring age year individual family history ataxia publication revised consensus diagnostic criterion multiple system atrophy emergence promising biomarkers provides thorough diagnostic framework that now enables diagnosis numerous acquired cause sloca including autoimmune disorder neurodegenerative disease ongoing development increased availability dna sequencing technology have uncovered several molecular cause sloca spastic paraplegia type very friedreich ataxia additional cause include sporadic genetic disorder such spinocerebellar atrophy type caused gaa expansion gene cerebellar ataxia neuropathy vestibular areflexia syndrome canvas caused biallelic expansion gene review present updated clinical approach to diagnosis management sloca that focus most important development field future challenge are also discussed including identification additional missing genetic cause sloca especially use genome sequencing improvement sloca prognostication implementation clinical trial neuroprotective intervention	Nat Rev Neurol	22/09/2025
10.1073/pnas.2519568122	crispr screen identify atpase vcp druggable therapeutic vulnerability cholangiocarcinoma	Yang W; Wang S; Ji S; Wang J; Lian S; Li Z; Jansen RA; Wu W; Niu K; Sun Z; Jia Q; Zheng J; Zhu H; Deng X; Wang L; Fan Z; Shi Y; Lieftink C; Guan M; Beijersbergen RL; Qin W; Gao Q; Bernards R; Jin H	cholangiocarcinoma cca remains lethal malignancy limited therapeutic option screening identified adenosine triphosphatase atpase protein vcp critical dependency cca compound screen revealed vcp inhibitor potently suppresses cca proliferation panel organoids inducing cellular senescence is known senescent cell persist can contribute to therapy resistance to address combined senolytic agent conatumumab which selectively eliminate senescent cca cell resulting enhanced tumor suppression vitro vivo clinical analysis showed vcp overexpression cca patient correlate poor prognosis study unveils quot punch quot strategy targeting senescence followed senolytic clearance offering promising therapeutic approach cca	Proc Natl Acad Sci U S A	30/09/2025
10.1093/ehjopen/oeaf117	tirzepatide compared semaglutide cardiovascular disease risk reduction obesity analysis trial	Mamas MA; Bays H; Li R; Upadhyay N; Irani T; Senyucel C; Dunn JP; Liu-Seifert H	aim approximately mortality is attributable to cardiovascular disease cvd aim analysis is to examine predicted cvd risk reduction following weight loss person obesity primary prevention tirzepatide semaglutide projected cvd event that could be potentially prevented usa method result wa phase randomized trial conducted participant obesity diabetes comparing tirzepatide mg semaglutide mg administered weekly subcutaneous injection predicted cvd risk were compared treatment baseline up to week participant prior cvd impact cardiovascular risk reduction wa estimated projected preventable cvd event year tirzepatide semaglutide usa average predicted cvd risk score treatment wa treatment tirzepatide wa associated significantly greater reduction predicted cvd risk compared semaglutide absolute reduction baseline respectively lt translating risk reduction to population who met treatment eligibility criterion prior cvd million estimated million cvd event could be potentially prevented year week tirzepatide treatment million semaglutide conclusion treatment tirzepatide wa associated greater predicted cvd risk reduction compared semaglutide post hoc analysis suggests treatment may provide greater benefit primary prevention cvd semaglutide people obesity overweight registration	Eur Heart J Open	01/09/2025
10.1016/j.ejso.2025.110445	ago breast commission recommendation surgical therapy breast cancer working group gynecologic cancer ago update	Reimer T; Kuehn T; Mueller V; Ditsch N; Fehm T; Albert US; Bartsch R; Bauerfeind I; Bjelic-Radisic V; Blohmer JU; Budach W; Dall P; Fallenberg EM; Fasching PA; Friedrich M; Gerber B; Gluz O; Harbeck N; Hartkopf A; Heil J; Hoerner-Rieber J; Huober J; Janni W; Kreipe HH; Krug D; Kuemmel S; Loibl S; Lueftner D; Lux MP; Maass N; Mundhenke C; Park-Simon TW; Reinisch M; Rhiem K; Rody A; Schmidt M; Schneeweiss A; Schuetz F; Sinn HP; Solbach C; Solomayer EF; Stickeler E; Thomssen C; Untch M; van Mackelenbergh M; Witzel I; Woeckel A; Wuerstlein R; Banys-Paluchowski M; Thill M	german guideline commission working group gynecologic cancer updated recommendation diagnosis treatment breast cancer march chapter oncological surgery are coordinated working group plastic aesthetic reconstructive surgery gynecology awogyn most important change include incorporation insema sound trial result guideline patient characteristic defined age year postmenopausal status hormone subtype tumor grading maximum preoperative size cm unsuspicious axillary ultrasound clinical examination sentinel lymph node biopsy slnb can be omitted surgery irradiation are planned patient macrometastatic sentinel lymph node slns undergoing mastectomy postoperative irradiation completion axillary lymph node dissection alnd is longer recommended neoadjuvant systemic therapy nst alnd is recommended targeted axillary dissection tad show macrometastases sentinel target lymph node node that wa marked had macrometastasis biopsy nst patient isolated tumor cell sentinel target lymph node should not receive alnd nst case status decision to perform completion alnd should be made basis oncoplastic surgery is safe may replace mastectomy select case	Eur J Surg Oncol	17/09/2025
10.1136/bmjebm-2025-113913	alcohol use risk dementia diverse population evidence cohort mendelian randomisation approach	Topiwala A; Levey DF; Zhou H; Deak JD; Adhikari K; Ebmeier KP; Bell S; Burgess S; Nichols TE; Gaziano M; Stein M; Gelernter J	objective to investigate relationship alcohol consumption dementia design prospective cohort analysis combined linear mendelian randomisation setting two cohort million veteran programme uk biobank genetic analysis used summary statistic association study gwas participant adult aged year baseline were included observational analysis mean year cohort year uk cohort genetic analysis used summary data multiple large gwas consortium million participant main outcome measure incident dementia determined health record linkage genetic proxy result participant developed dementia died observational analysis revealed association alcohol dementia risk higher risk wa observed heavy drinker gt drink week ci to alcohol use disorder aud hr ci to compared light drinker contrast mendelian randomisation genetic analysis identified monotonic increase dementia risk greater alcohol consumption sd increase drink week wa associated dementia increase weighted ivw ci to twofold increase aud prevalence wa associated increase dementia risk ivw ci to alcohol intake increased dementia individual who developed dementia also experienced decline alcohol intake time suggesting reverse early cognitive decline lead to reduced supposed protective alcohol effect observational study conclusion finding provide evidence relationship type alcohol use increased dementia risk correlational observational data suggested protective effect light drinking could be part attributable to reduced drinking seen early dementia genetic analysis did not support protective effect suggesting level alcohol consumption may contribute to dementia risk public health strategy that reduce prevalence alcohol use disorder could potentially lower incidence dementia to	BMJ Evid Based Med	23/09/2025
10.1016/j.heliyon.2023.e19582	antibacterial activity mechanism cinnamon essential oil nanoemulsion pseudomonas deceptionensis	Zhao D; Ma Y; Wang W; Xiang Q	work aimed to evaluate antibacterial activity mechanism cinnamon essential oil nanoemulsion con pseudomonas deceptionensis result revealed con could effectively inhibit proliferation deceptionensis cell manner incubation con minimum inhibitory concentration relative fluorescence intensity propidium iodide npn wa increased respectively membrane permeability deceptionensis cell wa significantly disrupted con treatment resulting leakage intracellular substance such protein electrolyte con also caused significant increase dibac fluorescence intensity deceptionensis cell result demonstrate con induced inactivation deceptionensis destroying integrity function bacterial membrane higher level intracellular reactive oxygen specie ro wa observed cell lt compared control cell moreover addition glutathione to growth medium remarkably decreased antimicrobial activity con deceptionensis further confirming oxidative stress played important role antimicrobial activity con overall con may exhibit antibacterial effect causing damage to bacterial membrane oxidative stress	Heliyon	01/09/2023
10.1093/nar/gkaf920	protein regulates dna mismatch repair gene implication genome stability	Provasek VE; Bacolla A; Rangaswamy S; Kodavati M; Mitra J; Yusuf IO; Malojirao VH; Vasquez V; Britz GW; Li GM; Xu Z; Mitra S; Garruto RM; Tainer JA; Hegde ML	is protein increasingly recognized role neurodegenerative condition including amyotrophic lateral sclerosis al frontotemporal dementia ftd characterized aberrant nuclear export cytoplasmic aggregation proteinopathy is hallmark feature case leading to detrimental cytosolic aggregate reduction nuclear functionality neuron building prior work linking proteinopathy to accumulation dna break dsbs neuron present investigation uncovers novel regulatory relationship dna mismatch repair mmr gene expression here show depletion overexpression directly affect expression key mmr gene alteration include change level various primary cell line independent proliferative status result specifically establish selectively influence expression influencing alternative transcript splicing pattern stability furthermore find aberrant mmr gene expression is linked to proteinopathy two distinct al mouse model brain spinal cord tissue al patient notably mmr depletion resulted partial rescue dna damage signaling moreover bioinformatics analysis tcga cancer database reveals significant association expression mmr gene expression mutational burden multiple cancer collectively finding implicate critical regulator mmr pathway unveil broad impact etiology neurodegenerative neoplastic pathology	Nucleic Acids Res	23/09/2025
10.1586/17512433.2014.944502	new problem arising old drug effect acetaminophen	Tiegs G; Karimi K; Brune K; Arck P	acetaminophen apap is one most commonly used drug taken worldwide treatment pain fever considered safe when taken recommended dos not higher apap overdose is currently most important cause acute liver failure alf alf may require liver transplantation can be fatal reason alf are mostly intentional suicidal unintentional overdose however result large scale epidemiological study provide increasing evidence second generation effect apap even when taken pharmacological dos most strikingly apap medication pregnancy ha been associated health problem including neurodevelopmental behavioral disorder such attention deficit hyperactivity disorder increase risk wheezing incidence asthma offspring article review epidemiological finding aim to shed light molecular cellular mechanism responsible prenatal risk asthma	Expert Rev Clin Pharmacol	01/09/2014
10.1038/s41590-025-02283-8	sting signal to late endolysosomal compartment using adaptor	Zhang BC; Pedersen A; Reinert LS; Li Y; Narita R; Idorn M; Hu L; Skouboe MK; Li S; Maimaitili M; Ding X; Cong Y; Zhao J; Frémond ML; Mikkelsen K; Gao Z; Huang JR; Thomsen EA; Mikkelsen JH; Venkatraman R; Thomsen MK; Iversen MB; Assil S; Zhang R; Henneman L; Jakobsen MR; Oxvig C; Dalgaard TS; Møller P; Fago A; Wang T; Andersen CBF; De Nardo D; Reggiori F; Ting JP; Mikkelsen JG; Bak RO; Mogensen TH; Li P; Paludan SR	is central activation immune response cytosolic dna activates pathway to induce type interferon ifns signaling thus instigating host defense pathological inflammation however mechanism underlying activation is unknown here report sting activates delayed manner following exit golgi to endolysosomal compartment activation is dependent transcription factor is independent type ifn signaling activation pattern is evolutionarily conserved tetrapod mechanistically monomer is recruited to sting delayed kinetics relative to recruitment to sting which promotes type ifn response engagement sting induces trafficking to late endolysosomal compartment supporting recruitment activation identify binding motif facilitates recruitment work defines signaling surface sting function adaptor immune signaling finding indicate sting signaling to is enabled only short time window exit golgi lysosomal degradation possibly limiting inflammation homeostatic condition	Nat Immunol	19/09/2025
10.1001/jamanetworkopen.2025.33815	olfactory dysfunction infection recover adult cohort	Horwitz LI; Becker JH; Huang W; Akintonwa T; Hornig-Rohan MM; Maranga G; Adams DR; Albers MW; Ayache M; Berry J; Brim H; Bryan TW; Charney AW; Clark RA; Cortez MM; D&#x27;Anza B; Davis H; Donohue SE; Erdmann N; Flaherman V; Fong TG; Frontera JA; Goldberg MP; Goldman JD; Harkins MS; Hodder SL; Jacoby VL; Jagannathan P; Jia X; Kelly JD; Krishnan JA; Kumar A; Laiyemo AO; Levitan EB; Martin JN; McCaffrey KM; McComsey GA; Metz TD; Murthy G; Nguyen H; Okumura M; Parry S; Parthasarathy S; Patterson TF; Peluso MJ; Sorochinsky C; Walker T; Wiegand SL; Wiley Z; Wisnivesky J; Ashktorab H; Foulkes A; Lee-Iannotti JK	importance olfactory dysfunction is common infection ha been associated cognitive loss other condition formal testing is needed to characterize presence severity pattern olfactory dysfunction objective to characterize olfactory dysfunction infection design setting participant prospective cohort study included adult enrolled researching covid to enhance recovery recover study all random sample change loss smell taste were offered olfactory testing performed site state territory participant included enrollee prior infection change loss prior infection change loss taste who underwent olfactory testing mean sd day index date data were collected october to june exposure infection main outcome measure olfactory function defined performance university pennsylvania smell identification test upsit test comprising unique odor result study included participant mean sd age year data available were female intersex infected participant change loss had hyposmia upsit including severe microsmia anosmia infected participant change loss had hyposmia including severe microsmia anosmia participant prior infection change loss scored upsit percentile compared percentile change loss prior known infection respectively younger woman had score corresponding to lower mean percentile participant who change loss smell abnormal upsit score more often reported cognitive problem normal upsit score conclusion relevance cohort study participant change loss smell taste wa accurate signal verified hyposmia high rate hyposmia reported change loss wa also observed formal smell testing may be considered prior infection to diagnose occult hyposmia counsel patient risk	JAMA Netw Open	02/09/2025
10.1038/s41581-025-01004-6	immunology sepsis translating new insight clinical practice	Kox M; Bauer M; Bos LDJ; Bouma H; Calandra T; Calfee CS; Chousterman BG; Derde LPG; Giamarellos-Bourboulis EJ; Gómez H; Netea MG; Ostermann M; van der Poll T; Scicluna BP; Seymour C; Shankar-Hari M; Shapiro N; Singer M; Venet F; Vlaar APJ; van Vught LA; Weis S; Joost Wiersinga W; Pickkers P	sepsis is defined organ dysfunction caused dysregulated host response to infection treatment that influence dysregulated host response are sparse immunopathophysiology sepsis entail overzealous inflammation causing acute organ dysfunction a well profound persistent response that increase susceptibility to secondary infection immune response sepsis is influence various endogenous exogenous factor including genetic makeup age sex comorbidities metabolism prior microbial exposure medication consequent heterogeneity syndrome hamper immunomodulatory treatment strategy that rely approach precision medicine approach is therefore warranted balanced application strategy is instrumental to achieve precision medicine phenotyping patient using clinical physiological microbiological molecular omics data enables identification more homogeneous patient subgroup several study suggest such approach can be used to tailor adjunctive immunomodulatory therapy patient sepsis a well repurposing existing drug to treat sepsis new drug aimed restoring immune homeostasis are investigation new clinical trial methodology including flexible platform trial bayesian statistic embedding trial health care system are increasingly being used to keep pace rapid development field sepsis immunobiology ultimately to improve clinical outcome	Nat Rev Nephrol	24/09/2025
10.1016/S0140-6736(25)01438-2	future type diabetes therapy	Ziegler AG; Cengiz E; Kay TWH	treatment type diabetes is entering transformative era teplizumab first immunotherapy treatment to delay onset clinical type diabetes ha been approved food drug administration other therapy show promise preserving function public health screening using islet autoantibody is expanding enabling earlier diagnosis reducing diabetic ketoacidosis allowing timely introduction treatment need insulin therapy replacement is shifting traditional transplantation organ donor islet pancreas to stem cell bioengineering method such encapsulation gene editing to create hypoimmune cell could reduce need immunosuppression that ha hampered replacement stem cell open door to personalised therapy innovation have been made available to small number patient scaling to widespread use remains challenge meanwhile glucose regulation is improving use automated insulin delivery system that combine glucose monitoring insulin pump insulin that are ultrarapid ultralong improve outcome minimising blood sugar fluctuation together breakthrough offer renewed hope improving management quality life people living type diabetes	Lancet	19/09/2025
10.1002/alz.70730	deficiency permit development lewy body dementia coexisting aβ pathology	Gao TY; Wang XZ; Xie YH; Wang T; Lu YB; Huang LL; Chen C; Zhang M; Ma X; Chen YL; Liang FX; Lou ZL; Li JS; Yu YF; Wu JB; Ma XR; Wang HL; Tang C; Zhang WP	introduction dementia lewy body dlb prevalent neurodegenerative dementia involves aggregate frequent amyloid beta aβ mechanistic driver remain unclear method crossed knockout mouse assessed behavioral pathological phenotype resulting animal also performed biochemical biophysical characterization kinase phosphorylation result dlb brain show deficiency aβ mirroring human dlb patient mouse spontaneously develop lewy pathology endogenous level affecting central peripheral nervous system heterogeneous phenotype mechanistically phosphorylates suppressing aggregation moreover level are correlated expression activity human brain discussion deficiency synergizes aβ to promote lewy pathology loss protective phosphorylation model recapitulates key dlb feature overexpression offering valuable tool future mechanistic therapeutic study highlight kinase deficiency reduced expression impaired activity is found human dementia lewy body dlb patient amyloid beta aβ specifically phosphorylates inhibiting aggregation preventing development lewy pathology mouse model recapitulates key feature human dlb exhibiting widespread lewy pathology heterogeneous phenotype alteration emerge novel genetic risk factor dlb opening new avenue diagnosis therapeutic intervention	Alzheimers Dement	01/09/2025
10.1038/s41467-025-63395-1	clinical implication bone marrow adiposity identified association mendelian randomization uk biobank	Xu W; Mesa-Eguiagaray I; Morris DM; Wang C; Gray CD; Sjöström S; Papanastasiou G; Badr S; Paccou J; Wang L; Li X; Timmers PRHJ; Timofeeva M; Semple SI; MacGillivray T; Theodoratou E; Cawthorn WP	bone marrow adiposity change diverse disease full scope are directly influenced marrow adiposity remains unknown to address previously measured bone marrow fat fraction femoral head total hip femoral diaphysis spine uk biobank participant here first use data phewas to identify disease associated marrow adiposity site reveals association incident disease disease category including osteoporosis fracture type diabetes cardiovascular disease cancer other condition that burden public health worldwide intriguingly type diabetes associate positively spine bone marrow adiposity negatively marrow adiposity femoral site then establish prss based snp use mendelian randomization to explore causal association marrow adiposity disease reveals that genetic predisposition to increased marrow adiposity is positively associated osteoporosis fracture mendelian randomization further suggests increased marrow adiposity diaphysis total hip is causally associated osteoporosis finding substantially advance understanding how marrow adiposity impact human health highlight potential biomarker therapeutic target diverse human disease	Nat Commun	23/09/2025
10.1038/s41586-021-03279-8	centromere are dismantled foundational meiotic protein	Hou H; Kyriacou E; Thadani R; Klutstein M; Chapman JH; Cooper JP	meiotic process are potentially dangerous to genome stability could be disastrous activated proliferative cell here show two key protein topoisomerase which form break meiotic cohesin can dismantle centromere dismantlement is normally observable only mutant cell that lack telomere bouquet which provides nuclear microdomain conducive to centromere reassembly however overexpression lead to level centromere dismantlement that can not be countered bouquet specific nucleosome remodelling factor mediate centromere dismantlement ectopic expression protein proliferating cell lead to loss mitotic kinetochore fission yeast human cell hence centromeric chromatin ha been characterized extraordinarily stable challenge stability may jeopardize kinetochore cancer that express meiotic protein	Nature	01/03/2021
10.1038/s41418-025-01584-7	novel lncrna modulates neural pyroptosis associated epilepsy stabilizing	Wang H; Wu L; Liu C; Zhao X; Cui L; Gao J; Zhang C; Du T; Shi L; Ji Y; Xiao Y; Zhang J; Tu W; Meng F; Han C	pyroptosis is strongly associated refractory epilepsy however underlying mechanism remain poorly understood increasing evidence ha shown long noncoding rna lncrnas participate various neurological disorder process regulating programmed cell death study identified novel lncrna screening which suppresses neural pyroptosis epilepsy demonstrated is aberrantly underexpressed hippocampus cortex epilepsy patient phenomenon that wa validated various mouse rat epilepsy model sirna viral manipulation experiment confirmed inhibits neuronal pyroptosis vivo vitro exerts antiepileptic effect mechanistically act scaffold to modulate protein stabilization enhancing ubiquitination thereby inhibiting neural pyroptosis suppression inflammasome signalling additionally downstream cytokine pyroptosis inhibit expression activation shared pathway pathway forming feedback loop finding identify critical regulator neural cell pyroptosis promising therapeutic target refractory epilepsy	Cell Death Differ	22/09/2025
10.1002/jev2.70164	sphingolipids extracellular vesicle released skeletal muscle plasma membrane control muscle stem cell fate muscle regeneration	Hakkar R; Brun CE; Leblanc P; Meugnier E; Berger-Danty E; Blanc-Brude O; Tacconi S; Jalabert A; Reininger L; Pesenti S; Calzada C; Gache V; Vasan SB; Pichon J; Larcher T; Errazuriz-Cerda E; Cassin C; Sung BH; Weaver A; Bongiovanni A; Rouger K; de Barros JP; Bouzakri K; Rome S	extracellular vesicle ev represent pathway which skeletal muscle skm cell influence fate neighbouring cell thereby regulating skm metabolic homeostasis regeneration are increasingly being explored therapeutic strategy to enhance muscle regeneration to induce myogenic differentiation induced pluripotent stem cell ipscs mechanism governing release muscle cell remain poorly described moreover muscle regeneration involves tightly regulated inflammatory response also important to determine how inflammation alters cargo function order to design more effective therapy to address knowledge gap isolated characterized large small ev lev sevs released skm cell basal condition response to inflammatory mediator elevated acute muscle injury chronic inflammatory condition such type diabetes then evaluated regenerative role ev subtypes vivo using mouse model muscle injury specific focus bioactive sphingolipid content using transmission scanning microscopy lipidomic profiling adenoviral construct to express labelled myotubes demonstrated skm cell release sevs lev primarily plasma membrane notably sevs were generated specialized membrane fold enriched ev marker alix interacting protein a well lipid lipid regeneration sevs promoted macrophage polarization migration muscle stem cell musc differentiation thereby accelerating muscle repair contrast lev inhibited promoted musc proliferation impaired transition to response essential step promoting musc differentiation treatment isolated muscle fibre revealed distinct effect sevs lev musc behaviour macrophage phenotype could be largely explained difference lipid composition particularly ratio subspecies however exposure altered ratio sevs impaired regenerative function musc effect macrophage migration polarization result demonstrate first time importance sphingolipid content ev released skeletal muscle regenerative function muscle tissue largely explained role carrier different subspecies suggests modulating sphingolipid composition ev could be viable strategy to enhance regenerative potential muscle tissue addition to therapeutic intervention	J Extracell Vesicles	01/09/2025
10.1186/s12944-025-02716-1	association atherogenic index plasma tinnitus evidence nhanes mediating role hypertension	Miao W; Wu C; Yuan D; Li Y; Wu T	background tinnitus is prevalent auditory disorder that significantly affect quality life emerging evidence suggesting connection metabolic dysregulation tinnitus pathogenesis atherogenic index plasma aip marker atherogenic lipid metabolism ha been associated cardiovascular disease risk remains underexplored context tinnitus objective study aimed to investigate relationship aip tinnitus prevalence adult to further examine hypertension mediates association method analyzed data participant national health nutrition examination survey nhanes tinnitus status wa determined aip wa calculated multivariable logistic regression model were used to assess association aip tinnitus stratified analysis mediation analysis were conducted to explore effect modification mediating role hypertension hypertension wa defined physician diagnosis use antihypertensive medication result elevated aip wa significantly associated increased risk tinnitus manner fully adjusted ci stronger association were observed younger participant female white smoker mediation analysis showed hypertension partially mediated association aip tinnitus accounting total effect conclusion higher aip is associated greater tinnitus prevalence hypertension serving partial mediator finding highlight potential value aip metabolic biomarker tinnitus risk stratification emphasize importance managing metabolic dysregulation tinnitus prevention	Lipids Health Dis	22/09/2025
10.1038/s41556-025-01749-z	membrane receptor cluster phosphatidylserine to activate phagocytosis	Boada-Romero E; Guy CS; Palacios G; Mari L; Poudel S; Li Z; Sharma P; Green DR	phagocytosis lap represents function autophagy protein which protein gabarap protein are lipidated phagosomes particle are engulfed phagocytic cell lap play role innate immunity inflammation anticancer response is initiated following phagocytosis particle that stimulate receptor tlr fc receptor a well following engulfment dying cell however how molecular process is initiated remains elusive here report receptor that engage lap enrich phosphatidylserine p phagosome membrane domain that are necessary sufficient lap to proceed subsequently p recruit complex to initiate enzymatic cascade leading to lap manipulation plasma membrane p content p binding rubicon domain receptor prevents lap delay phagosome maturation therefore initiation lap represents novel mechanism signal transduction following ligation surface receptor	Nat Cell Biol	22/09/2025
10.1111/all.70061	biologics to treat atopic dermatitis effectiveness safety future direction	de Bruin-Weller MS; Boesjes CM; Achten RA; Beck LA; Irvine AD; Vestergaard C; de Graaf M; van Wijk F; Bakker DS; Weidinger S	atopic dermatitis ad is one most common chronic inflammatory skin disease worldwide clinical presentation ad is heterogeneous is characterized relapsing remitting course most patient suffer mild ad approximately to experience severe disease activity which often requires systemic treatment systemic treatment option were limited to broad immunosuppressant which often had significant toxicity limited effectiveness advance understanding ad pathophysiology have led to development targeted biologic therapy including dupilumab tralokinumab lebrikizumab nemolizumab monoclonal antibody specifically block key cytokine involved ad improving disease control symptom relief dupilumab first approved biologic inhibits signaling tralokinumab lebrikizumab selectively block nemolizumab target which play crucial role pruritus review summarizes primarily data effectiveness safety biologics providing clinical guidance use management side effect also briefly discusses promising therapeutic target currently phase trial	Allergy	24/09/2025
10.1073/pnas.2506437122	increased expression improves skeletal muscle phenotype mouse	de Souza Leite F; Lambert MR; Zhang TY; Conner JR; Paulo JA; Oliveira SF; Guha Thakurta S; Bowles J; Gussoni E; Gygi SP; Widrick JJ; Kunkel LM	therapeutic strategy duchenne muscular dystrophy dmd will likely require complementary approach one possibility is to explore genetic modifier that improve muscle regeneration function beneficial effect overexpression were described escaper golden retriever muscular dystrophy grmd dog that had life validated zebrafish to clarify underlying biology overexpression dystrophic muscle generated transgenic mouse mdx model lack dystrophin overexpresses human striated muscle skeletal muscle mdx mdx mouse were studied time point expression mdx increased to time compared to mdx consequently mdx muscle were significantly bigger stronger dystrophic control increased number myofibers proteomics data show increased dysferlin mdx muscle association histone methyltransferase phenotype data support positive effect overexpression dystrophic muscle	Proc Natl Acad Sci U S A	30/09/2025
10.1001/jama.2024.3172	acetaminophen use pregnancy child risk autism adhd intellectual disability	Ahlqvist VH; Sjöqvist H; Dalman C; Karlsson H; Stephansson O; Johansson S; Magnusson C; Gardner RM; Lee BK	importance several study suggest acetaminophen paracetamol use pregnancy may increase risk neurodevelopmental disorder child true would have substantial implication management pain fever pregnancy objective to examine association acetaminophen use pregnancy child risk autism disorder adhd intellectual disability design setting participant nationwide cohort study sibling control analysis included sample child born to sweden december exposure use acetaminophen pregnancy prospectively recorded antenatal prescription record main outcome measure autism adhd intellectual disability based international classification disease ninth revision international classification disease tenth revision code health register result total child were exposed to acetaminophen pregnancy crude absolute risk year age not exposed v exposed to acetaminophen were v autism v adhd v intellectual disability model sibling control v use acetaminophen pregnancy wa associated marginally increased risk autism hazard ratio hr ci risk difference rd year age ci to adhd hr ci rd ci intellectual disability hr ci rd ci to to address unobserved confounding matched full sibling pair were also analyzed sibling control analysis found evidence acetaminophen use pregnancy wa associated autism hr ci rd ci to adhd hr ci rd ci to intellectual disability hr ci rd ci to similarly there wa evidence pattern sibling control analysis example autism compared use acetaminophen person low lt percentile medium percentile high gt percentile mean daily acetaminophen use had hr respectively conclusion relevance acetaminophen use pregnancy wa not associated child risk autism adhd intellectual disability sibling control analysis suggests association observed other model may have been attributable to familial confounding	JAMA	09/04/2024
10.1212/WNL.0000000000214144	intrinsic capacity defined using domain genetic risk incident parkinson disease prospective cohort study	Hu W; Tian G; Wang JN; Ma YB; Zheng ZA; Feng TJ; Niu XX; Yan YN; Liu BP; Jia CX	background objective intrinsic capacity ic world health measure healthy aging ha been linked to several neurologic disorder ha not been extrapolated to parkinson disease pd study aimed to explore association ic incident pd genetic risk modulated association method longitudinal analysis used data uk biobank prospective cohort study designed to investigate impact genetic environmental factor health outcome participant were voluntarily recruited assessment center united kingdom individual ic component data pd dementia baseline were included ic deficit score wa derived domain psychological exhaustion sleep duration sensory visual hearing impairment vitality grip strength weight loss locomotor function walking speed cognitive domain wa not assessed genetic risk wa estimated polygenic risk score incident pd wa identified using algorithm cox proportional hazard model were used to calculate hazard ratio hr ci result participant mean age sd year female included developed pd median year hr ci incident pd wa individual ic deficit score compared increment ic deficit wa associated ci increased risk pd low ic wa associated ci higher risk incident pd individual low ic high genetic risk were highest pd risk hr ci high genetic risk attenuated protective role high ic hr ci low risk v high risk interaction high ic wa still associated diminished risk pd group discussion high ic wa associated decreased risk pd even genetically individual absence cognitive domain may limit understanding association	Neurology	21/10/2025
10.1126/scitranslmed.ads5769	retinal polyunsaturated fatty acid supplementation revers vision decline mouse	Gao F; Tom E; Rydz C; Cho W; Kolesnikov AV; Sha Y; Papadam A; Jafari S; Joseph A; Ahanchi A; Balalaei Someh Saraei N; Lyon DC; Foik A; Nie Q; Grassmann F; Kefalov VJ; Skowronska-Krawczyk D	retina is uniquely enriched polyunsaturated fatty acid pufas primarily localized cell membrane where govern membrane biophysical property aging alteration lipid metabolism lead to reduced content very pufas retina which is associated normal reduction contrast sensitivity diminished photoreceptor function delayed dark adaptation recovery pathological macular degeneration amd elongation very long chain fatty encodes transmembrane protein that produce precursor to docosahexaenoic acid dha methylation status promoter is currently one best predictor chronological age here show lower abundance aged mouse retina is accompanied reduction visual function similarly mouse lacking enzymatic activity demonstrate reduced contrast sensitivity slower dark adaptation intravitreal supplementation direct product aged animal improved visual function to week reduced accumulation deposit gene expression pattern observed supplemented retina exhibited partial rejuvenation profile including decreased expression gene transcriptomic signature resembling younger retina last human genetic data iamdgc uk biobank linked two variant locus onset intermediate amd underlining translational importance finding work highlight supplementation potential therapeutic opportunity defines promising target intervention to prevent vision loss	Sci Transl Med	24/09/2025
10.1161/CIRCULATIONAHA.124.072312	pygm protects myocardial infarction enhancing glycogenolysis facilitating autophagic flux	Gan J; Zhao R; Zheng D; Peng Y; Wu M; Sun F; An R; Xu A; Chen M; Li Y; Lei W; Lin Z; Wu F	background pygm muscle glycogen phosphorylase enzyme glycogenolysis play indispensable role maintaining cardiac energy metabolism however role pygm pathogenesis myocardial infarction mi remains unclear method expression profile pygm cardiac tissue plasma sample subject mi were assessed using immunoblotting role pygm mi wa determined evaluating effect pygm deficiency replenishment pygm expression mouse mi result found circulating pygm level cardiac content were significantly decreased patient mi which wa associated impaired cardiac function loss pygm significantly exacerbated cardiac dysfunction damage mouse replenishment pygm profoundly reversed adverse effect mechanistically pygm enhanced glycogenolysis activating glycolysis pentose phosphate pathway thereby improving cardiac energy homeostasis mitigating oxidative stress addition pygm improved autophagic flux obstacle alleviated cardiac damage suppressing expression moreover genetic deficiency pharmacological blockage autophagy attenuated protective effect pygm cardiac injury knockdown substantially improved adverse impact mi cardiac dysfunction damage mouse conclusion pygm safeguard myocardial injury stimulating glycogenolysis promoting autophagic flux thus preserving myocardial energy homeostasis	Circulation	24/09/2025
10.1016/j.devcel.2025.07.002	emerging insight lineage plasticity pancreatic cancer initiation progression therapy resistance	Zhang X; Du Y; Behrens A; Lan L	lineage plasticity ability cell to switch one specialized identity to is fundamental cellular process embryonic development tissue regeneration process is often hijacked tumor cell various stage to facilitate cancer initiation progression metastasis therapy resistance is also recognized key contributor to intratumor heterogeneity ith pancreatic ductal adenocarcinoma pdac lineage plasticity is central to metaplasia adm associated reprogramming adr transition emt cancer stem cell csc regeneration molecular subtype rewiring mechanism generate diverse lineage trajectory shape pdac development progression therapeutic outcome review discus how normal tumor cell pancreatic epithelium acquire lineage plasticity implication pdac pathogenesis ith metastasis therapy resistance also highlight recent discovery suggesting potential therapeutic strategy targeting key regulator lineage plasticity pdac	Dev Cell	22/09/2025
10.1111/all.70060	distinct role human skin barrier dysfunction atopic dermatitis	D&#x27;Avino P; Kim J; Li M; Gessner P; Westermann P; Pat Y; Beha C; Traidl-Hoffmann C; Bost J; Gaudenzio N; Messner CB; Akdis CA; Mitamura Y	background atopic dermatitis ad is chronic inflammatory skin disease characterized eczema epithelial barrier dysfunction cytokine contributes to ad pathogenesis to date most skin study rely reconstructed keratinocytes which do not represent real skin response objective here report distinct effect human skin intact barrier immune cell method spatial transcriptomics skin wa performed ex vivo skin barrier integrity wa evaluated using electrical impedance spectroscopy eis untargeted proteomics complemented analysis skin biopsy ad patient result spatial transcriptomics demonstrated ad lesion showed reduced expression key barrier gene including flg disrupted skin barrier ex vivo human skin combining cytokine alone downregulated gene critical barrier function keratinization addition downregulated antimicrobial peptide upregulated interestingly reduced upregulated suggesting immune proteomic analysis confirmed three cytokine reduced expression key skin barrier protein particularly filaggrin dupilumab treatment ad patient month restored gene had limited effect pathway conclusion comprehensive study provides insight distinct immune profile following stimulation human skin highlighting complex interplay disrupting skin barrier function modulating innate immune response	Allergy	23/09/2025
10.1136/gutjnl-2025-335103	expansion corpus progenitor accelerates ulcer healing inhibits gastric dysplasia	Zheng B; Kobayashi H; Tu R; Huang K; Zhi X; Lian G; Wu F; Qian J; Ochiai Y; Waterbury QT; Malagola E; Lu J; Hata M; Zeng Y; Zheng H; Zhang P; Li S; Zamechek L; Wang X; Chen F; Wang TC	background receptor is expressed corpus isthmus progenitor parietal cell regulating acid secretion cell turnover however role gastrin progenitor mucosal regeneration remains unexplored objective to study role axis corpus progenitor gastric injury regeneration design generated mouse to trace corpus progenitor homeostasis injury condition hypogastrinaemia hypergastrinaemia injury model included acute ulceration chronic pylorus gastritis mnu exposure result hypergastrinaemia significantly expanded isthmus progenitor whereas hypogastrinaemia reduced gastric ulceration induced twofold elevation plasma gastrin day antral expansion complete ulcer healing day gastrin infusion proton pump inhibitor ppi treatment further elevated gastrin promoted complete ulcer healing day whereas ablation minimised gastrin impaired healing abrogated benefit ppi lt vagus nerve muscarinic receptor mediated gastrin elevation progenitor expansion ulcer healing ablation mouse increased colonisation exacerbated inflammation atrophy metaplasia dysplasia lt hypergastrinaemia wa protective similarly mnu model ablation worsened gastric pathology hypergastrinaemia mitigated conclusion report novel role gastrin ulcer healing hypogastrinaemia is risk factor poor ulcer healing corpus atrophy potentially cancer physiological gastrin response are protective hypergastrinaemia play key role ulcer healing gastrin signalling may prevent gastric preneoplasia	Gut	22/09/2025
10.1136/thorax-2024-222397	risk prediction drug target identification chronic obstructive pulmonary disease	Zhang Y; Ye Z; Yang S; Zhang Y; Huang Y; Xiang H; Wu Y; Zhang Y; Gan X; Qin X	background chronic obstructive pulmonary disease copd is leading cause global mortality yet existing risk prediction model remain limited study aimed to develop validate risk score copd comparing performance copd polygenic risk score prss clinical risk factor exploring underlying biological pathway causal association method study analysed uk biobank participant england training testing set validation cohort least absolute shrinkage selection operator regression identified predictive protein training set model performance assessed using harrell net reclassification improvement nri integrated discrimination improvement index idi pathway mendelian randomisation mr analysis explored biological mechanism causal effect result testing set developed risk score strongly predicted incident copd high accuracy ci to outperformed pr ci to matched clinical model ci to simplified panel retained robust performance ci to adding protein score to clinical factor improved risk reclassification nri idi mr analysis identified adm protective increased risk pathway analysis implicated inflammation extracellular remodelling protein matrix were central player interaction network similar result were found validation cohort conclusion protein biomarkers outperform genetic risk score complement clinical factor copd prediction streamlined panel offering clinical feasibility study identifies novel pathway causal therapeutic target further validation is needed prior to routine clinical implementation	Thorax	24/09/2025
10.1200/JCO-25-00925	outcome polarix study comparing patient diffuse large lymphoma	Morschhauser F; Salles G; Sehn LH; Herrera AF; Friedberg JW; Trněný M; Lenz G; Sharman JP; Herbaux C; Burke JM; Matasar M; Collins GP; Mehta-Shah N; Oberic L; Chauchet A; Jurczak W; Song Y; Pinto A; Rai S; Izutsu K; Greil R; Mykhalska L; Bergua-Burgués JM; Cheung MC; Shin HJ; Hapgood G; Munhoz E; Abrisqueta P; Gau JP; Jiang Y; McCall B; Chohan S; Sugidono M; Yan M; Batlevi CL; Tilly H; Flowers CR	polarix study identifier polatuzumab vedotin rituximab cyclophosphamide doxorubicin prednisone showed significant survival pfs benefit versus rituximab cyclophosphamide doxorubicin vincristine prednisone patient previously untreated diffuse large lymphoma dlbcl median month update sustained pfs benefit favoring were observed global population median month demonstrated significant pfs benefit hazard ratio hr ci to pfs rate ci to ci to respectively not statistically significant overall survival analysis showed hr ci to data cut compared ci to data cut expanded population patient had death arm respectively exploratory analysis showed favorable survival rate subgroup including activated dlbcl international prognostic index score tolerability wa similar treatment arm finding confirm represents standard care frontline treatment dlbcl	J Clin Oncol	24/09/2025
10.1002/edm2.70113	evaluating rate pancreatitis pancreatic cancer receptor agonist systematic review randomised controlled trial	Wen J; Nadora D; Bernstein E; How-Volkman C; Truong A; Joy B; Kou M; Muttalib Z; Alam A; Frezza E	aim evaluates rate cancer receptor agonist ra randomised controlled trial rcts method following preferred reporting item systematic review prisma systematic search wa performed pubmed embase cochrane library ra rcts that evaluated cancer wa conducted to evaluate risk analysis wa performed background medication result study utilising dulaglutide exenatide liraglutide semaglutide beinaglutide retatrutide tirzepatide patient mean age year to mean week to were included study showed significantly increased risk pancreatitis rr ci not when stratified background medication rr ci background medication rr ci pancreatic cancer ra use showed significant association rr ci however significant increase wa found background medication rr ci not rr ci conclusion ra carry slightly increased risk pancreatitis which is not significant when stratified background medication use overall risk pancreatic cancer wa not observed slight association wa found when stratified background medication however difference is likely minimal given numerous study excluded where treatment arm had zero event	Endocrinol Diabetes Metab	01/09/2025
10.1007/s10654-021-00754-4	prenatal postnatal exposure to acetaminophen relation to autism spectrum hyperactivity symptom childhood six european cohort	Alemany S; Avella-García C; Liew Z; García-Esteban R; Inoue K; Cadman T; López-Vicente M; González L; Riaño Galán I; Andiarena A; Casas M; Margetaki K; Strandberg-Larsen K; Lawlor DA; El Marroun H; Tiemeier H; Iñiguez C; Tardón A; Santa-Marina L; Júlvez J; Porta D; Chatzi L; Sunyer J	potential etiological role early acetaminophen exposure autism spectrum condition asc disorder adhd is inconclusive aimed to study association collaborative study six european cohort total pair were included study prenatal postnatal to month acetaminophen exposure wa assessed maternal questionnaire interview asc adhd symptom were assessed year age using validated instrument child were classified having symptom using recommended cutoff instrument hospital diagnosis were also available one cohort analysis were adjusted child maternal characteristic indication acetaminophen use adjusted effect estimate were combined using proportion child having symptom ranged asc adhd result indicated child prenatally exposed to acetaminophen were more likely to subsequently have borderline clinical asc ci adhd symptom ci compared to child boy girl showed higher odds asc adhd symptom prenatal exposure association were slightly stronger boy postnatal exposure to acetaminophen wa not associated asc adhd symptom result replicate previous work support providing clear information to pregnant woman partner potential risk acetaminophen use	Eur J Epidemiol	01/10/2021
10.1016/j.phymed.2025.157262	liquiritin alleviates parkinson disease inhibition ferroptosis	Cai Y; Huang G; Shan C; Zhang X; YuYan L; Fu Y; Ren M; Yan T; Xu M; Zhu L	background parkinson disease pd is progressive neurodegenerative disorder increasing global prevalence cs is chinese medicine compound reported neuroprotective property however precise bioactive constituent underlying mechanism cs context pd remain poorly defined purpose study aimed to systematically evaluate therapeutic potential cs characterize bioactive constituent elucidate potential molecular mechanism pd method network framework wa established to predict potential target cs pd pd mouse model were validated behavioral test histopathology staining immunohistochemistry ihc western blot wb machine learning roc curve analysis pinpointed key gene linked to cs pd functional enrichment highlighting possible pathway further validation wa performed using ihc gpx mda wb assay wa employed to characterize bioactive cs component followed druggability screening molecular docking molecular dynamic md simulation vitro cell exposed to were used to evaluate neuroprotective effect liquiritin liq principal active compound cs ldh oxidative stress marker gpx mda lipid peroxidation iron accumulation ferroorange wb additional validation ferroptosis modulation wa performed vivo vitro result multidisciplinary investigation employing prediction experimental validation consistently demonstrated neuroprotective effect cs pd mouse machine learning roc curve analysis vivo validation identified cs ameliorates pd inhibiting ferroptosis pparα activation intriguingly cs exhibited therapeutic potential counteracting pathological manifestation mouse integrated analysis involving druggability screening molecular docking md simulation demonstrated liq to be core bioactive compound cs mechanistic study revealed liq protects mpp ferroptosis cell activation pathway pharmacological inhibition pparα abolished liq protective effect ferroptosis pd progression definitively establishing pparα activation essential neuroprotection conclusion liq major bioactive component cs ameliorates pd pathology inhibiting ferroptosis activation signaling pathway finding uncover novel mechanism provide promising therapeutic framework prevention treatment pd	Phytomedicine	15/09/2025
10.1016/j.ejca.2025.115789	cabazitaxel patient prostate cancer efficacy safety data study	Mandel P; Groener D; Follacchio G; Ürün Y; Bourlon MT; Sabet A; Grünwald F; Tural D; Büttner T; Kopp RM; Taha T; Chun FK; Facchini G; Myint ZW; Seront E; Conteduca V; Quiroga MNG; Aurilio G; Palacios GA; Bögemann M; Roviello G; Matrana MR; Sammarco E; Laguado MIZ; Galli L; Ansari J; Danielli L; Molina-Cerrillo J; Rescigno P; Yazgan SC; Bastos DA; Jazieh AR; Monteiro FSM; Soares A; Massari F; Wenzel M; Capoccetti F; Santoni M	background radioligand therapy lu wa recently introduced clinical practice latin america most european country progressive metastatic prostate cancer mcrpc however multicenter data outcome are scant method data collaboration progressive mcrpc patient treated cabazitaxel were collected retrospective analysis wa performed including overall survival o progression free survival pfs time to treatment failure ttf rate result data patient receiving cabazitaxel one two line arpi docetaxel were analyzed rate were higher ttf o were significantly longer patient even multivariable adjustment effect held true most subgroup such age lt year ecog distant lymph node one two line prior arpi incidence grade adverse event were comparable treatment cabazitaxel cohort differed according to type adverse event sensitivity analysis adjustment showed similar effect conclusion analyzing currently largest cohort comparing cabazitaxel provided robust information being least equally effective possibly even superior to cabazitaxel regarding outcome reasonable side effect	Eur J Cancer	12/09/2025
10.3389/fnut.2025.1642913	advanced lung cancer inflammation index new predictor colon cancer elderly patient study	Zhong H; Chen Y; Wu W; Liu S; Fan Y; Liu H; Lin R; Wan J; He M	background nutritional inflammatory status have been implicated colon cancer risk advanced lung cancer inflammation index ali is composite prognostic index that incorporates body mass index bmi serum albumin ratio nlr reflecting nutritional systemic inflammatory state however role predicting colon cancer prevalence elderly individual remains unclear method used ali composite marker reflecting inflammation status nutritional health ali is calculated bmi serum where higher value indicate better nutritional status lower systemic inflammation to evaluate association ali colon cancer prevalence conducted multivariate logistic regression applied extreme gradient boosting xgboost machine learning model performed subgroup analysis additionally smoothed logistic regression model wa used to identify ali threshold predictive colon cancer result study included elderly participant colon cancer prevalence ali wa significantly lower colon cancer group compared to lt multivariable logistic regression revealed significant inverse association ali colon cancer lt individual highest ali tertile experiencing lower risk compared to lowest tertile trend generalized additive model showed linear relationship identifying inflection point predictive threshold sensitivity analysis confirmed robustness finding particularly individual aged year female unmarried individual alcohol consumer bmi xgboost model ali demonstrated highest predictive value colon cancer auc outperforming traditional demographic clinical variable such age bmi furthermore ali showed positive association dietary health status lt wa not significantly related to bowel habit conclusion study demonstrated ali prognostic index is significantly inversely associated risk colon cancer older adult thus ali may serve promising biomarker risk stratification particularly subgroup such unmarried female alcohol consumer lower bmi strong predictive value confirmed machine learning support potential role personalized prevention further study are required to explore underlying mechanism including dietary microbial factor	Front Nutr	01/01/2025
10.1186/s40779-025-00649-5	are combination approach beneficial cell lung cancer evidence experimental clinical study	Thyagarajan A; Gajjar V; Sahu RP	having multiple treatment option overall outcome including survival rate cell lung cancer nsclc patient remain relatively low indicating need to explore new approach to achieve improved therapeutic response to end repurposed drug such metformin have been evaluated many cancer type including nsclc metformin widely used oral hypoglycemic drug type diabetes exhibit anticancer property synergy several standard care agent review provide comprehensive overview role anticancer mechanism combination approach treatment nsclc logically discussed experimental evidence vitro vivo study utilizing metformin alone then combination chemotherapeutic agent targeted therapy immunotherapy also present clinical trial that underscore beneficial adverse outcome metformin use combination targeted therapy chemotherapeutic agent emphasize limitation challenge treatment diabetic nsclc patient appears regardless diverse anticancer mechanism biguanide benefit may be confined to specific patient subgroup which open new avenue to be explored nsclc treatment	Mil Med Res	23/09/2025
10.1186/s12974-025-03539-8	inhibition ephrin receptor signaling paraventricular nucleus attenuates dermatitis synaptic plasticity immune homeostasis modulation	Ren Q; Gao Z; Han W; Tang Y; Shi M; Yue Y; Xin X; Zhang C; Liu E; Dong B; Yue Q; Sun J	psoriasis pathophysiology involves dysregulated neuroimmune crosstalk yet central mechanism involved remain incompletely understood here show hypothalamic paraventricular nucleus pvn orchestrates cutaneous inflammation transsynaptic circuit using neural tracing chemogenetic approach revealed functional connectivity pvn sympathetic neuron psoriatic skin reactivation imiquimod imq targeted recombination active population trap neuron which form specific quot inflammatory memory quot is essential psoriasis progression can drive chronic inflammation rna sequencing identified ephrin receptor critical mediator synaptic plasticity pvn inflammatory engram neuron inhibition ephrin receptor ligand binding pvn normalized dendritic spine remodelling suppressed sympathetic nerve hyperactivity restored balance cell mouse mechanistically blockade ephrin receptor attenuated sympathetic norepinephrine overflow thereby mitigating inflammation study identifies axis which inhibition pvn restores skin immune homeostasis furthermore study elucidates central neural mechanism skin inflammation promotes transition psoriasis treatment approach to synergistic neuroimmune strategy involving quot quot interaction	J Neuroinflammation	24/09/2025
10.1177/00333549231218277	hepatitis care continuum to inform public health action	Spradling PR; Bocour A; Kuncio DE; Ly KN; Harris AM; Thompson ND	application care continuum model ccm can identify gap diagnosis care treatment population common condition challenge are inherent developing ccm chronic hepatitis contrast treatment hiv hepatitis treatment is not indicated people chronic hepatitis clinical endpoint are not clear receiving treatment whom treatment is not indicated remain risk complication topical review examines data element necessary to develop apply chronic hepatitis ccms jurisdictional health department level conducted nonsystematic review publication ovid medline ovid embase scopus not date limited database which yielded publication review jurisdictional health department properly supported could develop focused ccms using chronic hepatitis registry updated longitudinally using electronic laboratory reporting data case reporting data ccms could be applied to identify disparity improve rate testing access to care treatment which are necessary to reduce liver disease chronic hepatitis mortality investment public health surveillance infrastructure including substantial enhancement electronic laboratory reporting case reporting use supplementary data source could enable jurisdictional health department to develop modified ccms chronic hepatitis that focus least initially quot early quot ccm step which emphasize optimization hepatitis diagnosis linkage to care ongoing clinical diagnosed people which can lead to improved outcome	Public Health Rep	11/01/2024
10.1136/jitc-2024-010812	autophagy inhibition improves efficacy anlotinib inhibitor treatment nsclc	Tang H; You T; Ge H; Bai C; Wang Y; Sun Z; Han Q; Zhao RC	background fibroblast cafs are major cellular component tumor microenvironment tme are closely related to immune suppression enhancement cell death efficacy antiangiogenic tyrosine kinase receptor inhibitor tkis is partly due to elimination cafs which improves immunosuppressive microenvironment however remains unclear antiangiogenic tkis regulate autophagy cafs thereby affecting immunotherapy response method first examined effect autophagy inhibition anlotinib tme immunotherapy response animal experiment then caf model were established vitro effect mechanism autophagy inhibition efficacy anlotinib cafs were further explored vitro to specifically validate role caf autophagy additionally constructed llc mouse model cafs transfected sirna control sirna result llc cell lung cancer model autophagy inhibitor chloroquine significantly enhanced inducing more apoptosis cafs macrophage reshaping tme to promote cell infiltration knockdown autophagy inhibition cafs effect therapy wa significantly attenuated versus control confirming caf autophagy is core to tme regulation vitro anlotinib induced caf autophagy inhibition inhibiting caf autophagy enhanced caf apoptosis impaired cafs ability to recruit macrophage conclusion autophagy inhibition enhances effect antiangiogenic tkis tumor cell cafs directly indirectly regulates tme which might explain why autophagy inhibition enhances efficacy antiangiogenic tkis combined therapy	J Immunother Cancer	21/09/2025
10.1172/JCI180927	inhibition pten drive resistance to inhibitor breast cancer	Kumari N; Wright SC; Witham CM; Monserrat L; Palafox M; Charles Richard JL; Costa C; Elkabets M; Agostino M; Klemm T; Eccles MK; Garnham A; Wu T; Nilsson JA; Walz N; Venugopal V; Cerra A; Vasilevski N; Bridgeman SC; Bassi S; Saei A; Helal M; Neundorf P; Riedel A; Rosenfeldt M; Gill J; Pahor N; Hartmann O; Chung J; Sidhu SS; Moderau N; Jha S; Rodon J; Diefenbacher ME; Komander D; Serra V; Eichhorn P	activating mutation gene encoding catalytic subunit are most frequent genomic alteration breast cancer alpelisib inhibitor that target is recommended drug patient advanced breast cancer however clinical success inhibitor ha been limited narrow therapeutic window lipid phosphatase pten is potent tumour suppressor major negative regulator pathway unsurprisingly inactivating mutation pten correlate tumour progression resistance to inhibition due to persistent signalling here demonstrate inhibition lead rapidly to inactivation pten using functional genetic screen show effect is mediated signalling axis which stabilizes resulting phosphorylation tail pten phosphorylation inhibits pten dimerization thus prevents activation downregulation inhibitor resistant breast cancer model patient derived organoids to inhibition induces tumour regression study establishes enhancing pten activity is new strategy to treat mutant tumour provides strong rationale pursuing inhibitor clinic	J Clin Invest	23/09/2025
10.1542/peds.2016-3840	prenatal exposure to acetaminophen risk adhd	Ystrom E; Gustavson K; Brandlistuen RE; Knudsen GP; Magnus P; Susser E; Davey Smith G; Stoltenberg C; Surén P; Håberg SE; Hornig M; Lipkin WI; Nordeng H; Reichborn-Kjennerud T	objective to estimate association maternal use acetaminophen pregnancy paternal use pregnancy disorder adhd offspring adjusting familial risk adhd indication acetaminophen use method diagnosis were obtained norwegian patient registry offspring norwegian mother child cohort study including adhd estimated hazard ratio hr adhd diagnosis using cox proportional hazard model result adjusting maternal use acetaminophen pregnancy familial risk adhd indication acetaminophen use observed modest association prenatal maternal use acetaminophen hr confidence interval ci hr ci trimester hr ci hr more day maternal acetaminophen use wa ci use lt day wa negatively associated adhd hr ci acetaminophen use fever infection to day wa associated adhd hr ci paternal maternal use acetaminophen were similarly associated adhd conclusion maternal use acetaminophen pregnancy wa negatively associated adhd offspring maternal use acetaminophen pregnancy wa substantially associated adhd even adjusting indication use familial risk adhd other potential confounders	Pediatrics	01/11/2017
10.1001/jamanetworkopen.2025.32650	efficacy safety ammoxetine major depressive disorder randomized clinical trial	He S; Chen JX; Yu X; Lin H; Wang Z; Li X; Zhou Y; Liu YS; Zhang H; Wang J; An C; Liu H; Li C; Ni S; Li H	importance major depressive disorder mdd is most prevalent mental health disorder causing substantial disability economic burden several treatment exist mild adverse effect up to to patient do not tolerate respond to ammoxetine novel selective serotonin norepinephrine reuptake inhibitor ha been found to reduce adverse effect hepatotoxicity more potent inhibition serotonin norepinephrine transporter making more tolerable effective objective to evaluate efficacy safety ammoxetine treating adult mdd design setting participant phase randomized clinical trial wa multicenter study ammoxetine treatment patient mdd china patient aged to year study center were randomized daily ammoxetine placebo group march june followed up week intervention participant were randomized to treatment group ammoxetine ammoxetine placebo main outcome measure primary outcome wa change depression rating scale madrs total score baseline to week efficacy analysis were performed set using l mean difference safety set analysis wa performed using descriptive statistic result enrolled patient mean sd age year female were randomized to ammoxetine group to ammoxetine group to placebo group set ammoxetine dos led to statistically significant improvement madrs total score week compared placebo l mean change se baseline were ammoxetine ammoxetine placebo difference v placebo were ci to ammoxetine ci to ammoxetine consistent result were observed set analysis week ammoxetine l mean change ci to ammoxetine l mean change ci to superior to placebo adverse event were reported participant receiving ammoxetine receiving ammoxetine receiving placebo most were mild to moderate severity conclusion relevance randomized clinical trial demonstrated superiority placebo ammoxetine treatment patient mdd addition dos ammoxetine were generally well tolerated trial registration identifier	JAMA Netw Open	02/09/2025
10.1021/jacs.5c07917	marine natural product chagosendine induces cuproptosis colorectal cancer cell targeting	Tao X; Wang H; Wang Q; Wang C; Shao CW; Jin Y; Yu D; Hu H; Zhang Q; Xu M; Geng X; Xu H; Li L; Shen R; Guo YW; Li XW; Liu S; Zhang W	colorectal cancer crc treatment is hampered high recurrence rate drug resistance cuproptosis cell death mechanism offer new therapeutic approach here identified marine natural product chagosendine chc which kill tumor cell increasing intracellular copper ion concentration chc related metal coordination homodimer alkaloid were rapidly synthesized purified further pharmacological study vitro chc significantly inhibited rko crc cell growth induced phase arrest cell death overcame oxaliplatin resistance vivo chc suppressed colorectal tumor growth mouse obvious toxic effect mechanistically chc induces cuproptosis targeting increasing intracellular copper ion ro level tumor cell leading to cell death thus chc present novel crc treatment strategy showing strong antitumor activity potential to overcome oxaliplatin resistance promising clinical prospect	J Am Chem Soc	22/09/2025
10.1177/12034754251368849	canadian consensus androgenetic alopecia approach management	Landells I; Chow E; Gupta AK; Jasso Olivares JC; Thuraisingam T; Ahluwalia R; Tan JKL; Pratt M; Yadav G; Chivers Q; Vezina N; Laforest T; Raad E; Owen J; Dayeh NR	androgenetic alopecia aga is most common hair loss condition affecting to canadian men woman year age nonscarring hereditary condition can significantly affect patient impacting overall quality life multitude intervention willingness people aga to try treatment there are clear canadian guideline management expert panel physician developed consensus recommendation intervention management aga male female adult intervention were reviewed seven intervention are recommended including oral dutasteride oral finasteride topical finasteride topical minoxidil plasma microneedling oral minoxidil five intervention are recommended near consensus intralesional dutasteride ketoconazole shampoo low level laser therapy aminexil part regimen are not recommended adenosine cetirizine carboxytherapy syrup microfilament thread injectable minoxidil caffeine ceramide topical herbal formulation piroctone olamine shampoo rosemary oil shampoo lotion hair care product containing fermented papaya fermented mangosteen caffeine basic fibroblast growth factor bfgf flutamide	J Cutan Med Surg	23/09/2025
10.26603/001c.38017	relationship running biomechanics hip muscle strength injury female collegiate runner	Venable EN; Seynaeve LA; Beale ST; Gamez A Jr; Domingo A; Rosenthal MD; Rauh MJ	background female collegiate xc runner have high incidence injury rri limited report are available that have examined potential intrinsic factor that may increase rri risk population purpose to examine relationship rri hip muscle strength lower extremity running kinematics female collegiate xc runner study design prospective observational cohort method participant included twenty female ncaa collegiate xc runner southern california university who competed intercollegiate season questionnaire wa used to gather demographic information hip muscle strength wa measured isokinetic dynamometry sidelying position normalized runner body weight kg running kinematic variable were examined using qualisys motion capture visual analysis rri occurrence wa obtained questionnaire independent were used to determine mean difference injured runner hip abductor muscle strength selected running kinematics pearson correlation coefficient were calculated to examine relationship hip muscle performance kinematic variable result rri information wa gathered participant xc season runner sustained rri there were significant difference mean hip abductor normalized muscle strength mean normalized hip muscle strength asymmetry injured runner xc season similarly significant difference were found mean value selected kinematic variable runner who did who did not report rri moderate relationship were found hip abductor strength variable right knee adduction footstrike maximum right knee adduction stance left supination footstrike right peak pronation stance left supination footstrike right peak pronation stance conclusion hip abduction muscle strength hip abduction strength asymmetry selected running kinematic variable were not associated elevated risk rri female collegiate xc runner	Int J Sports Phys Ther	01/01/2022
10.1016/S1474-4422(25)00304-7	consensus recommendation use mri diagnosis multiple sclerosis	Barkhof F; Reich DS; Oh J; Rocca MA; Li DKB; Sati P; Azevedo CJ; Bagnato F; Calabresi PA; Ciccarelli O; Dwyer MG; DeLuca GC; De Stefano N; Enzinger C; Filippi M; Granziera C; Halper J; Henry RG; Gasperini C; Gauthier S; Kappos L; Laule C; Newsome SD; Montalban X; Morrow SA; Schoonheim MM; Sicotte N; Toosy A; Wilken J; Yousry T; Sastre-Garriga J; Traboulsee A; Ontaneda D; Rovira À	mri play increasingly important role diagnosis multiple sclerosis discus expanded role mri mcdonald diagnostic criterion multiple sclerosis which include optic nerve fifth anatomical location addition to periventricular juxtacortical cortical infratentorial spinal cord region diagnosis multiple sclerosis can now be confirmed when criterion dissemination space are fulfilled detection typical lesion least four location additional evidence recommend appropriate imaging strategy mri acquisition protocol aspect multiple sclerosis diagnosis including sequence detection symptomatic optic nerve lesion diagnostic imaging should always cover brain spinal cord include sequence assessment central vein sign paramagnetic rim lesion which can be especially helpful case when conventional imaging finding are insufficient to establish diagnosis discus how to handle diagnosis radiologically isolated presentation multiple sclerosis which are included criterion present recommendation image interpretation avoidance misdiagnosis extend recommendation to use mri diagnosis multiple sclerosis older people child people vascular comorbidities migraine people living europe north america finally provide recommendation standardisation mri acquisition communication result to enable earlier diagnosis maintaining high diagnostic specificity	Lancet Neurol	01/10/2025
10.1097/IJG.0000000000001167	comparison fellow eye acute primary angle closure phacomorphic angle closure	Moghimi S; Fathollahzadeh N; Chen R; Lin SC; Weinreb RN	purpose to compare anterior segment parameter fellow eye acute primary angle closure apac fellow eye phacomorphic angle closure ac to identify parameter that could be used to differentiate fellow eye entity method study included unaffected fellow eye apac unaffected fellow eye phacomorphic ac eye control subject patient underwent anterior segment optical coherence tomography imaging anterior chamber depth anterior chamber area anterior chamber width acw iris thickness iris curvature lens vault lv angle parameter including distance were measured qualified image using customized software compared group using linear mixed model result fellow eye apac had smallest axial length aod anterior chamber depth anterior chamber area acw greatest lv followed fellow eye phacomorphic ac adjustment age sex pupil diameter curvature were comparable fellow eye phacomorphic ac control angle parameter had highest area characteristic curve discrimination fellow eye apac eye phacomorphic ac multivariable analysis lt µm odds ratio lv gt µm acw lt mm younger age were factor that discriminated fellow eye apac phacomorphic ac conclusion difference ocular biometric parameter can be detected fellow eye apac phacomorphic ac narrower angle more anteriorly displaced lens thicker iris are main parameter that distinguish fellow eye apac phacomorphic ac	J Glaucoma	01/03/2019
10.1097/JS9.0000000000003552	deciphering pathogenic mechanism bdcpp exposure endometrial cancer progression integrated approach combining network toxicology machine learning molecular docking	Wang Z; Fu Y; Cai Q; Zong L	background endometrial cancer ec is one most common gynecological malignancy globally increasing attention ha been paid to role environmental pollutant ec development epidemiological study have demonstrated significant association elevated urinary concentration bi phosphate bdcpp increased risk ec however hub gene underlying mechanism ec remain poorly understood material method potential target bdcpp ec were retrieved multiple database interaction ppi network wa constructed based common target enrichment analysis wa performed using go kegg reactome database clinical transcriptomic data ec patient were downloaded tcga subsequently machine learning model were employed to screen hub gene risk score bdcpp exposure wa calculated based hub gene gene set enrichment analysis gsea wa conducted hub gene molecular docking wa performed to predict binding affinity bdcpp to hub gene result identified potential target implicated ec machine learning pinpointed eight hub gene plau thrb bdcpp exposure risk score model offer framework predicting prognosis ec patient moderate accuracy molecular docking revealed binding potential bdcpp hub gene finding highlight pivotal role inflammatory activation hormonal disruption altered lipid metabolism epigenetic dysregulation pathogenic mechanism gsea further emphasized critical role nucleocytoplasmic transport polycomb repressive complex mrna surveillance pathway process conclusion study investigated hub gene underlying mechanism ec finding not only offer novel insight role environmental pollutant ec development also present analytical framework elucidating carcinogenic mechanism other environmental chemical	Int J Surg	24/09/2025
10.1080/09546634.2025.2555210	spesolimab child generalized pustular psoriasis accompanied epilepsy hyperactivity	Wang Y; Qin J; Peng L; He L; Yang B; Yang M; Feng Y	objective to evaluate therapeutic efficacy safety spesolimab pediatric gpp treatment method report male pediatric patient refractory generalized pustular psoriasis gpp comorbid epilepsy hyperactivity hypoproteinaemia coexistence gt homozygous mutation gt heterozygous variation may have worsened disease phenotype result spesolimab treatment achieved complete rapid response pustule erythema scale cleared week conclusion spesolimab is effective treating pediatric gpp patient is potential to be clinical treatment strategy pediatric gpp future	J Dermatolog Treat	01/12/2025
10.1002/advs.202506345	suppresses atherosclerosis promoting polarization macrophage glycogen metabolic reprogramming	Shen L; Yu J; Chen W; Bi Y; Yang Z; Lu C; Jiang C; Yang Y; Chen M; Zou J; Lv L; Chen X; Ji J	identifying target that promote macrophage polarization hypoxic plaque microenvironment is crucial modulating immune metabolism optimizing energy dynamic atherosclerotic cardiovascular disease ascvd treatment high phagocytic activity macrophage reduces foam cell formation secretion cytokine enhances plaque stability mitigating atherosclerosis progression sequencing bioinformatics analysis protein phosphatase regulatory subunit is identified key regulator linking glycogen metabolism to macrophage polarization integrated approach combined transcriptomic analysis human atherosclerotic plaque macrophage revealing dual role induces macrophage polarization maintains energy supply plaque absence accelerates plaque progression regulates macrophage polarization energy metabolism phosphorylated which play dual role activating transcriptional program axis nucleus enhancing metabolic activity axis mitochondrion play dual role metabolic regulation macrophage phenotype modulation orchestrating glycogen metabolic reprogramming polarization present novel strategy drug development significant potential clinical translation	Adv Sci (Weinh)	23/09/2025
10.3389/fimmu.2025.1620768	increased risk antiphospholipid syndrome patient psoriasis retrospective cohort study	Wang Q; Cui R; Du Y; Wang YH; Wei JC; Dai SM	objective psoriasis is associated systemic inflammation immune dysregulation raising concern potential link to antiphospholipid syndrome aps however evidence risk aps psoriasis patient remains limited material method retrospective cohort study utilized data trinetx collaborative network propensity score matching wa performed to balance demographic variable comorbidities medication use psoriasis patient univariate cox proportional hazard model subgroup analysis were used to estimate hazard ratio aps method wa used to plot cumulative incidence curve result matching cohort included patient psoriasis patient exhibited significantly higher aps incidence case control hr ci psoriatic arthritis psa further amplified risk hr ci subgroup analysis identified elevated aps susceptibility older adult female american individual chronic comorbidities conclusion psoriasis psoriatic arthritis are significant risk factor aps highlighting need targeted screening management strategy population	Front Immunol	01/01/2025
10.1093/cvr/cvaf159	oxidized mediates cholesterol transport dysfunction inflammasome activation to drive aortic valve calcification	Jiang C; Yao D; Shen Q; Tian R; Fan L; Zheng Q; Qian X; Liu Z; Huang Y; Dong N	aim calcific aortic valve disease cavd is becoming more prevalent population ageing however there is currently medical therapy available early lipid deposition lipoprotein ldl mediates chronic inflammation accelerates calcification progression however mechanism still need to be further explored method result study identified transcription factor fox human valvular interstitial cell vics pivotal regulator aortic valve calcification bulk analysis were conducted to establish is induced oxidized ldl oxldl vics to elucidate role osteogenic differentiation small interfering rna recombinant adenovirus were utilized to modulate expression vics diet hfd mouse served vivo model to investigate role aortic valve calcification analysis bulk western blot indicated significant activation oxldl vics silencing inhibiting osteogenic differentiation deletion markedly reduced aortic valve calcification mouse shown decreased calcium deposition aortic valve leaflet chromatin immunoprecipitation sequencing were performed to reveal regulatory mechanism uncovering direct interaction promoter which subsequently inhibits expression axis study demonstrated mediates vics cholesterol transport dysfunction using showed intracellular cholesterol accumulation can activate inflammasome promoting osteogenic differentiation vics additionally wa found recombinant could reduce aortic valve calcification vitro vivo conclusion identified transcription factor inhibits expression axis promotes cholesterol transport dysfunction activation inflammasome vics thereby accelerating progression cavd	Cardiovasc Res	24/09/2025
10.1016/S0140-6736(25)01576-4	oral icotrokinra versus placebo oral deucravacitinib participant plaque psoriasis amp two phase randomised trial	Gold LS; Armstrong AW; Bissonnette R; Magnolo N; Vender RB; Sebastian M; Galimberti ML; Tsianakas A; Arnone M; Wallace P; Simon M; Riera-Monroig J; Gerdes S; Waibel J; Gonzalez-Cantero A; Schwarz B; Tada Y; Cecchini M; Ehst B; Kircik L; Kephart L; Reyes-Servin O; Edem BE; Campbell JH; Shen YK; Cresswell K; Li S; DeKlotz CMC; Nunes F; Papp KA	background monoclonal antibody targeting are efficacious treating plaque psoriasis must be delivered intravenous subcutaneous injection here aimed to evaluate efficacy safety icotrokinra targeted oral peptide that selectively bind receptor compared placebo deucravacitinib adult plaque psoriasis method phase randomised trial which are being done site country site country respectively randomly assigned respectively adult plaque psoriasis diagnosed least week involvement psoriasis area severity index pasi investigator global assessment iga to oral icotrokinra mg placebo deucravacitinib mg participant randomly assigned to placebo deucravacitinib transitioned to icotrokinra week week respectively coprimary endpoint were proportion participant achieving iga clear almost clear skin least improvement least improvement pasi pasi week icotrokinra versus placebo study are registered advance are ongoing finding enrolled participant jan to may enrolled participant march to june participant advance patient screened advance patient screened were randomly assigned to icotrokinra placebo deucravacitinib coprimary endpoint were met trial higher proportion versus participant achieved iga advance v treatment difference ci v seven lt pasi advance v six treatment difference ci v one lt week study adverse event rate to week were icotrokinra placebo respectively most common adverse event were nasopharyngitis upper respiratory tract infection eight to week adverse event rate were lower icotrokinra deucravacitinib interpretation icotrokinra showed superior clinical response rate versus placebo deucravacitinib phase plaque psoriasis trial similar adverse event rate to placebo finding suggest potential oral icotrokinra to provide robust efficacy favourable safety profile funding johnson amp johnson	Lancet	18/09/2025
10.1111/liv.70367	target trial emulation dual agonist to reduce major adverse liver outcome type diabetes	Henney AE; Riley DR; Anson M; Azmi S; Alam U; Cuthbertson DJ	background clinical trial suggest receptor agonist ra dual insulinotropic polypeptide gip ra improve metabolic dysfunction associated steatohepatitis mash patient metabolic steatotic liver disease masld aimed to compare estimate relative effect tirzepatide semaglutide liraglutide reducing risk major adverse liver outcome malos patient type diabetes design setting participant emulated target trial based network electronic health record ehrs million patient three target trial were emulated eligible patient who had prior malo diagnosis comparing therapy involving tirzepatide semaglutide liraglutide versus inhibitor therapy identified diagnosis malo occurring period compared treatment group using survival analysis cohort underwent propensity score matching confounders performed sensitivity analysis relating to geographical location combination metformin treatment adherence also performed analysis therapy result matching identified three target trial comprised patient treated tirzepatide semaglutide liraglutide respectively reference patient period tirzepatide hr ci semaglutide hr were associated significant reduction risk incident malo compared whereas liraglutide wa not hr ci comparison tirzepatide wa associated significantly lower risk incident malo compared liraglutide hr ci not semaglutide hr ci semaglutide wa not associated reduced risk compared liraglutide hr ci conclusion treatment tirzepatide to lesser extent semaglutide patient wa associated lower incidence malo compared year largely driven reduction rate compensated decompensated cirrhosis reduction malo wa not demonstrated use liraglutide finding highlight comparative benefit tirzepatide semaglutide versus should prompt more robust randomised controlled study to evaluate role preventing malo increasingly prevalent patient population masld	Liver Int	01/10/2025
10.1038/s41588-025-02321-z	rapid epigenomic classification acute leukemia	Steinicke TL; Benfatto S; Capilla-Guerra MR; Monteleone AB; Young JH; Shankar S; Michaels PD; Tsai HK; Good JD; Kreso A; van Galen P; Schliemann C; Chen EC; Griffin GK; Hovestadt V	acute leukemia requires precise molecular classification urgent treatment however diagnostic test are do not capture full spectrum acute leukemia heterogeneity here developed framework to classify acute leukemia using dna methylation profiling first assembled comprehensive reference cohort sample defined methylation class classification matched lineage classification most case revealed heterogeneity addition to captured genetic category using reference developed neural network marlin rapid leukemia subtype inference acute leukemia classification sparse dna methylation profile retrospective cohort profiled nanopore sequencing prediction were concordant conventional diagnosis case marlin classification patient suspected acute leukemia provided accurate prediction five five case which were typically generated sample receipt summary present framework rapid acute leukemia classification complement enhances diagnostics	Nat Genet	22/09/2025
10.1177/22799036221110020	health health inequality impact assessment measure to control basque country navarre spain	Urtaran-Laresgoiti M; González-Rábago Y; Martín U; Rivadeneyra-Sicilia A; Morteruel M	article describes result health health inequality impact assessment pandemic control measure region basque country navarre spain literature review wa conducted pubmed web science wos database addition to individual interview focus group expert key informant different profile citizen wide variety social determinant health have been affected measure which included individual behavior service disruption formal care educational setting health care provision change have particularly affected certain population group including child adolescent older people health condition disability together caregiver woman a well people low level education income resource future scenario will be necessary to pay attention to potential impact policy response health inequality to avoid increase existing health gap	J Public Health Res	01/07/2022
10.1519/JSC.0000000000001019	time course resistance muscle hypertrophy elderly	Lixandrão ME; Damas F; Chacon-Mikahil MP; Cavaglieri CR; Ugrinowitsch C; Bottaro M; Vechin FC; Conceição MS; Berton R; Libardi CA	extended period resistance training rt induce muscle hypertrophy nevertheless to date study ha investigated time window necessary to observe significant change muscle area csa older adult therefore study investigated time course muscle hypertrophy week session rt elderly fourteen healthy older subject were randomly allocated rt control group rt wa composed set repetition repetition maximum leg press machine time course vastus lateralis muscle hypertrophy csa wa assessed weekly basis ultrasonography leg press muscle strength wa assessed dynamic test result demonstrated rt group increased leg press week training significant increase vastus lateralis muscle csa were observed only session training week conclusion training protocol promoted muscle mass accrual older subject wa only observable session rt week	J Strength Cond Res	01/01/2016
10.1021/acsnano.5c11211	mesenchymal stem extracellular vesicle ameliorate temporomandibular joint osteoarthritis suppressing osteoclast activity axis	Yang Z; Zhang S; Faqeer A; Anjum S; Deng Y; Cao J; Yu T; Zhang Y	temporomandibular joint osteoarthritis tmjoa is common degenerative oral disease remains one most challenging joint disorder to treat clinically is characterized excessive subchondral bone loss early stage cartilage damage later stage recent year mesenchymal stem cell msc derived extracellular vesicle have attracted widespread attention potential role modulating oa pathology however application tmjoa remains underexplored mechanism underlying therapeutic effect are not fully understood study evaluate therapeutic effect human umbilical cord mesenchymal stem extracellular vesicle tmjoa focus subchondral bone investigate underlying molecular mechanism mirna sequencing result demonstrated treatment significantly reduced osteoclast oc activity transferring which further suppressed expression integrin osteoclast rat tmjoa model injection demonstrated protective effect subchondral bone cartilage primarily suppression osteoclast activity consequently result highlight potential therapy promising effective approach treatment tmjoa	ACS Nano	22/09/2025
10.1126/science.adt1630	predicting interaction human proteome	Zhang J; Humphreys IR; Pei J; Kim J; Choi C; Yuan R; Durham J; Liu S; Choi HJ; Baek M; Baker D; Cong Q	interaction ppi are essential biological function coevolutionary analysis deep learning dl based protein structure prediction have enabled comprehensive ppi identification bacteria yeast approach have had limited success more complex human proteome overcame challenge enhancing coevolutionary signal deeper multiple sequence alignment harvested petabyte unassembled genomic data developing new dl network trained augmented datasets interaction million predicted protein structure systematically screened million human protein pair predicted interaction expected precision which interaction were not identified previous experimental screen model predicted interaction provide numerous hypothesis protein function mechanism human disease	Science	25/09/2025
10.1001/jamaoncol.2025.3700	ribociclib endocrine therapy hormone early breast cancer outcome natalee randomized clinical trial	Fasching PA; Stroyakovskiy D; Yardley DA; Huang CS; Crown J; Bardia A; Chia S; Im SA; Martin M; Xu B; Loi S; Barrios C; Untch M; Moroose R; Visco F; Hortobagyi GN; Slamon DJ; Fresco R; Zarate JP; Li Z; Waters S; Hurvitz SA	importance ribociclib nonsteroidal aromatase inhibitor nsai ha demonstrated statistically significant invasive survival idf benefit nsai alone patient hormone formerly early breast cancer evaluating efficacy safety adjuvant ribociclib planned treatment period is critical understanding impact recurrence objective to evaluate efficacy safety adjuvant ribociclib exploratory analysis natalee new adjuvant trial ribociclib randomized clinical trial patient no longer receiving ribociclib treatment design setting participant exploratory analysis international randomized phase trial analyzed adjuvant treatment premenopausal postmenopausal woman men hormone early breast cancer eligible patient had anatomic stage iia additional risk factor axillary lymph node iib iii disease american joint committee cancer staging manual eighth edition data cutoff date wa april intervention patient were randomized to receive ribociclib mg once daily day cycle month nsai letrozole mg anastrozole mg once daily continuously month nsai alone men premenopausal woman also received goserelin mg once day administered subcutaneously main outcome measure primary end point wa idf secondary efficacy end point included distant survival survival overall survival survival wa evaluated method result patient included analysis median range age year female median idf wa month range month ribociclib nsai continued to show idf benefit nsai alone hazard ratio ci idf rate v difference percentage point rate v difference percentage point efficacy benefit wa consistent subgroup secondary end point overall survival data remain immature trend favor ribociclib nsai nsai alone wa observed hazard ratio ci incidence adverse event ha remained stable conclusion relevance exploratory analysis natalee randomized clinical trial median treatment duration demonstrated consistent idf benefit ribociclib nsai nsai alone trial registration identifier	JAMA Oncol	25/09/2025
10.1002/advs.202509351	nonalcoholic fatty liver disease exacerbates advancement renal fibrosis modulating renal pirb macrophage axis	Wei S; Shou D; Huang S; Wang Y; Liu Q; Liu J; Lv X; Zeng Y; Wei L; Lin H; Chen J; Chen Y; Zhong H; Zhou Y; Ma W; Wang L; Qian G; Guo J; Sun D	renal fibrosis is critical pathological hallmark chronic kidney disease nonalcoholic fatty liver disease nafld ha been implicated kidney disease progression specific role underlying mechanism renal fibrosis remain poorly understood study aim to investigate mechanism establishing mouse model renal fibrosis unilateral ureteral obstruction uuo combined nafld rna sequencing untargeted metabolomics flow cytometry immunofluorescence are performed vitro experiment involving primary renal macrophage coculture model is demonstrated nafld exacerbates renal fibrosis hepatocytes release significant level which activates renal pirb macrophage specialized macrophage disrupt linoleic acid metabolism increase production inflammatory cytokine aggravating renal fibrosis addition pirb macrophage promote activation proliferation cell which can further contribute to worsening renal fibrosis thus axis is crucial signaling pathway liver kidney pirb macrophage play pivotal role progression renal fibrosis finding suggest potential therapeutic target to treat renal fibrosis	Adv Sci (Weinh)	25/09/2025
10.2147/CPAA.S497904	pharmacotherapy obesity recent update	Fredrick TW; Camilleri M; Acosta A	narrative review describe recent update regarding medication february describe physiologic mechanism underpinning development hunger satiation maintenance satiety to address target medication efficacy mechanism additional beneficial effect medication are then further detailed review focus medication obesity select medication currently development undergoing phase trial start focusing medication orlistat phentermine also highlight setmelanotide heritable obesity mechanism action comparative efficacy receptor agonist liraglutide semaglutide are reviewed tirzepatide dual agonist is described weight loss is compared to alternative medication additional incretin target pipeline include dual to glucagon receptor triple agonist targeting glucagon gip novel agonist oral formulation agonist amylin agonist finally provide best practice adjunct to pharmacologic treatment obesity monitoring efficacy obesity treatment adjusting medication regimen provider	Clin Pharmacol	01/01/2025
10.1002/advs.202508574	clinically inspired multimodal treatment using induced neural stem exosomes promotes recovery traumatic brain injury microglial modulation	Li J; Xu M; Cai B; Li X; Liang Z; Xia X; Zhang H; Zhang Z; Tan F; Zheng JC	traumatic brain injury tbi pose serious physical psychosocial economic threat to million patient globally year current treatment option primarily surgery medication vary tbi severity there is universal therapeutic agent applicable surgical medical context present study exosomes derived induced neural stem cell versatile therapeutic agent tbi are investigated using preclinical murine model treatment is found to exert therapeutic effect mediating neuroprotection thereby promoting functional cognitive recovery tbi mouse besides two clinically inspired administration modality are established local delivery systemic delivery efficacy is enhanced novel injectable hydrogel rvg targeting systemic delivery respectively finally unprecedented characterization mouse brain tissue treatment confirms microglia represent predominant type cell affected two microglial subpopulation are identified reduced state differentiation connectivity neuron is predicted activation nrxn signaling pathway overall finding demonstrated offer versatile potent treatment platform clinical potential tbi management	Adv Sci (Weinh)	24/09/2025
10.3389/fnhum.2023.1101432	development running is not related to time onset independent walking longitudinal case study	Bach MM; Zandvoort CS; Cappellini G; Ivanenko Y; Lacquaniti F; Daffertshofer A; Dominici N	introduction child start to run master walking how running develops however is largely unknown method assessed maturity running pattern two very young typically developing child longitudinal design spanning three year leg trunk kinematics electromyography collected six recording session more hundred stride entered analysis recorded walking first session session first independent step two toddler age month fast walking running subsequent session more kinematic neuromuscular parameter were determined session stride equivalent data five young adult served to define mature running dimensionality reduction using principal component analysis hierarchical cluster analysis based average pairwise correlation distance to adult running cluster served measure maturity running pattern result child developed running yet one running pattern did not reach maturity whereas other did expected mature running appeared later session gt month onset independent walking interestingly mature running alternated episode immature running session clustering approach separated discussion additional analysis accompanying muscle synergy revealed participant who did not reach mature running had more difference muscle contraction when compared to adult other one may speculate difference muscle activity may have caused difference running pattern	Front Hum Neurosci	01/01/2023
10.1681/ASN.0000000856	drive aberrant activation injury glomerular endothelial cell lupus nephritis	Qing J; Wen J; Wang X; Zhao Y; Shen X; Huang X; Wei R; Wang X; Kang M; Bai L; Zhou L; Wang X; Tong Q; Wu J	background lupus nephritis severe complication systemic lupus erythematosus is closely associated abnormal activation glomerular endothelial cell significance core mechanism underlying glomerular endothelial cell activation remain elusive method performed rna sequencing kidney tissue lupus nephritis patient mouse model to investigate transcriptional alteration glomerular endothelial cell validated finding two lupus nephritis model lupus nephritis mouse genetically modified mouse cultured cell were employed to further validate key discovery additionally panel cytokine stimulation wa used to elucidate underlying cause glomerular endothelial cell injury lupus nephritis result wa identified critical regulator showing significant upregulation glomerular endothelial cell lupus nephritis patient mouse model elevated expression correlated enhanced glomerular endothelial cell proliferation migration increased expression adhesion molecule activated pathway leading to upregulation downstream target thereby promoting glomerular endothelial cell hyperactivation overexpression amplified glomerular endothelial cell proliferation migration whereas inhibition id signaling knockout attenuated effect moreover targeting signaling reduced infiltration macrophage lupus nephritis kidney experiment confirmed glomerular endothelial cell promoted macrophage differentiation inflammatory phenotype complement component wa identified critical upstream inducer glomerular endothelial cell inhibition signaling antagonist effectively suppressed upregulation conclusion finding highlight key regulator glomerular endothelial cell injury inflammation lupus nephritis targeting upstream activator such effectively treated improved lupus nephritis	J Am Soc Nephrol	22/09/2025
10.1038/s41388-025-03569-9	fibroblast drive lung adenocarcinoma progression transition	Ren Y; Ming R; Zuo A; Liu S; Ba Y; Zhang Y; Chen Y; Pan T; Luo P; Cheng Q; Deng J; Yue Y; Xu H; Weng S; Han X; Zhou D; Liu Z	role fibroblast cafs initiation invasion phase human lung adenocarcinoma luad development is not fully understood study utilized rna sequencing spatial transcriptomics combination vivo vitro model to decode dynamic interaction human luad progression focusing primarily adenocarcinoma situ ai minimally invasive adenocarcinoma mia invasive adenocarcinoma iac identified matrix caf mcaf subtype characterized high expression which wa closely associated poor clinical outcome tumor recurrence invasive dynamic luad spatial transcriptomics multiplex immunohistochemistry analysis revealed caf subpopulation wa closely associated tumor cell clear spatial colocalization vivo vitro experiment demonstrated secreted mcafs directly bind to tumor cell enhancing tumor transition emt program study highlight mcafs key regulator interaction identifies axis potential therapeutic target luad	Oncogene	19/09/2025
10.1097/AOG.0000000000005802	acetaminophen pregnancy hyperactivity disorder autism spectrum disorder	Damkier P; Gram EB; Ceulemans M; Panchaud A; Cleary B; Chambers C; Weber-Schoendorfer C; Kennedy D; Hodson K; Grant KS; Diav-Citrin O; Običan SG; Shechtman S; Alwan S	acetaminophen is common medication that recently gained substantial medium attention regarding use pregnant individual clinical perspective discus strength limitation published literature effect maternal acetaminophen use pregnancy child risk developing hyperactivity disorder adhd autism spectrum disorder asd study included were specifically selected basis quality validity adhd asd outcome definition total identified study commentary editorial relevance critically reviewed nine study original data that satisfied inclusion criterion three most study that have reported positive finding are difficult to interpret have important bias notably high degree selection bias variability selection adjustment various potential confounders unmeasured familial confounding when unobserved familial confounding sibling analysis wa controlled association weakened substantially suggests residual confounding shared genetic environmental factor may have caused upward bias original observation according to current scientific evidence utero exposure to acetaminophen is unlikely to confer clinically important increased risk childhood adhd asd current level evidence doe not warrant change to clinical guideline treatment fever pain pregnancy prospective research designed to account familial psychosocial environmental factor related to maternal use acetaminophen child neurodevelopment should be undertaken	Obstet Gynecol	01/02/2025
10.7759/cureus.26995	systematic review link autism spectrum disorder acetaminophen mystery to resolve	Khan FY; Kabiraj G; Ahmed MA; Adam M; Mannuru SP; Ramesh V; Shahzad A; Chaduvula P; Khan S	purpose study is to review published paper investigating maternal acetaminophen ap use pregnancy effect offspring neurodevelopment particularly autism spectrum disorder asd acetaminophen is analgesic antipyretic considered safe pregnancy recent study have found association acetaminophen immune system alteration asthma adverse neurodevelopmental outcome used online database central science direct google scholar to search study relevant to topic screened paper title abstract then availability screened article were checked eligibility using relevant quality assessment tool study design extracting analyzing data finalized study screening were ineligible final selection included paper prospective cohort study two review article one found wide range neurodevelopmental outcome data collection so included autism spectrum disorder intelligent quotient iq disorder adhd isolated language attention executive function communication behavior psychomotor development study showed association acetaminophen use listed neurodevelopmental outcome use increased dose frequency were associated stronger association extracted collective evidence study suggesting acetaminophen role developing adverse neurodevelopmental outcome is urgent to do more research association pregnant woman can be cautioned precise use acetaminophen	Cureus	01/07/2022
10.1002/advs.202413170	multiomics analysis reveal essential role tryptophan treatment csdmards rheumatoid arthritis	Jian C; Zhu J; Wu J; Zhang Y; Chen J; Wang H; Liu H; Xu K; Huang J; Zhu X; Wei Y; Li S; Wang T; Huang X; Zou Q; Zhang J; Su J; Du X; Lu Y; Zhou T; Zhou Y; Tang M; Li B; Zhou X; Wei Q; Yan Q; Zeng F	rheumatoid arthritis ra is autoimmune disease characterized heterogeneity response to conventional synthetic antirheumatic drug csdmards study aim to elucidate molecular difference response mechanism ra patient to csdmards multiomics approach particular focus role tryptophan trp treatment plasma fecal peripheral blood mononuclear cell pbmcs were collected metabolomics microbiomics transcriptomics transcriptomics proteomics phosphoproteomics analysis additionally experiment controlled clinical trial were conducted to validate finding comprehensive analysis revealed significant alteration metabolic profile microbiota composition immune cell indicating role trp modulating therapeutic response to csdmards vitro experiment demonstrated trp significantly inhibited proliferation pbmcs reducing secretion furthermore vivo study showed trp treatment decreased arthritis score histological score mouse clinical data further confirmed dietary supplementation trp significantly improved disease activity score alleviated inflammatory ra patient study highlight crucial regulatory role trp ra therapy providing novel insight optimizing clinical treatment strategy ra	Adv Sci (Weinh)	23/09/2025
10.1002/advs.202416575	steroid receptor drive macrophage reprogramming mediating transcription pancreatic cancer perineural invasion	Cheng K; Liu L; Gong M; Ji Y; Bai C; Guo X; Chen H; Pan J; Zhang Y; Yuan Y	perineural invasion pni is hallmark pancreatic cancer aggressiveness however feasibility manipulating macrophage tam reprogramming to influence pni development remains unclear method using vitro vivo sciatic nerve injection model coupled protein identification liquid spectrometry role steroid receptor is investigated tam reprogramming pni is tam promotes pni binding to signal transducer activator transcription to enhance matrix metallopeptidase transcription knockdown attenuated characteristic tam reduced secretion suppressed pni importantly blocking axis using tam inhibitor attenuated pni progression vivo reprograms tam activation to facilitate pni targeting disrupts axis present novel therapeutic strategy pni pancreatic cancer	Adv Sci (Weinh)	23/09/2025
10.1073/pnas.2419888122	triple checkpoint blockade enhances adoptive cell immunotherapy mouse model ovarian cancer	Alencar GF; Mohamed AO; Burnett MG; Jean SS; Nelson AR; Su Y; Voillet V; Bates BM; Rodgers Suarez M; Ruskin SL; Trieu L; Lam JL; Bekiranov S; Gottardo R; Greenberg PD; Anderson KG	survival rate ovarian cancer patient remains underscoring need innovative therapy one promising approach involves engineering cell to specifically target protein uniquely overexpressed tumor thereby controlling tumor growth toxicity to healthy tissue mesothelin msln contributes to malignant invasive phenotype ovarian cancer ha limited expression healthy cell making candidate immunotherapy target previous result mouse model ovarian cancer demonstrated cell engineered to express cell receptor tcr targeting msln tcr msln mediated therapeutic activity delaying tumor growth prolonging mouse survival however inhibitory ligand expressed tumor microenvironment tme interacted inhibitory receptor activated cell suppressing antitumor function hypothesized combining engineered cell checkpoint blockade would enhance cell function improve therapeutic efficacy administration monospecific antibody targeting individual inhibitory pathway had significant impact cell efficacy contrast combination blockade engineered cell significantly improved cell function overall animal survival relative to treatment antibody alone tcr msln singlet doublet antibody combination rna sequencing revealed tcr msln cell treated triplet antibody combination increased expression gene involved interferon response metabolic function reduced expression gene associated exhaustion result suggest strategy to disrupt multiple inhibitory pathway simultaneously may be necessary improved adoptive cell therapy efficacy patient	Proc Natl Acad Sci U S A	30/09/2025
10.1016/j.intimp.2025.115557	identification gene diagnostic biomarkers therapeutic target hcc machine learning experimental validation	Zhang J; Geng W; Sun H; Chen J; Fan Y; Tan K	liver cancer particularly hepatocellular carcinoma hcc remains significant health burden poor survival rate due to late diagnosis limited treatment option sorafenib inhibitor is standard therapy advanced hcc use often lead to drug resistance ferroptosis form regulated cell death ha emerged crucial target cancer therapy showing potential to enhance treatment efficacy overcome drug resistance previous study have demonstrated sorafenib trigger ferroptosis hcc cell ferroptosis play significant role development sorafenib resistance however intricate interplay ferroptosis sorafenib resistance remains poorly understood hampering development effective therapeutic strategy study focus intricate interplay ferroptosis sorafenib resistance hcc using dataset identified differentially expressed gene associated sorafenib resistance notably gene stratified hcc patient distinct subgroup different drug sensitivity immune cell infiltration response to chemotherapy immunotherapy machine learning algorithm three hub gene were identified to be closely associated sorafenib resistance novel signature comprising gene emerged robust diagnostic model validated roc curve analysis predicting sorafenib resistance hcc patient furthermore experimental validation confirmed upregulation expression hcc cell sorafenib treatment altering expression profile knockdown hcc cell potently enhanced ferroptosis thereby alleviating sorafenib resistance finding not only identify pivotal gene diagnostic biomarkers sorafenib resistance also provide insight role ferroptosis modulating sorafenib responsiveness study offer promising strategy to overcome sorafenib resistance improve patient outcome hcc treatment highlighting potential therapy cancer management	Int Immunopharmacol	21/09/2025
10.1038/s41467-025-64088-5	epigenetic regulation suppresses astrocytic immune response mouse	Park S; Park H; Byun YG; Wei X; Eom J; Joo J; Lee AJ; Diao Y; Chung WS; Jung I	astrocyte are critical contributor to brain disorder yet mechanism underlying selective vulnerability to specific disease remain poorly understood here demonstrate act key regulator early postnatal astrocyte development shaping immune response mouse integrative analysis gene expression chromatin accessibility chromatin interaction identify tfs uniquely associated early postnatal maturation mouse lacking astrocytic exhibit detectable developmental abnormality mouse display heightened susceptibility to exacerbated immune response following experimental autoimmune encephalomyelitis eae many dysregulated eae response gene are linked to candidate element altered early loss driving exacerbated inflammatory response notably only depletion early not late astrocyte development induces epigenetic reprogramming that prime astrocytic immune response	Nat Commun	22/09/2025
10.1158/2159-8290.CD-24-0556	molecular functional landscape resistance to folfiri chemotherapy metastatic colorectal cancer	Avolio M; Leto SM; Sassi F; Lupo B; Grassi E; Catalano I; Zanella ER; Vurchio V; Cottino F; Tsantoulis PK; Lazzari L; Luraghi P; Ferri M; Galimi F; Berrino E; Bellomo SE; Viviani M; Sogari A; Mauri G; Tosi F; Cruciani F; Sartore-Bianchi A; Siena S; Borghi F; Torri V; Élez E; Tabernero J; Nieva M; Montagut C; Tarazona N; Cervantes A; Tejpar S; Bardelli A; Marchiò C; Marsoni S; Bertotti A; Trusolino L	combination irinotecan folfiri remains treatment metastatic colorectal cancer mcrc yet benefit only half patient using xenograft pdxs investigated biological underpinnings heterogeneous response model showed transcriptional upregulation innate immunity mitochondrial metabolism gene together reduced expression dna polymerase sensitive counterpart exhibited phenotype genomic scar homologous recombination hr deficiency not caused genetic epigenetic loss hr gene low abundance recombinase tumoroids forced overexpression attenuated hr scar damage hr inhibition atm blockade enhanced drug sensitivity predictive relevance key response determinant wa validated clinical sample work illuminates functional facet brcaness mcrc introduces actionable biomarkers target offering prospect to improve clinical broaden therapeutic option chemorefractory patient	Cancer Discov	22/09/2025
10.1161/HYPERTENSIONAHA.107.098475	effect candesartan compared amlodipine hypertensive patient high cardiovascular risk candesartan antihypertensive survival evaluation japan trial	Ogihara T; Nakao K; Fukui T; Fukiyama K; Ueshima K; Oba K; Sato T; Saruta T	candesartan antihypertensive survival evaluation japan trial wa designed to compare effect angiotensin ii receptor blocker candesartan calcium channel blocker amlodipine incidence cardiovascular event represented composite sudden death cerebrovascular cardiac renal vascular event japanese hypertensive patient conducted prospective randomized study blinded assessment end point japanese hypertensive patient mean age year mean body mass index patient were followed average year blood pressure wa well controlled regimen systolic blood blood pressure mm hg regimen mm hg regimen year primary cardiovascular event occurred patient regimen regimen produced significant difference cardiovascular morbidity mortality japanese hypertensive patient hazard ratio ci to primary end point category there wa significant difference regimen diabetes occurred fewer patient taking candesartan taking amlodipine which resulted relative risk reduction hazard ratio ci to disclosed regimen produced statistical difference term primary cardiovascular end point whereas candesartan prevented diabetes more effectively amlodipine	Hypertension	01/02/2008
10.1016/j.phymed.2025.157246	comparison efficacy action mechanism chinese patent medicine liver fibrosis cirrhosis	Fu L; Xie J; Wang Z; Jiang T; Zeng Y; Yan J; Sun R; Huang M; Du S; Wang X; Liu Y; Xi K; Chen A; Ma X; Zeng J; Efferth T	background liver fibrosis is critical stage liver disease progression can advance to cirrhosis appropriate treatment hepatitis virus infection is primary cause liver fibrosis antiviral drug entecavir are widely used to treat liver fibrosis cirrhosis additionally chinese patent medicine such biejiajian pill bjp liuwei wuling tablet lwt fufang biejia ruangan tablet fft fuzheng huayu capsule fzc anluo huaxian pill ahp demonstrate therapeutic effect however there is still insufficient agreement most effective therapy how work objective study aim to identify most effective chinese patent medicine treating liver fibrosis cirrhosis combining network network pharmacology also summarises evaluates potential mechanism effective treatment method based published clinical research data aim is to provide scientific evidence clinical finally result were verified experiment aim is to provide scientific basis clinical method conducted comprehensive search eight database pubmed web science excerpta medica database embase cochrane library china national knowledge infrastructure cnki weipu database vip wanfang study published up to april applying inclusion exclusion criterion clinical outcome such hyaluronic acid ha laminin ln type iv collagen type iii procollagen aspartate aminotransferase ast alanine aminotransferase alt total bilirubin tbil were analyzed interaction ppi network wa constructed using network pharmacology core gene identified cytohubba cytoscape gene ontology go kyoto encyclopedia gene genome kegg pathway analysis were used to explore underlying mechanism next validated prediction using vivo experiment observing pathological change staining masson trichrome staining picro sirius red staining immunohistochemistry performing protein expression analysis using western blotting result total study involving patient were included surface cumulative ranking curve sucra rank probability were used to assess therapeutic efficacy prescription liver fibrosis ahp wa most effective followed lwt fzc bjp fft cirrhosis treatment lwt wa most effective followed ahp fzc bjp fft combined network pharmacology analysis revealed ahp lwt might play role liver fibrosis cirrhosis regulating target such signal transducer activator transcription matrix metallopeptidase protein kinase etc animal experiment have shown chinese patent medicine such lwt ahp can significantly improve liver damage mouse reduce level muscle actin transforming growth factor beta fibronectin fn ccl group increasing expression content conclusion ahp lwt are most effective treatment liver fibrosis cirrhosis respectively according to current network lwt ahp may play role liver fibrosis cirrhosis regulating target such providing solid foundation clinical treatment strategy	Phytomedicine	11/09/2025
10.1002/mgg3.830	genetics genetic counseling psychiatry result opinion survey professional user	Martorell L; Sanfeliu A; Blázquez A; Lojo E; Cortés MJ; de Pablo J; Vilella E	background heritability several psychiatric disorder is high specific variant have been identified therefore genetic counseling genetic testing can be prescribed to psychiatric patient service are not standardized most population aim study were to gather opinion mental health professional user regarding genetics psychiatric disorder usefulness genetic counseling unit psychiatry method survey wa conducted province tarragona spain analyzed valid questionnaire professional user result percent professional strongly believed psychiatric disorder have genetic basis rated genetic counseling unit psychiatry very extremely useful however only few professional reported patient asked genetics disease possibility transmitting disease to offspring percent user strongly believed psychiatric disorder have genetic basis responded talked family genetics disease were worried transmitting disease to offspring however only reported psychiatrist had talked to topic remarkably user would consider genetic counseling unit very extremely useful conclusion present study showed mental health professional were more aware genetic basis psychiatric disorder user considered implementation genetic counseling service very useful	Mol Genet Genomic Med	01/08/2019
10.1016/j.lanhl.2025.100761	bone quality response to lifestyle intervention older adult obesity trial randomised controlled trial	Gregori G; Mediwala S; Liebschner M; Kim D; Bryant MS; Klonis N; Armamento-Villareal R; Qualls C; Villareal DT	background lifestyle intervention weight loss might exacerbate bone loss osteoporosis however there is limited knowledge effect bone quality examined lifestyle intervention can preserve enhance bone quality reduction bone mineral density method lifestyle intervention to improve bone quality study wa randomised controlled trial conducted baylor college medicine michael debakey va medical center houston tx usa including older adult aged year obesity bmi participant were randomly assigned to receive intensive lifestyle intervention intensive lifestyle group consisting weight management exercise training healthy lifestyle healthy lifestyle group consisting educational session healthy diet outcome were change distal tibia cortical thickness measured using peripheral quantitative ct hip bone strength failure load assessed finite element analysis ct scan primary endpoint wa analysed intention to treat randomly assigned patient trial is registered completed finding participant assessed eligibility person nov nov were included study mean age year sd male female month weight loss wa greater intensive lifestyle group healthy lifestyle group kg se v kg group difference were noted change distal tibia cortical thickness intensive lifestyle group mm se healthy lifestyle group mm difference ci to change hip failure load month did not differ intensive lifestyle group se healthy lifestyle group difference ci to adverse event intensive lifestyle group included small number musculoskeletal event fall one participant neck pain two foot shoulder back leg pain one interpretation lifestyle intervention preserved bone quality older adult obesity weight loss further research is needed to determine lifestyle intervention can reduce fracture risk older adult obesity funding national institute diabetes digestive kidney disease niddk department veteran affair	Lancet Healthy Longev	30/09/2026
10.1038/s41418-025-01589-2	promotes metabolic steatotic liver disease progression stabilization pparγ	Luo H; Zhu C; Wang Y; Dai Y; Hao P; Cai H; Bai W; Zhang Z; Wan J; Zhang Y; Sun Y; Zhang Z; Wu Y; Zhai Y; Wu W; Lei H; Xu H; He M; Wu Y	metabolic steatotic liver disease masld is leading cause chronic liver disease worldwide molecular mechanism underlying pathogenesis are not fully understood here identify deubiquitinating enzyme protease key regulator hepatic lipid metabolism masld progression show expression is significantly upregulated liver tissue masld patient diet hfd mouse model knockout pharmacological inhibition alleviates hepatic steatosis improves systemic metabolic parameter vivo vitro strikingly sirna markedly attenuates masld mouse model highlighting therapeutic potential mechanistically directly interacts stabilizes peroxisome receptor pparγ removing ubiquitin chain lysine domain thereby preventing proteasomal degradation enhancing transcriptional activity axis promotes hepatic lipid accumulation drive masld progression finding novel regulatory mechanism masld pathogenesis suggest may represent promising druggable therapeutic target metabolic liver disease	Cell Death Differ	24/09/2025
10.4415/ANN_11_01_17	rare disease orphan drug	Taruscio D; Capozzoli F; Frank C	according to regulation ec european parliament council rare disease are chronically debilitating condition affecting no more person european community is estimated to distinct rare disease affect up to total eu population therefore condition can be considered rare taken individually affect significant proportion european population when considered single group several initiative have been undertaken international european national level to tackle public health a well research issue related to prevention diagnosis treatment surveillance disease development innovative effective medical product diagnosis treatment is frequently hampered several factor including limited knowledge natural history difficulty setting up clinical study due to limited number patient affected specific disease weak interest sponsor due to restricted market opportunity therefore incentive other facilitation have been adopted many part world including eu order to facilitate development commercialization diagnostic tool treatment devoted to rare disease paper illustrates mainly european initiative will discus problematic controversial aspect surrounding orphan drug finally activity measure adopted italy are presented	Ann Ist Super Sanita	01/01/2011
10.1002/cre2.920	evaluation effect punica granatum flower tablet pain healing minor recurrent aphthous stomatitis randomized clinical trial	Lavaee F; Parhizkar E; Tavakoli F; Zarshenas MM; Asmarian N	objective purpose study wa to determine therapeutic effect punica granatum pg flower recurrent aphthous stomatitis comparison corticosteroid therapy material method randomized clinical trial wa conducted patient who had been referred to shiraz dental school ra all participant used granatum flower tablet triadent month apart time compared experimental group patient received pomegranate flower tablet three tablet daily day control group oral paste triadent ha been prescribed three time day day visual analog scale va size ra were evaluated day data were analyzed spss version wilcoxon test wa used result mean age participant wa year old study patient were men patient were woman mean value va using prescribed treatment evaluated group day wa significantly different such va value were lower pg flower tablet triadent value lt size oral lesion participant who used pg flower tablet wa significantly less who used triadent evaluation day value lt day value descending slope va day to triadent pg flower tablet user wa significant noticeable value lt conclusion according to result study granatum flower tablet triadent are useful reducing size period healing va patient ra pg flower tablet is more effective	Clin Exp Dent Res	01/08/2024
10.7326/ANNALS-24-00960-JC	acetaminophen use pregnancy wa not linked to autism adhd intellectual disability offspring	Worringer E; Rowland K	ahlqvist vh sjöqvist dalman al acetaminophen use pregnancy child risk autism adhd intellectual disability jama	Ann Intern Med	01/08/2024
10.2337/db25-0492	combined weight loss exercise training alters skeletal muscle subcellular lipid localization intermuscular adipose tissue cellular composition	Zemski Berry K; Garfield A; Whytock KL; Macias E; Zarini S; Jambal P; Stepaniak T; Bowen S; Perreault L; Johnson C; Kahn D; Kerege A; Tamburini IJ; Nguyen CM; Viesi CH; Seldin M; Sun Y; Walsh M; Sparks LM; Bergman BC	subcellular lipid accumulation intermuscular adipose tissue imat accumulation are associated insulin resistance impact combined weight loss exercise training localization lipid imat cellular composition is not known adult obesity female male year completed supervised weight loss exercise training intervention insulin sensitivity wa measured using clamp basal vastus lateralis biopsy were collected postintervention intervention body weight body fat decreased respectively peak insulin sensitivity increased respectively lipidomics revealed reduced sarcolemmal nuclear triglyceride unchanged triglyceride diacylglycerols increased increased nuclear pkcε pkcθ pkcδ activation sphingolipid level increased cytosolic accumulation rna sequencing showed altered imat cellular composition including increased progenitor vascular cell macrophage decreased preadipocytes bulk muscle rna sequencing indicated upregulation gene related to muscle remodeling cellular respiration there were change relationship nuclear diacylglycerols gene expression postintervention finding dissociate improvement insulin sensitivity total muscle diacylglycerol sphingolipid level highlight role subcellular lipid redistribution imat remodeling insulin sensitization article highlight evaluation subcellular fractionated muscle revealed decrease sarcolemmal nuclear triglyceride increase nuclear diacylglycerols cytosolic sphingolipids postintervention weight loss revealed alteration cellular composition intermuscular adipose tissue upregulation gene related to muscle remodeling cellular respiration finding dissociate improvement insulin sensitivity total muscle sphingolipid level highlight role intermuscular adipose tissue remodeling enhanced insulin sensitivity	Diabetes	22/09/2025
10.1016/S0140-6736(25)01206-1	oncolytic virus anticancer agent clinical progress remaining challenge	Appleton E; Chiocca EA; Ungerechts G; Melcher A; Vile R	immunotherapy ha transformed treatment cancer yet many patient do not have response lasting benefit strategy to overcome resistance remain crucial importance oncolytic virus offer promising approach unique ability to selectively replicate to destroy cancer cell remodel immunosuppressive tumour microenvironment stimulate antitumour immunity interest potential oncolytic virus ha grown steadily past two decade fuelled advance cancer immunology viral engineering however clinical translation ha not kept pace plethora promising new construct have entered clinical testing several barrier continue to restrict widespread clinical implementation therapeutic paper highlight key milestone oncolytic virus clinical development discusses challenge that remain clinical reflection considers how future research might be streamlined to achieve meaningful benefit patient	Lancet	20/09/2025
10.2460/ajvr.67.10.1681	pharmacokinetics clarithromycin concentration body fluid bronchoalveolar cell foal	Womble AY; Giguère S; Lee EA; Vickroy TW	objective to determine pharmacokinetics clarithromycin concentration body fluid bronchoalveolar bal cell foal animal healthy foal procedure crossover design clarithromycin wa administered to foal iv intragastric ig route initial ig administration additional dos were administered ig interval concentration clarithromycin metabolite were measured serum use liquid chromatography microbiologic assay wa used to measure clarithromycin activity serum urine peritoneal fluid synovial fluid csf pulmonary epithelial lining fluid bal cell result iv administration elimination hour mean sd body clearance apparent volume distribution steady state were determined clarithromycin metabolite wa detected foal hour clarithromycin administration oral bioavailability clarithromycin wa maximum serum concentration clarithromycin multiple ig administration wa ig administration multiple dos clarithromycin concentration peritoneal fluid csf synovial fluid were similar to lower concentration serum whereas concentration urine pelf bal cell were significantly higher concentration serum conclusion clinical relevance oral administration clarithromycin hour maintains concentration serum pelf bal cell that are higher minimum inhibitory concentration rhodococcus equiisolates entire dosing interval	Am J Vet Res	01/10/2006
10.1038/s41418-025-01582-9	ubiquitination alleviates energy autophagy promote prostate cancer growth context spop mutation	Chen S; Lin J; Yang Z; Wang Y; Wang Q; Wang D; Qu Y; Lin Q; Liu J; Yan S; Wang Z; Qian X; Xiao Y; Li X; Chen Y; Fang W; Zhao J; Lu Z; Ren H; Zhu Y; Ma L	spop most frequently mutated gene prostate cancer ha been implicated aberrant activation stress granule presenting significant challenge disease management however mechanistic link spop mutation cellular energy stress remains inadequately explored study demonstrate expression is positively correlated mutation spop upregulation ubiquitin ligase human prostate cancer specimen mechanistically spop mutation induce upregulation which subsequently bind to catalyzes polyubiquitylation modification enhances stability facilitating cellular adaptation to energy stress consequently promoting prostate cancer progression notably pharmacological inhibition using chimera effectively suppressed tumor growth mouse bearing prostate cancer cell collectively finding elucidate pivotal role spop mutation modulating energy stress response ubiquitylation therapeutic potential targeting prostate cancer	Cell Death Differ	20/09/2025
10.1021/acsnano.5c06003	hydrogel loaded aminoethyl exosomes attenuates hepatic fibrosis targeting activated hepatic stellate cell	Sun Z; Zheng Q; Zhang Y; Bai C; Wang F; Yang P; Zhu D; Liu X; Li S; Liu D; Li R; He L; Yao J; Li X	stem regenerative research ha highlighted therapeutic potential human umbilical cord mesenchymal stem exosomes hepatic tissue regeneration repair however exosomes undergo rapid clearance following systemic administration limiting therapeutic potential insufficient retention sustained release study innovative delivery platform encapsulating aminoethyl anisamide aeaa exosomes wa developed to mitigate hepatic fibrosis synthesizing hydrogel iii gel composed carboxymethyl chitosan oxidized dextran iron tannate then encapsulating umbilical cord mesenchymal stem exosomes functionalized aeaa implanted mouse hepatic fibrosis intraperitoneal injection to evaluate therapeutic effect hydrogel hydrogel had favorable physical property optimal biocompatibility profile system significantly reduced oxidative stress alleviated hepatic fibrosis additionally revealed system ameliorates hepatic fibrogenesis mainly modulating oxidative stress collagen deposition inflammatory cascade liver tissue strategy offer targeted efficient approach treating liver fibrosis induced chronic hepatic injury improves targeting efficiency therapeutic outcome engineered exosome delivery	ACS Nano	23/09/2025
10.1172/JCI194080	nanoparticle therapy prevention treatment experimental allergy mouse	Rochman Y; Kotliar M; Klingler AM; Rochman M; Alameh MG; Melamed JR; Osswald GA; Caldwell JM; Felton JM; Mack LE; Hargis J; Lewkowich IP; Barski A; Weissman D; Rothenberg ME	allergic disease have reached epidemic proportion globally calling attention to need better treatment preventive approach herein developed messenger rna mrna lipid nanoparticle lnp strategy therapy prevention allergic response immunization modulated cell differentiation inhibiting generation helper type type cell allergen exposure experimental asthma model induced ovalbumin naturally occurring house dust mite hdm major hdm allergen der treatment attenuated clinicopathology preventive established allergy model including reduction eosinophilia mucus production airway hypersensitivity enhancing production igg antibody maintaining low ige level additionally vaccine mouse elicited cell response seen following mrna vaccination human underscoring conserved immune mechanism specie regardless protein notably vaccination combination mtor inhibitor reduced cell response affecting effect preventive model asthma technology render therapy promising approach prevention treatment allergic disease	J Clin Invest	23/09/2025
10.1186/s13567-023-01248-9	streptococcus sheep mastitis outbreak detected italy is distinct bovine isolates	Rosa MN; Vezina B; Marogna G; Canu A; Molotzu MR; Tola S	streptococcus ruminantium is causative agent several bovine ovine disease however report are uncommon application whole genome sequencing to identify is rare report first time severe ovine mastitis outbreak caused ruminantium italy ruminantium wa isolated adult lactating ewe diffuse nodule mammary parenchyma predominantly serous clotted milk outbreak isolates five additional historical italian isolates were genomically characterised then analysed context publicly available ruminantium genome antimicrobial susceptibility testing wa performed to determine mics antibiotic result showed isolates were susceptible to antimicrobial tested kanamycin single nucleotide variant analysis confirmed clonal outbreak sheep snvs two others were colonised more distantly related clone pairwise snvs indicating presence multiple infecting lineage five historical ruminantium isolates were comprised singleton pairwise snvs to outbreak isolates ovine isolates were found to be genetically distinct to bovine isolates forming monophyletic group bovine isolates were similarly made singleton clone two isolates taken together genomic analysis using globally available genome is consistent general opportunistic pathogenesis ruminantium encourage future genomic surveillance effort to facilitate outbreak detection a well improve understanding zoonotic pathogen	Vet Res	12/12/2023
10.1073/pnas.2503966122	inorganic sulfate is critical mycobacterium tuberculosis lung tissue colonization redox balance	Le Mouëllic W; Levillain F; Wu TD; Caouaille M; Bousso P; Poquet Y; Neyrolles O	tuberculosis remains deadliest infectious disease caused single pathogen highlighting urgent need novel therapy deeper understanding mycobacterium tuberculosis metabolism could uncover specific vulnerability inform development new treatment sulfur essential bacterial growth survival fuel key pathway including redox buffering coenzyme production previous study suggest tuberculosis utilizes various substrate to meet sulfur requirement primary source sulfur exploited vivo infection remain unclear here reveal tuberculosis acquires inorganic sulfate transporter macrophage infection using nanosims high spatial resolution secondary ion mass spectrometry analysis observed significant enrichment intracellular bacteria correlating metabolic activity deletion subi abolished sulfate uptake impairing bacterial growth vitro reducing tuberculosis survival murine macrophage lung infected mouse finally data demonstrate sulfate acquisition is essential maintaining mycobacterial redox balance resisting nitrosative stress vitro vivo thus many intracellular pathogen tuberculosis depends energetically costly inorganic sulfate assimilation pathway to survive host environment finding challenge prior assumption that organic reduced sulfur source such methionine fuel tuberculosis sulfur metabolism infection animal cell lack sulfate assimilation pathway uncovering critical role sulfate import tuberculosis pathogenesis highlight pathway promising therapeutic target targeting system could either directly impair tuberculosis survival infection sensitize bacillus to oxidative stress disrupting redox homeostasis	Proc Natl Acad Sci U S A	30/09/2025
10.1038/s42255-025-01354-2	license macrophage glutaminolysis restorative function atherosclerosis	Benhmammouch S; Borowczyk C; Pierrot-Blanchet C; Barouillet T; Murcy F; Dussaud S; Blanc M; Blériot C; Örd T; Habbouche L; Vaillant N; Gerber Y; Cochain C; Gautier EL; Ginhoux F; Thorp EB; Biessen EAL; Sluimer JC; Bodoy S; Palacin M; Bailly-Maitre B; Kaikkonen MU; Yvan-Charvet L	atherosclerosis is condition characterized chronic inflammation arterial wall atherosclerotic plaque macrophage are key player site disease where metabolic reprogramming dictate progression pathogenesis here show reduced macrophage glutaminase activity is related to glutaminase gls not expression glutamine synthetase serf metabolic rheostat controlling nutrient flux cell vitro macrophage restorative function context atherosclerosis relies more heavily glutamine influx enhanced glutamine flux is largely mediated exchanger macrophage macrophage have reduced glutamine influx glutaminolysis impeding downstream signalling involved macrophage restorative function vivo deletion accelerates atherosclerosis mouse more complex necrotic core composition finally regulation glutaminolysis drive macrophage metabolic transcriptional rewiring atherosclerosis diverting exogenous gln flux to balance remodelling restorative function thus uncover role glutamine uptake upstream glutaminolysis atherosclerotic plaque development stability	Nat Metab	01/09/2025
10.2174/011570159X417328250908080404	unraveling role perivascular macrophage alzheimer disease insight crosstalk immunometabolism ferroptosis	Miao X; Yue W; Wang J; Chen J; Qiu L; Paerhati H; Zhou Q; Li P; Wu A; Zhang M	introduction recent evidence increasingly support potential role perivascular macrophage pvms unique subpopulation brain immune cell pathogenesis alzheimer disease ad strategically positioned interface pvms sense redox status modulate immunity potentially influence form regulated cell death increasingly implicated ad however involvement pvms ad pathology specifically entail mechanism related to crosstalk immunometabolism ferroptosis precise molecular pathway linking pvms immunometabolism ferroptosis to ad remains unclear method first obtained rna sequencing data pvms ad patient control subject geo database identified differentially expressed gene degs applied mendelian randomization mr robustness validated analysis to pinpoint key gene degs causal relevance to ad next identified gene key gene examined association immune cell infiltration immunometabolic signaling pathway also predicting regulatory transcription factor to inform potential therapeutic strategy result identified degs pvms ad control group which were primarily enriched immune metabolic pathway mr analysis established eight gene causally negatively associated ad risk ivw analysis identified lt robustness confirmed analysis being recognized known ferroptosis driver immune cell infiltration analysis revealed significant difference monocyte neutrophil proportion ad identified sole gene significantly correlated monocyte abundance key gene demonstrated distinct association immunometabolic pathway expression wa positively associated signaling showed enrichment cell high notch signaling activity exhibited robust association multiple pathway implicated ferroptosis including bile acid metabolism cholesterol homeostasis pathway suggesting potential mechanism that mediate crosstalk immunometabolism ferroptosis transcription factor analysis highlighted shared regulation cebpd family indicating convergent transcriptional control gene conclusion study identifies eight key gene pvms that may protect ad mechanism involving interplay immunometabolism ferroptosis finding provide novel insight function pvms ad pathophysiology suggest potential therapeutic target devastating neurodegenerative disease	Curr Neuropharmacol	18/09/2025
10.1093/aje/kwaa257	behavioral problem age year prenatal postnatal exposure to acetaminophen outcome	Inoue K; Ritz B; Ernst A; Tseng WL; Yuan Y; Meng Q; Ramlau-Hansen CH; Strandberg-Larsen K; Arah OA; Obel C; Li J; Olsen J; Liew Z	several study have reported association prenatal acetaminophen exposure behavioral outcome young child aimed to evaluate association prenatal postnatal exposure to acetaminophen behavioral problem child age year using behavioral measure reported parent child studied pair danish national birth cohort enrolled strength difficulty questionnaire sdq response were collected estimated risk ratio behavioral problem including total difficulty a well internalizing externalizing behavior following prenatal pregnancy postnatal first month birth acetaminophen exposure sdq score were moderately correlated higher externalizing internalizing behavior prenatal acetaminophen exposure wa associated higher risk total difficulty internalizing externalizing problem based sdq association being stronger greater cumulative week acetaminophen use postnatal exposure wa associated higher risk internalizing behavior association were weak null score prosocial behavior study corroborates published association prenatal exposure to acetaminophen behavioral problem extends literature to early adolescence	Am J Epidemiol	01/06/2021
10.1126/scitranslmed.adt9100	inhibition enables potential therapy aml degradation xenograft	Ma L; Zhang K; Zhang Z; Wang C; Ma M; Liu Y; Zhao Y; Gong Z; Liu N; Wei M; Liu X; Zhou J; Liu S; Yang C; Yang G	ae fusion protein is key target treating acute myeloid leukemia aml investigation identified protease deubiquitinating enzyme ae knockdown decreased aml cell growth induced differentiation vitro vivo addition developed screening hts method identified potent selective inhibitor lead compound wa identified selective inhibitor targeting domain region also induced aggregation precipitation target protein which led to dysfunction exhibited excellent vivo bioavailability tolerability effectively inhibited growth aml cell animal model addition xenograft pdx model compound when combined improved therapeutic effect study present promising targeted therapeutic possibility treatment aml require further study	Sci Transl Med	24/09/2025
10.1097/JS9.0000000000003527	association dietary intake pancreatic disease mendelian randomization study	Zhang Q; Yu S; Gao D; Gong J	background pancreatic disease including acute pancreatitis chronic pancreatitis pancreatic cancer pose significant health challenge role diet disease is not well understood due to confounding factor observational study objective study aim to clarify causal relationship dietary intake pancreatic disease using mendelian randomization mr method mr approach wa employed utilizing genetic data uk biobank dietary exposure finngen consortium pancreatic disease outcome genetic variant were selected instrumental variable iv to assess impact dietary component acute chronic pancreatitis a well pancreatic cancer were performed to validate finding datasets multivariable mr mvmr analysis assessed independent effect dietary factor result analysis revealed dried fruit intake wa protective acute chronic pancreatitis lt conversely red wine bread were linked to increased acute pancreatitis risk pork wa associated chronic pancreatitis oily fish intake correlated higher risk pancreatic cancer confirmed dried fruit protective association acute pancreatitis mvmr analysis indicated independent causal relationship dried fruit acute chronic pancreatitis conclusion study showed protective effect dried fruit vegetable pancreatic disease red wine bread pork may elevate risk dietary modification could serve effective preventive strategy warranting further exploration underlying mechanism	Int J Surg	24/09/2025
10.1186/s40001-025-03196-w	artificial intelligence healthcare medicine clinical application therapeutic advance future perspective	Fahim YA; Hasani IW; Kabba S; Ragab WM	healthcare system worldwide face growing challenge including rising cost workforce shortage disparity access quality particularly country artificial intelligence ai ha emerged transformative tool capable addressing issue enhancing diagnostics treatment planning patient monitoring healthcare efficiency ai role modern medicine span disease detection personalized care drug discovery predictive analytics telemedicine wearable health technology leveraging machine learning deep learning ai can analyze complex data set including electronic health record medical imaging genomic profile to identify pattern predict disease progression recommend optimized treatment strategy ai also ha potential to promote equity enabling solution remote setting such mobile diagnostics wearable biosensors lightweight algorithm successful deployment requires addressing critical challenge including data privacy algorithmic bias model interpretability regulatory oversight maintaining human clinical oversight emphasizing scalable ethical implementation key strategy include clinician training ai literacy adoption resource efficient tool global collaboration robust regulatory framework to ensure transparency safety accountability complementing rather replacing healthcare professional ai can reduce error optimize resource improve patient outcome expand access to quality care review emphasizes responsible integration ai powerful catalyst innovation sustainability equity healthcare delivery worldwide	Eur J Med Res	23/09/2025
